Parameters
Default parameter values used in simulations.
Alri
Name |
Description |
Type |
Value |
---|---|---|---|
base_inc_rate_ALRI_by_RSV |
baseline incidence rate of Alri caused by RSV in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.165623001012122, 0.0368943809605977, 0.011883807410198] |
base_inc_rate_ALRI_by_Rhinovirus |
baseline incidence of Alri caused by Rhinovirus in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0243368081563306, 0.0564272209432261, 0.0181754025659935] |
base_inc_rate_ALRI_by_HMPV |
baseline incidence of Alri caused by HMPV in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0316242920447732, 0.01106932885584, 0.00356546901880363] |
base_inc_rate_ALRI_by_Parainfluenza |
baseline incidence of Alri caused by Parainfluenza 1-4 in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0400689053941642, 0.0125990679490263, 0.00405820325903094] |
base_inc_rate_ALRI_by_Strep_pneumoniae_PCV13 |
baseline incidence of Alri caused by Streptoccocus pneumoniae PCV13 serotype in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.00839805492638728, 0.0086009815601405, 0.00277040583791159] |
base_inc_rate_ALRI_by_Strep_pneumoniae_non_PCV13 |
baseline incidence of Alri caused by Streptoccocus pneumoniae non PCV13 serotype in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.00971808948465436, 0.0056295094957977, 0.00181328443302487] |
base_inc_rate_ALRI_by_Hib |
baseline incidence of Alri caused by Haemophilus influenzae type b in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.00456369209787862, 0.00223809928508262, 0.000720899502209533] |
base_inc_rate_ALRI_by_H.influenzae_non_type_b |
baseline incidence of Alri caused by Haemophilus influenzae non-type b in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0178046628079453, 0.00771804577106646, 0.00248600917371134] |
base_inc_rate_ALRI_by_Enterobacteriaceae |
baseline incidence of Alri caused by Enterobacteriaceae in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.00577447898013911, 0.00776959582619209, 0.002502613624339] |
base_inc_rate_ALRI_by_other_Strepto_Enterococci |
baseline incidence of Alri caused by other streptococci and Enterococci including Streptococcus pyogenes and Enterococcus faecium in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.00739221008020393, 0.000441075977443103, 0.000142072094251877] |
base_inc_rate_ALRI_by_Staph_aureus |
baseline incidence of Alri caused by Staphylococcus aureus in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0230583713892271, 0.00164959730828988, 0.000531340984878809] |
base_inc_rate_ALRI_by_Influenza |
baseline incidence of Alri caused by Influenza type A, B, and C in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0156895896609387, 0.00577122651203705, 0.00185893197294524] |
base_inc_rate_ALRI_by_P.jirovecii |
baseline incidence of Alri caused by P. jirovecii in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.00532021183938121, 0.00406616141018573, 0.00130972462037058] |
base_inc_rate_ALRI_by_other_viral_pathogens |
baseline incidence of Alri caused by other viral pathogens in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0289052989892286, 0.0340001707821008, 0.0109515723253317] |
base_inc_rate_ALRI_by_other_bacterial_pathogens |
baseline incidence of Alri caused by other viral pathogens in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.0340967151177136, 0.0275272316777052, 0.00886661630515269] |
base_inc_rate_ALRI_by_other_pathogens_NoS |
baseline incidence of Alri caused by other pathogens not otherwise specified in age groups 0-11, 12-23, 24-59 months, per child per year |
List |
[0.012096954443426, 0.0244908799021158, 0.00788859692140824] |
proportion_pneumonia_in_RSV_ALRI |
proportion of RSV-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.469523118748083, 0.493147834326293] |
proportion_pneumonia_in_Rhinovirus_ALRI |
proportion of Rhinovirus-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.233411098940226, 0.300943850285401] |
proportion_pneumonia_in_HMPV_ALRI |
proportion of HMPV-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.514096212711081, 0.607661832402657] |
proportion_pneumonia_in_Parainfluenza_ALRI |
proportion of Parainfluenza-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.381306534835401, 0.586394378700289] |
proportion_pneumonia_in_Strep_pneumoniae_PCV13_ALRI |
proportion of S. pneumoniae PCV13-type-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.419837201436785, 1] |
proportion_pneumonia_in_Strep_pneumoniae_non_PCV13_ALRI |
proportion of S. pneumoniae non PCV13-type-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.584526531211357, 0.47010416567094] |
proportion_pneumonia_in_Hib_ALRI |
proportion of Hib ALRI-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.643816417750475, 0.591228432603006] |
proportion_pneumonia_in_H.influenzae_non_type_b_ALRI |
proportion of H.influenzae non type-b-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.484067635967411, 0.685783925920651] |
proportion_pneumonia_in_Staph_aureus_ALRI |
proportion of S. aureus-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.314311461687961, 0.668460076932899] |
proportion_pneumonia_in_Enterobacteriaceae_ALRI |
proportion of Enterobacteriaceae-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.542743088827561, 0.397386416381317] |
proportion_pneumonia_in_other_Strepto_Enterococci_ALRI |
proportion of other Streptococci- and Enterococci-attributed ALRI manifesting as pneumoniaby age, (based on PERCH CXR+ results) |
List |
[0.794939501527616, 1] |
proportion_pneumonia_in_Influenza_ALRI |
proportion of Influenza-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.274661773216931, 0.477667070122735] |
proportion_pneumonia_in_P.jirovecii_ALRI |
proportion of P. jirovecii-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.773174448993322, 0.650848699225084] |
proportion_pneumonia_in_other_viral_pathogens_ALRI |
proportion of other viral pathogens-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.264286065267648, 0.301616616612727] |
proportion_pneumonia_in_other_bacterial_pathogens_ALRI |
proportion of other bacterial pathogens-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.321708555070697, 0.424616377668989] |
proportion_pneumonia_in_other_pathogens_NoS_ALRI |
proportion of other pathogens NoS-attributed ALRI manifesting as pneumonia by age, (based on PERCH CXR+ results) |
List |
[0.323847892119005, 0.256639724815326] |
rr_ALRI_HIV/AIDS |
relative rate of acquiring Alri for children with HIV+/AIDS |
Real |
6.51 |
rr_ALRI_incomplete_measles_immunisation |
relative rate of acquiring Alri for children with incomplete measles immunisation |
Real |
1.8 |
rr_ALRI_low_birth_weight |
relative rate of acquiring Alri for infants with low birth weight |
Real |
3.6 |
rr_ALRI_non_exclusive_breastfeeding |
relative rate of acquiring Alri for not exclusive breastfeeding upto 6 months |
Real |
2.7 |
rr_ALRI_indoor_air_pollution |
relative rate of acquiring Alri for indoor air pollution |
Real |
1.57 |
prob_viral_pneumonia_bacterial_coinfection |
probability of primary viral pneumonia having a bacterial co-infection |
Real |
0.3 |
proportion_bacterial_coinfection_pathogen |
list of proportions of each bacterial pathogens in a viral/bacterial co-infection pneumonia,the current values used are the pathogen attributable fractions (AFs) from PERCH for all ages. The AFs were scaled to bacterial pathogens only causes - value assumed to be the proportions of bacterial pathogens causing co-/secondary infection |
List |
[0.107, 0.072, 0.038, 0.141, 0.134, 0.117, 0.052, 0.338] |
max_alri_duration_in_days_without_treatment |
maximum duration in days of untreated ALRI episode, assuming an average of 7 days |
Real |
14.0 |
overall_progression_to_severe_ALRI |
probability of progression to severe ALRI |
Real |
0.12 |
prob_pulmonary_complications_in_pneumonia |
probability of pulmonary complications in (CXR+) pneumonia |
Real |
0.215 |
prob_pleural_effusion_in_pulmonary_complicated_pneumonia |
probability of pleural effusion in pneumonia with pulmonary complications |
Real |
0.938 |
prob_empyema_in_pulmonary_complicated_pneumonia |
probability of empyema in pneumonia with pulmonary complications |
Real |
0.315 |
prob_lung_abscess_in_pulmonary_complicated_pneumonia |
probability of lung abscess in pneumonia with pulmonary complications |
Real |
0.049 |
prob_pneumothorax_in_pulmonary_complicated_pneumonia |
probability of pneumothorax in pneumonia with pulmonary complications |
Real |
0.049 |
prob_hypoxaemia_in_pneumonia |
probability of hypoxaemia in pneumonia cases |
Real |
0.479 |
prob_hypoxaemia_in_other_alri |
probability of hypoxaemia in bronchiolitis and other alri cases |
Real |
0.273 |
prob_bacteraemia_in_pneumonia |
probability of bacteraemia in pneumonia |
Real |
0.039 |
prob_progression_to_sepsis_with_bacteraemia |
probability of progression to sepsis from bactereamia |
Real |
0.3 |
proportion_hypoxaemia_with_SpO2<90% |
proportion of hypoxaemic children with SpO2 <90% |
Real |
0.3576 |
scaler_on_risk_of_death |
Multiplicative scaler on the overall risk of death, for the purpose of calibration. |
Real |
0.75 |
base_odds_death_ALRI_age<2mo |
baseline odds of death from ALRI for young infants aged 0 month and severe pneumonia (base group) |
Real |
0.041965 |
or_death_ALRI_age<2mo_very_severe_pneumonia |
odds ratio of death from ALRI for young infants with very severe pneumonia |
Real |
3.994783 |
or_death_ALRI_age<2mo_P.jirovecii |
odds ratio of death from ALRI for young infants with P. jirovecii infection |
Real |
5.460986 |
or_death_ALRI_age<2mo_by_month_increase_in_age |
odds ratio of death from ALRI for young infants by 1 month increase in age (1 month olds) |
Real |
0.6033254 |
base_odds_death_ALRI_age2_59mo |
baseline odds of death from ALRI for children aged 2 months, male, no SAM, and non-severe pneumonia classification (base group) |
Real |
0.0244725 |
or_death_ALRI_age2_59mo_female |
odds ratio of death from ALRI for children who are female |
Real |
1.327285 |
or_death_ALRI_age2_59mo_very_severe_pneumonia |
odds ratio of death from ALRI for children with very severe pneumonia |
Real |
8.382832 |
or_death_ALRI_age2_59mo_P.jirovecii |
odds ratio of death from ALRI for children with P. jirovecii infection |
Real |
13.74696 |
or_death_ALRI_age2_59mo_by_month_increase_in_age |
odds ratio of death from ALRI by 1 month increase in age for 2 to 59 months olds |
Real |
0.9661072 |
or_death_ALRI_age2_59mo_SAM |
odds ratio of death from ALRI for children with severe acute malnutrition |
Real |
7.216448 |
or_death_ALRI_SpO2<90% |
odds ratio of death from ALRI for children with oxygen saturation < 90%, base group: SpO2 <=93% |
Real |
5.04 |
or_death_ALRI_SpO2_90_92% |
odds ratio of death from ALRI for children with oxygen saturation between 09 to 92%, base group: SpO2 <=93% |
Real |
1.54 |
or_death_ALRI_sepsis |
odds ratio of death from ALRI for children with complication of sepsis (compared to if not) |
Real |
151.9 |
or_death_ALRI_pneumothorax |
odds ratio of death from ALRI for children with complication of pneumothorax (compared to if not) |
Real |
77.4 |
prob_cough_in_pneumonia |
probability of cough in pneumonia |
Real |
1.0 |
prob_difficult_breathing_in_pneumonia |
probability of difficulty breathing in pneumonia |
Real |
1.0 |
prob_fever_in_pneumonia |
probability of fever in pneumonia |
Real |
0.82 |
prob_chest_indrawing_in_pneumonia |
probability of chest indrawing in pneumonia |
Real |
0.74 |
prob_tachypnoea_in_pneumonia |
probability of tachypnoea in pneumonia |
Real |
0.834 |
prob_danger_signs_in_pneumonia |
probability of any danger sign in pneumonia, including: : unable to drink, convulsions, cyanosis, head nodding/bobbing, irritability, abnormally sleepy, lethargy, nasal flaring, grunting |
Real |
0.28 |
prob_cough_in_other_alri |
probability of cough in bronchiolitis or other alri |
Real |
1.0 |
prob_difficult_breathing_in_other_alri |
probability of difficulty breathing in bronchiolitis or other alri |
Real |
1.0 |
prob_fever_in_other_alri |
probability of fever in bronchiolitis or other alri |
Real |
0.76 |
prob_tachypnoea_in_other_alri |
probability of tachypnoea in bronchiolitis or other alri |
Real |
0.758 |
prob_chest_indrawing_in_other_alri |
probability of chest wall indrawing in bronchiolitis or other alri |
Real |
0.33 |
prob_danger_signs_in_other_alri |
probability of any danger signs in bronchiolitis or other alri |
Real |
0.3 |
prob_danger_signs_in_sepsis |
probability of any danger signs in ALRI complicated by sepsis |
Real |
1.0 |
prob_danger_signs_in_SpO2<90% |
probability of any danger signs in children with SpO2 <90% |
Real |
0.313 |
prob_danger_signs_in_SpO2_90-92% |
probability of any danger signs in children with SpO2 between 90-92% |
Real |
0.133 |
prob_chest_indrawing_in_SpO2<90% |
probability of chest indrawing in children with SpO2 <90% |
Real |
0.701 |
prob_chest_indrawing_in_SpO2_90-92% |
probability of chest indrawing in children with SpO2 between 90-92% |
Real |
0.445 |
prob_cyanosis_in_other_alri |
probability of cyanosis in bronchiolitis or other alri |
Real |
0.04 |
prob_cyanosis_in_pneumonia |
probability of cyanosis in pneumonia |
Real |
0.06 |
prob_cyanosis_in_SpO2<90% |
probability of cyanosis when SpO2 < 90% |
Real |
0.078 |
rr_Strep_pneum_VT_ALRI_with_PCV13_age<2y |
relative rate of acquiring S. pneumoniae vaccine-type Alri for children under 2 years of age immunised wth PCV13 |
Real |
0.18 |
rr_Strep_pneum_VT_ALRI_with_PCV13_age2to5y |
relative rate of acquiring S. pneumoniae vaccine-type Alri for children aged 2 to 5 immunised wth PCV13 |
Real |
0.32 |
rr_all_strains_Strep_pneum_ALRI_with_PCV13 |
relative rate of acquiring S. pneumoniae all types Alri for children immunised wth PCV13 |
Real |
0.45 |
effectiveness_Hib_vaccine_on_Hib_strains |
effectiveness of Hib vaccine against H. influenzae typ-b ALRI |
Real |
0.86 |
rr_Hib_ALRI_with_Hib_vaccine |
relative rate of acquiring H. influenzae type-b Alri for children immunised wth Hib vaccine |
Real |
0.14 |
days_between_treatment_and_cure |
number of days between any treatment being given in an HSI and the cure occurring. |
Integer |
28 |
tf_1st_line_antibiotic_for_severe_pneumonia |
Risk of treatment failure for a person with danger_signs_pneumonia being treated with first lineintravenous antibiotics |
Real |
0.11 |
rr_tf_1st_line_antibiotics_if_cyanosis |
Relative Risk for treatment failure for persons with danger_signs_pneumonia being treated with first line intravenous antibiotics if the person has the symptom of cyanosis.having that symptom. |
Real |
1.55 |
rr_tf_1st_line_antibiotics_if_SpO2<90% |
Relative Risk for treatment failure for persons with danger_signs_pneumonia being treated with first line intravenous antibiotics if the person has oxygen saturation < 90%. |
Real |
1.28 |
rr_tf_1st_line_antibiotics_if_abnormal_CXR |
Relative Risk for treatment failure for persons with danger_signs_pneumonia being treated with first line intravenous antibiotics if the person has a disease_type of “pneumonia”. |
Real |
1.71 |
rr_tf_1st_line_antibiotics_if_MAM |
Relative Risk for treatment failure for persons with danger_signs_pneumonia being treated with first line intravenous antibiotics if the person has un_clinical_acute_malnutrition == “MAM”. |
Real |
1.48 |
rr_tf_1st_line_antibiotics_if_SAM |
Relative Risk for treatment failure for persons with danger_signs_pneumonia being treated with first line intravenous antibiotics if the person has un_clinical_acute_malnutrition == “SAM”. |
Real |
2.02 |
rr_tf_1st_line_antibiotics_if_HIV/AIDS |
Relative Risk for treatment failure for persons with danger_signs_pneumonia being treated with first line intravenous antibiotics if the person has HIV and is not currently being treated. |
Real |
1.8 |
or_mortality_improved_oxygen_systems |
Odds Ratio for the effect of oxygen provision to a person that needs oxygen who receives it, compares to a patient who does not. N.B. The inverse of this is used to reflect the increase in odds of death for a patient that needs oxygen but does not receive it. |
Real |
0.52 |
tf_3day_amoxicillin_for_fast_breathing_with_SpO2>=90% |
probability of treatment failure by day 6 or relapse by day 14 of 3-day course amoxicillin for treating fast-breathing pneumonia |
Real |
0.101 |
tf_3day_amoxicillin_for_chest_indrawing_with_SpO2>=90% |
probability of treatment failure by day 6 or relapse by day 14 of 3-day course amoxicillin for treating chest-indrawing pneumonia without hypoxaemia (SpO2>=90%) |
Real |
0.125 |
tf_5day_amoxicillin_for_chest_indrawing_with_SpO2>=90% |
probability of treatment failure by day 6 or relapse by day 14 of 5-day course amoxicillin for treating chest-indrawing pneumonia without hypoxaemia (SpO2>=90%) |
Real |
0.108 |
tf_7day_amoxicillin_for_fast_breathing_pneumonia_in_young_infants |
probability of treatment failure by day 6 or relapse by day 14 of 5-day course amoxicillin for treating chest-indrawing pneumonia without hypoxaemia (SpO2>=90%) |
Real |
0.054 |
tf_oral_amoxicillin_only_for_severe_pneumonia_with_SpO2>=90% |
probability of treatment failure by day 2 for oral amoxicillin given to severe pneumonia (danger-signs) without hypoxaemia (SpO2>=93%) |
Real |
0.6 |
tf_oral_amoxicillin_only_for_non_severe_pneumonia_with_SpO2<90% |
probability of treatment failure or relapsefor oral amoxicillin given to non-severe pneumonia (fast-breathing or chest-indrawing) with hypoxaemia (SpO2<90%) |
Real |
0.2826 |
tf_oral_amoxicillin_only_for_severe_pneumonia_with_SpO2<90% |
probability of treatment failure or relapsefor oral amoxicillin given to severe pneumonia (danger-signs) with hypoxaemia (SpO2<90%) |
Real |
0.8 |
tf_2nd_line_antibiotic_for_severe_pneumonia |
probability of treatment failure by end of IV therapy for 2nd line antibiotic either cloxacillin or ceftriaxone to treat severe pneumonia (danger-signs) |
Real |
0.235 |
sensitivity_of_classification_of_fast_breathing_pneumonia_facility_level0 |
sensitivity of correct classification and treatment decision by the HSA trained in iCCM, using paper-based tools, for fast-breathing pneumonia |
Real |
0.7 |
sensitivity_of_classification_of_danger_signs_pneumonia_facility_level0 |
sensitivity of correct classification and referral decision by the HSA trained in iCCM, using paper-based tools, for danger-signs pneumonia |
Real |
0.7 |
sensitivity_of_classification_of_non_severe_pneumonia_facility_level1 |
sensitivity of correct classification and treatment decision for non-severe pneumonia at facility level 1a and 1b |
Real |
0.7 |
sensitivity_of_classification_of_severe_pneumonia_facility_level1 |
sensitivity of correct classification and referral decision for severe pneumonia at facility level 1a and 1b |
Real |
0.7 |
sensitivity_of_classification_of_non_severe_pneumonia_facility_level2 |
sensitivity of correct classification and treatment decision for non-severe pneumonia at facility level 2 |
Real |
0.7 |
sensitivity_of_classification_of_severe_pneumonia_facility_level2 |
sensitivity of correct classification and treatment decision for severe pneumonia at facility level 2 |
Real |
0.7 |
prob_iCCM_severe_pneumonia_treated_as_fast_breathing_pneumonia |
probability of misdiagnosis of iCCM severe pneumonia (with chest-indrawing or danger signs) given treatment for non-severe pneumonia (fast-breathing) at facility level O |
Real |
0.7 |
prob_IMCI_severe_pneumonia_treated_as_non_severe_pneumonia |
probability of misdiagnosis of IMCI severe pneumonia (with danger signs) given treatment for non-severe pneumonia ( fast-breathing or chest-indrawing) at facility level 1a/1b/2 |
Real |
0.7 |
or_care_seeking_perceived_severe_illness |
The Odds Ratio for healthcare seeking for the symptom of chest-indrawing |
Real |
2.4 |
pulse_oximeter_and_oxygen_is_available |
Control the availability of the pulse oximeter and oxygen. “Default” does not over-ride availability; “Yes” forces them to be available; “No” forces them to not be available |
Categorical |
Default |
prob_for_followup_if_treatment_failure |
The probability for scheduling a follow-up appointment following treatment failure |
Real |
0.3 |
BladderCancer
Name |
Description |
Type |
Value |
---|---|---|---|
init_prop_bladder_cancer_stage |
initial proportions in bladder cancer categories for person aged 15-19 and no tobacco and no schisto_h |
List |
[5e-05, 5e-05, 5e-05] |
init_prop_blood_urine_bladder_cancer_by_stage |
initial proportions of those with bladder cancer categories that have the symptom blood urine |
List |
[0.2, 0.5, 0.7] |
init_prop_pelvic_pain_bladder_cancer_by_stage |
initial proportions of those with bladder cancer categories that have pelvic pain |
List |
[0.0, 0.3, 0.5] |
init_prop_with_blood_urine_diagnosed_bladder_cancer_by_stage |
initial proportions of people that have symptom of blood urine that have been diagnosed |
List |
[0.7, 0.9, 0.9] |
init_prop_with_pelvic_pain_diagnosed_bladder_cancer_by_stage |
initial proportions of people that have symptom of pelvic pain that have been diagnosed |
List |
[0.0, 0.7, 0.9] |
init_prop_treatment_status_bladder_cancer |
initial proportions of people with bladder cancer that had initiated treatment |
List |
[0.05, 0.05, 0.05] |
init_prob_palliative_care |
initial probability of being under palliative care if in metastatic |
Real |
0.95 |
r_tis_t1_bladder_cancer_none |
probability per 3 months of incident tis_t1 bladder cancer, amongst people with no bladder cancer(for person aged 15-19 and no tobacco and no schisto_h) |
Real |
1e-05 |
rr_tis_t1_bladder_cancer_none_age3049 |
rate ratio for tis_t1 bladder cancer for age 30-49 |
Real |
2.0 |
rr_tis_t1_bladder_cancer_none_age5069 |
rate ratio for tis_t1 bladder cancer for age 50-69 |
Real |
3.0 |
rr_tis_t1_bladder_cancer_none_agege70 |
rate ratio for tis_t1 bladder cancer for age 70+ |
Real |
3.0 |
rr_tis_t1_bladder_cancer_none_tobacco |
rate ratio for tis_t1 bladder cancer for tobacco smokers |
Real |
3.5 |
rr_tis_t1_bladder_cancer_none_schisto_h |
rate ratio for tis_t1 bladder cancer for schisto_h |
Real |
5.0 |
r_t2p_bladder_cancer_tis_t1 |
probability per 3 months of t2+ bladder cancer, amongst people with tis_t1 bladder cancer |
Real |
0.05 |
rr_t2p_bladder_cancer_undergone_curative_treatment |
rate ratio for t2+ bladder cancer for people with tis_t1 bladder cancer if had curative treatment at tis_t1 bladder cancer stage |
Real |
0.1 |
r_metastatic_t2p_bladder_cancer |
probability per 3 months of metastatic bladder cancer amongst people with t2+ bladder cancer |
Real |
0.05 |
rr_metastatic_undergone_curative_treatment |
rate ratio for metastatic bladder cancer for people with t2+ bladder cancer if had curative treatment at t2+ bladder cancer stage |
Real |
0.2 |
rate_palliative_care_metastatic |
prob palliative care this 3 month period if metastatic bladder cancer |
Real |
0.2 |
r_death_bladder_cancer |
probability per 3 months of death from bladder cancer amongst people with metastatic bladder cancer |
Real |
0.05 |
r_blood_urine_tis_t1_bladder_cancer |
probability per 3 months of blood_urine in a person with tis_t1 bladder cancer |
Real |
0.01 |
rr_blood_urine_t2p_bladder_cancer |
rate ratio for blood_urine if have t2p bladder cancer |
Real |
3.0 |
rr_blood_urine_metastatic_bladder_cancer |
rate ratio for blood_urine if have metastatic bladder cancer |
Real |
3.0 |
r_pelvic_pain_tis_t1_bladder_cancer |
probability per 3 months of pelvic_pain in a person with tis_t1 bladder cancer |
Real |
0.0003 |
rr_pelvic_pain_t2p_bladder_cancer |
rate ratio for pelvic_pain if have t2p bladder cancer |
Real |
200.0 |
rr_pelvic_pain_metastatic_bladder_cancer |
rate ratio for pelvic_pain if have metastatic bladder cancer |
Real |
300.0 |
rp_bladder_cancer_age3049 |
relative prevalence at baseline of bladder cancer/cancer age 30-49 |
Real |
2.0 |
rp_bladder_cancer_age5069 |
relative prevalence at baseline of bladder cancer/cancer age 50-69 |
Real |
3.0 |
rp_bladder_cancer_agege70 |
relative prevalence at baseline of bladder cancer/cancer age 70+ |
Real |
3.0 |
rp_bladder_cancer_tobacco |
relative prevalence at baseline of bladder cancer if tobacco |
Real |
3.5 |
rp_bladder_cancer_schisto_h |
relative prevalence at baseline of bladder cancer if schisto_h |
Real |
5.0 |
sensitivity_of_cystoscopy_for_bladder_cancer_blood_urine |
sensitivity of cystoscopy_for diagnosis of bladder cancer given blood urine |
Real |
1.0 |
sensitivity_of_cystoscopy_for_bladder_cancer_pelvic_pain |
sensitivity of cystoscopy_for diagnosis of bladder cancer given pelvic pain |
Real |
1.0 |
BreastCancer
Name |
Description |
Type |
Value |
---|---|---|---|
init_prop_breast_cancer_stage |
initial proportions in cancer categories for woman aged 15-29 |
List |
[5e-05, 5e-05, 5e-05, 1.5e-05] |
init_prop_breast_lump_discernible_breast_cancer_by_stage |
initial proportions of those with cancer categories that have the symptom breast_lump_discernible |
List |
[0.5, 0.8, 0.9, 0.98] |
init_prop_with_breast_lump_discernible_diagnosed_breast_cancer_by_stage |
initial proportions of people that have breast_lump_discernible that have been diagnosed |
List |
[0.9, 0.9, 0.9, 0.9] |
init_prop_treatment_status_breast_cancer |
initial proportions of people with breast cancer previously treated |
List |
[0.1, 0.1, 0.1, 0.1] |
init_prob_palliative_care |
initial probability of being under palliative care if in stage 4 |
Real |
0.8 |
r_stage1_none |
probabilty per 3 months of incident stage 1 breast, amongst people with no breast cancer |
Real |
2e-06 |
rr_stage1_none_age3049 |
rate ratio for stage1 breast cancer for age 30-49 |
Real |
20.0 |
rr_stage1_none_agege50 |
rate ratio for stage1 breast cancer for age 50+ |
Real |
20.0 |
r_stage2_stage1 |
probabilty per 3 months of stage 2 breast cancer amongst people with stage 1 |
Real |
0.15 |
rr_stage2_undergone_curative_treatment |
rate ratio for stage 2 breast cancer for people with stage 1 breast cancer if had curative treatment at stage 1 |
Real |
0.05 |
r_stage3_stage2 |
probabilty per 3 months of stage 3 breast cancer amongst people with stage 2 |
Real |
0.15 |
rr_stage3_undergone_curative_treatment |
rate ratio for stage 3 breast cancer for people with stage 2 breast cancer if had curative treatment at stage 2 |
Real |
0.05 |
r_stage4_stage3 |
probabilty per 3 months of stage 4 breast cancer amongst people with stage 3 |
Real |
0.15 |
rr_stage4_undergone_curative_treatment |
rate ratio for stage 4 breast cancer for people with stage 3 breast cancer if had curative treatment at stage 3 |
Real |
0.5 |
r_death_breast_cancer |
probabilty per 3 months of death from breast cancer amongst people with stage 4 breast cancer |
Real |
0.1 |
r_breast_lump_discernible_stage1 |
rate ratio for breast_lump_discernible if have stage 1 breast cancer |
Real |
0.05 |
rr_breast_lump_discernible_stage2 |
rate ratio for breast_lump_discernible if have stage 2 breast cancer |
Real |
2.0 |
rr_breast_lump_discernible_stage3 |
rate ratio for breast_lump_discernible if have stage 3 breast cancer |
Real |
4.0 |
rr_breast_lump_discernible_stage4 |
rate ratio for breast_lump_discernible if have stage 4 breast cancer |
Real |
10.0 |
rp_breast_cancer_age3049 |
relative prevalence at baseline of breast cancer if age3049 |
Real |
20.0 |
rp_breast_cancer_agege50 |
relative prevalence at baseline of breast cancer if agege50 |
Real |
20.0 |
sensitivity_of_biopsy_for_stage1_breast_cancer |
sensitivity of biopsy_for diagnosis of stage 1 breast cancer |
Real |
0.8 |
sensitivity_of_biopsy_for_stage2_breast_cancer |
sensitivity of biopsy_for diagnosis of stage 2 breast cancer |
Real |
0.95 |
sensitivity_of_biopsy_for_stage3_breast_cancer |
sensitivity of biopsy_for diagnosis of stage 3 breast cancer |
Real |
0.95 |
sensitivity_of_biopsy_for_stage4_breast_cancer |
sensitivity of biopsy_for diagnosis of stage 4 breast cancer |
Real |
0.95 |
CardioMetabolicDisorders
Name |
Description |
Type |
Value |
---|---|---|---|
diabetes_onset |
all the parameters that specify the linear models for onset of diabetes |
Series |
|
hypertension_onset |
all the parameters that specify the linear models for onset of hypertension |
Series |
|
chronic_kidney_disease_onset |
all the parameters that specify the linear models for onset of chronic_kidney_disease |
Series |
|
chronic_lower_back_pain_onset |
all the parameters that specify the linear models for onset of chronic_lower_back_pain |
Series |
|
chronic_ischemic_hd_onset |
all the parameters that specify the linear models for onset of chronic_ischemic_hd |
Series |
|
diabetes_removal |
all the parameters that specify the linear models for removal of diabetes |
Series |
|
hypertension_removal |
all the parameters that specify the linear models for removal of hypertension |
Series |
|
chronic_kidney_disease_removal |
all the parameters that specify the linear models for removal of chronic_kidney_disease |
Series |
|
chronic_lower_back_pain_removal |
all the parameters that specify the linear models for removal of chronic_lower_back_pain |
Series |
|
chronic_ischemic_hd_removal |
all the parameters that specify the linear models for removal of chronic_ischemic_hd |
Series |
|
diabetes_hsi |
all the parameters that specify diagnostic tests and treatments for diabetes |
Series |
|
hypertension_hsi |
all the parameters that specify diagnostic tests and treatments for hypertension |
Series |
|
chronic_kidney_disease_hsi |
all the parameters that specify diagnostic tests and treatments for chronic_kidney_disease |
Series |
|
chronic_lower_back_pain_hsi |
all the parameters that specify diagnostic tests and treatments for chronic_lower_back_pain |
Series |
|
chronic_ischemic_hd_hsi |
all the parameters that specify diagnostic tests and treatments for chronic_ischemic_hd |
Series |
|
ever_stroke_onset |
all the parameters that specify the linear models for onset of ever_stroke |
Series |
|
ever_heart_attack_onset |
all the parameters that specify the linear models for onset of ever_heart_attack |
Series |
|
diabetes_death |
all the parameters that specify the linear models for death from diabetes |
Series |
|
hypertension_death |
all the parameters that specify the linear models for death from hypertension |
Series |
|
chronic_kidney_disease_death |
all the parameters that specify the linear models for death from chronic_kidney_disease |
Series |
|
chronic_lower_back_pain_death |
all the parameters that specify the linear models for death from chronic_lower_back_pain |
Series |
|
chronic_ischemic_hd_death |
all the parameters that specify the linear models for death from chronic_ischemic_hd |
Series |
|
ever_stroke_death |
all the parameters that specify the linear models for death from ever_stroke |
Series |
|
ever_heart_attack_death |
all the parameters that specify the linear models for death from ever_heart_attack |
Series |
|
ever_stroke_hsi |
all the parameters that specify diagnostic tests and treatments for ever_stroke |
Series |
|
ever_heart_attack_hsi |
all the parameters that specify diagnostic tests and treatments for ever_heart_attack |
Series |
|
diabetes_initial_prev |
initial prevalence of condition |
Series |
|
hypertension_initial_prev |
initial prevalence of condition |
Series |
|
chronic_kidney_disease_initial_prev |
initial prevalence of condition |
Series |
|
chronic_lower_back_pain_initial_prev |
initial prevalence of condition |
Series |
|
chronic_ischemic_hd_initial_prev |
initial prevalence of condition |
Series |
|
interval_between_polls |
months between the main polling event |
Integer |
3 |
pr_bmi_reduction |
probability of an individual having a reduction in BMI following weight loss treatment |
Real |
0.1 |
prob_care_provided_given_seek_emergency_care |
The probability that correct care is fully provided to persons that have sought emergency care for a Cardio-metabolic disorder. |
Real |
0.5 |
diabetes_onset
value |
---|
1.15 |
0 |
0 |
0 |
0 |
1 |
1 |
1.6 |
2.21538 |
Only first 10 rows of 67 are shown.
hypertension_onset
value |
---|
0.95 |
0 |
0 |
0 |
0 |
0.337838 |
1.00338 |
1.00338 |
1 |
Only first 10 rows of 67 are shown.
chronic_kidney_disease_onset
value |
---|
1.25 |
0 |
0 |
0 |
0 |
0.515464 |
0.515464 |
0.515464 |
1 |
Only first 10 rows of 67 are shown.
chronic_lower_back_pain_onset
value |
---|
1 |
0 |
0 |
0 |
0 |
0.69 |
1 |
1.44615 |
2.21538 |
Only first 10 rows of 67 are shown.
chronic_ischemic_hd_onset
value |
---|
2.3 |
0 |
0 |
0 |
0 |
0.140136 |
1 |
1 |
1 |
Only first 10 rows of 67 are shown.
diabetes_removal
value |
---|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Only first 10 rows of 67 are shown.
hypertension_removal
value |
---|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Only first 10 rows of 67 are shown.
chronic_kidney_disease_removal
value |
---|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Only first 10 rows of 67 are shown.
chronic_lower_back_pain_removal
value |
---|
0.8 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
Only first 10 rows of 67 are shown.
chronic_ischemic_hd_removal
value |
---|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Only first 10 rows of 67 are shown.
diabetes_hsi
value |
---|
216 |
1 |
233 |
0.1 |
0.42 |
0.3846 |
0.8 |
hypertension_hsi
value |
---|
1 |
221 |
0.05 |
0 |
0.3797 |
0.8 |
chronic_kidney_disease_hsi
value |
---|
47 |
1 |
2064 |
0 |
0 |
0.02 |
0.8 |
chronic_lower_back_pain_hsi
value |
---|
1 |
226 |
0 |
0 |
0 |
0.1 |
chronic_ischemic_hd_hsi
value |
---|
1 |
226 |
0 |
0 |
0.05 |
0.8 |
ever_stroke_onset
value |
---|
0.9 |
0 |
0 |
0 |
0 |
0.15 |
0.15 |
0.15 |
0.17 |
Only first 10 rows of 67 are shown.
ever_heart_attack_onset
value |
---|
1.5 |
0 |
0 |
0 |
0 |
0.05 |
0.05 |
0.05 |
0.05 |
Only first 10 rows of 67 are shown.
diabetes_death
value |
---|
3.2 |
0 |
0 |
0 |
0 |
0.2 |
0.2 |
0.25 |
0.25 |
Only first 10 rows of 67 are shown.
hypertension_death
value |
---|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Only first 10 rows of 67 are shown.
chronic_kidney_disease_death
value |
---|
2.2 |
0 |
0 |
0 |
0 |
0.25 |
0.2 |
0.2 |
0.3 |
Only first 10 rows of 67 are shown.
chronic_lower_back_pain_death
value |
---|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Only first 10 rows of 67 are shown.
chronic_ischemic_hd_death
value |
---|
1.4 |
0 |
0 |
0 |
0 |
0.673277 |
0.673277 |
0.615122 |
0.641215 |
Only first 10 rows of 67 are shown.
ever_stroke_death
value |
---|
1 |
0 |
0 |
0 |
0 |
0.2 |
0.2 |
0.35 |
0.35 |
Only first 10 rows of 67 are shown.
ever_heart_attack_death
value |
---|
1.8 |
0 |
0 |
0 |
0 |
0.1 |
0.1 |
0.15 |
0.15 |
Only first 10 rows of 67 are shown.
ever_stroke_hsi
value |
---|
1 |
226 |
0 |
234 |
0.59 |
ever_heart_attack_hsi
value |
---|
1 |
226 |
0 |
225 |
0.481 |
diabetes_initial_prev
value |
---|
0 |
0 |
0 |
0.00168696 |
0.00168696 |
0.0100913 |
0.0100913 |
0.0203044 |
0.0203044 |
Only first 10 rows of 42 are shown.
hypertension_initial_prev
value |
---|
0 |
0 |
0 |
0.0468696 |
0.0468696 |
0.101778 |
0.101778 |
0.128891 |
0.128891 |
Only first 10 rows of 42 are shown.
chronic_kidney_disease_initial_prev
value |
---|
0 |
0 |
0 |
0.0003 |
0.0003 |
0.0009 |
0.0009 |
0.0033 |
0.0033 |
Only first 10 rows of 42 are shown.
chronic_lower_back_pain_initial_prev
value |
---|
0.0053 |
0.0229 |
0.0341 |
0.0411 |
0.0534 |
0.0657 |
0.0819 |
0.0973 |
0.1095 |
Only first 10 rows of 42 are shown.
chronic_ischemic_hd_initial_prev
value |
---|
0 |
0 |
0.0001 |
0.0005 |
0.0015 |
0.0033 |
0.0065 |
0.0125 |
0.0225 |
Only first 10 rows of 42 are shown.
CareOfWomenDuringPregnancy
Name |
Description |
Type |
Value |
---|---|---|---|
prob_seek_anc2 |
Probability a woman who is not predicted to attended four or more ANC visits will attend ANC2 |
List |
[0.98, 0.98] |
prob_seek_anc3 |
Probability a woman who is not predicted to attended four or more ANC visits will attend ANC3 |
List |
[0.55, 0.55] |
prob_seek_anc5 |
Probability a woman who is predicted to attend four or more ANC visits will attend ANC5 |
List |
[0.125, 0.125] |
prob_seek_anc6 |
Probability a woman who is predicted to attend four or more ANC visits will attend ANC6 |
List |
[0.0625, 0.0625] |
prob_seek_anc7 |
Probability a woman who is predicted to attend four or more ANC visits will attend ANC7 |
List |
[0.03125, 0.03125] |
prob_seek_anc8 |
Probability a woman who is predicted to attend four or more ANC visits will attend ANC8 |
List |
[0.03125, 0.03125] |
effect_of_ifa_for_resolving_anaemia |
treatment effectiveness of starting iron and folic acid on resolving anaemia |
List |
[0.7, 0.7] |
treatment_effect_blood_transfusion_anaemia |
treatment effectiveness of blood transfusion for anaemia in pregnancy |
List |
[0.9, 0.9] |
prob_intervention_delivered_urine_ds |
probability a woman will receive the intervention “urine dipstick” given that the HSI has ran and the consumables are available (proxy for clinical quality) |
List |
[0.53, 0.53] |
prob_intervention_delivered_bp |
probability a woman will receive the intervention “blood pressure measurement” given that the HSI has ran and the consumables are available (proxy for clinical quality) |
List |
[0.7, 0.69] |
prob_adherent_ifa |
probability a woman who is given iron and folic acid will adhere to the treatment for their pregnancy |
List |
[0.37, 0.34] |
prob_intervention_delivered_syph_test |
probability a woman will receive the intervention “Syphilis test” given that the HSI has ran and the consumables are available (proxy for clinical quality) |
List |
[0.43, 0.14] |
prob_intervention_delivered_gdm_test |
probability a woman will receive the intervention “GDM screening” given that the HSI has ran and the consumables are available (proxy for clinical quality) |
List |
[0.48, 0.48] |
prob_delivery_modes_ec |
probabilities that a woman admitted with eclampsia will deliver normally, via caesarean or via assisted vaginal delivery |
List |
[[0, 0, 1], [0, 0, 1]] |
prob_delivery_modes_spe |
probabilities that a woman admitted with severe pre-eclampsia will deliver normally, via caesarean or via assisted vaginal delivery |
List |
[[0.05, 0.05, 0.9], [0.05, 0.05, 0.9]] |
sensitivity_bp_monitoring |
sensitivity of blood pressure monitoring to detect hypertension |
List |
[0.74, 0.74] |
specificity_bp_monitoring |
specificity of blood pressure monitoring to detect hypertension |
List |
[0.79, 0.79] |
sensitivity_urine_protein_1_plus |
sensitivity of a urine dipstick test to detect proteinuria at 1+ |
List |
[0.541, 0.541] |
specificity_urine_protein_1_plus |
specificity of a urine dipstick test to detect proteinuria at 1+ |
List |
[0.841, 0.841] |
sensitivity_poc_hb_test |
sensitivity of a point of care Hb test to detect anaemia |
List |
[0.851, 0.851] |
specificity_poc_hb_test |
specificity of a point of care Hb test to detect anaemia |
List |
[0.801, 0.801] |
sensitivity_fbc_hb_test |
sensitivity of a Full Blood Count test to detect anaemia |
List |
[1.0, 1.0] |
specificity_fbc_hb_test |
specificity of a Full Blood Count test to detect anaemia |
List |
[1.0, 1.0] |
sensitivity_blood_test_glucose |
sensitivity of a blood test to detect raised blood glucose |
List |
[1.0, 1.0] |
specificity_blood_test_glucose |
specificity of a blood test to detect raised blood glucose |
List |
[1.0, 1.0] |
sensitivity_blood_test_syphilis |
sensitivity of a blood test to detect syphilis |
List |
[0.82, 0.82] |
specificity_blood_test_syphilis |
specificity of a blood test to detect syphilis |
List |
[0.96, 0.96] |
Contraception
Name |
Description |
Type |
Value |
---|---|---|---|
Method_Use_In_2010 |
Proportion of women using each method in 2010, by age. |
Dataframe |
|
Pregnancy_NotUsing_In_2010 |
Probability per year of a women not on contraceptive becoming pregnant, by age. |
Dataframe |
|
Pregnancy_NotUsing_HIVeffect |
Relative probability of becoming pregnant whilst not using a a contraceptive for HIV-positive women compared to HIV-negative women. |
Dataframe |
|
Failure_ByMethod |
Probability per month of a women on a contraceptive becoming pregnant, by method. |
Dataframe |
|
rr_fail_under25 |
The relative risk of becoming pregnant whilst using a contraceptive for woman younger than 25 years compared to older women. |
Real |
2.2 |
Initiation_ByMethod |
Probability per month of a women who is not using any contraceptive method of starting use of a method, by method. |
Dataframe |
|
Interventions_Pop |
Pop (population scale contraception intervention) intervention multiplier. |
Dataframe |
|
Interventions_PPFP |
PPFP (post-partum family planning) intervention multiplier. |
Dataframe |
|
Initiation_ByAge |
The effect of age on the probability of starting use of contraceptive (add one for multiplicative effect). |
Dataframe |
|
Initiation_AfterBirth |
The probability of a woman starting a contraceptive immidiately after birth, by method. |
Dataframe |
|
Discontinuation_ByMethod |
The probability per month of discontinuing use of a method, by method. |
Dataframe |
|
Discontinuation_ByAge |
The effect of age on the probability of discontinuing use of contraceptive (add one for multiplicative effect). |
Dataframe |
|
Prob_Switch_From |
The probability per month that a women switches from one form of contraceptive to another, conditional that she will not discontinue use of the method. |
Dataframe |
|
Prob_Switch_From_And_To |
The probability of switching to a new method, by method, conditional that the woman will switch to a new method. |
Dataframe |
|
days_between_appts_for_maintenance |
The number of days between successive family planning appointments for women that are maintaining the use of a method (for each method insorted(self.states_that_may_require_HSI_to_maintain_on), i.e.[IUD, implant, injections, other_modern, pill]). |
List |
[4383, 1461, 91, 91, 91, 91] |
age_specific_fertility_rates |
Data table from official source (WPP) for age-specific fertility rates and calendar period. |
Dataframe |
|
scaling_factor_on_monthly_risk_of_pregnancy |
Scaling factor (by age-group: 15-19, 20-24, …, 45-49) on the monthly risk of pregnancy and contraceptive failure rate. This value is found through calibration so that, at the beginning of the simulation, the age-specific monthly probability of a woman having a live birth matches the WPP age-specific fertility rate value for the same year. |
List |
[1.227, 0.7191, 0.6632, 0.84945, 0.86135, 0.645, 0.941] |
max_number_of_runs_of_hsi_if_consumable_not_available |
The maximum number of time an HSI can run (repeats occur if the consumables are not available). |
Integer |
1000 |
max_days_delay_between_decision_to_change_method_and_hsi_scheduled |
The maximum delay (in days) between the decision for a contraceptive to change and the topen date of the HSI that is scheduled to effect the change (when using the healthsystem). |
Integer |
7 |
use_interventions |
if True: FP interventions (pop & ppfp) are simulated from the date ‘interventions_start_date’, if False: FP interventions (pop & ppfp) are not simulated. |
Boolean |
False |
interventions_start_date |
The date since which the FP interventions (pop & ppfp) are implemented, if at all (ie, if use_interventions==True |
Date |
2023-01-01 00:00:00 |
Method_Use_In_2010
age |
not_using |
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|---|---|
16 |
0.956447 |
0 |
0.000853971 |
0.0187874 |
0 |
0.0204953 |
0 |
0 |
0.00256191 |
0 |
0.000853971 |
17 |
0.917373 |
0.00105932 |
0 |
0.0413136 |
0 |
0.0275424 |
0 |
0 |
0.00317797 |
0.00741525 |
0.00105932 |
18 |
0.843715 |
0.00679502 |
0 |
0.103058 |
0 |
0.0396376 |
0 |
0 |
0 |
0.00566251 |
0 |
19 |
0.738693 |
0.0188442 |
0 |
0.182161 |
0 |
0.0376884 |
0 |
0 |
0.00125628 |
0.0138191 |
0.00251256 |
20 |
0.693305 |
0.0107991 |
0 |
0.218143 |
0 |
0.0410367 |
0.00431965 |
0 |
0.00215983 |
0.0215983 |
0.00323974 |
21 |
0.644362 |
0.0173482 |
0.00123916 |
0.272615 |
0 |
0.0371747 |
0.00123916 |
0 |
0.00123916 |
0.00743494 |
0.00619579 |
22 |
0.634744 |
0.018931 |
0 |
0.26392 |
0 |
0.0356347 |
0.00445434 |
0 |
0.00556793 |
0.0155902 |
0.00668151 |
23 |
0.642616 |
0.00676437 |
0.00225479 |
0.264938 |
0 |
0.0394588 |
0.00338219 |
0 |
0.00789177 |
0.0124014 |
0.00676437 |
24 |
0.588101 |
0.020595 |
0.00114416 |
0.286041 |
0 |
0.0297483 |
0.0125858 |
0 |
0.00800915 |
0.0228833 |
0.00915332 |
Only first 10 rows of 35 are shown.
Pregnancy_NotUsing_In_2010
age |
AnnualProb |
---|---|
16 |
0.0780862 |
17 |
0.148498 |
18 |
0.298088 |
19 |
0.402345 |
20 |
0.532862 |
21 |
0.552413 |
22 |
0.586474 |
23 |
0.569371 |
24 |
0.598742 |
Only first 10 rows of 35 are shown.
Pregnancy_NotUsing_HIVeffect
RR_pregnancy |
|
---|---|
16 |
1.4 |
17 |
1.4 |
18 |
1.4 |
19 |
1.4 |
20 |
0.9 |
21 |
0.9 |
22 |
0.9 |
23 |
0.9 |
24 |
0.9 |
Only first 10 rows of 35 are shown.
Failure_ByMethod
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|
0.00192848 |
0 |
0.000530667 |
9.50789e-05 |
0.00117109 |
0 |
0 |
0.000552797 |
0.00358032 |
0.004923 |
Initiation_ByMethod
not_using |
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|---|
0.993934 |
0.000397942 |
1.84759e-05 |
0.00382829 |
0.000117488 |
0.000793041 |
0.000274295 |
2.5582e-05 |
9.2853e-05 |
0.000358621 |
0.000159177 |
Interventions_Pop
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|
2.5 |
11 |
1.6 |
8 |
2.6 |
2 |
5 |
1 |
1 |
1 |
Interventions_PPFP
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|
2.5 |
11 |
1.6 |
8 |
2.6 |
2 |
5 |
1 |
1 |
1 |
Initiation_ByAge
age |
r_init1_age |
---|---|
16 |
0.224538 |
17 |
0.147192 |
18 |
0.089718 |
19 |
0.0469456 |
20 |
0.0151724 |
21 |
-0.00829227 |
22 |
-0.0254293 |
23 |
-0.0377144 |
24 |
-0.0462588 |
Only first 10 rows of 35 are shown.
Initiation_AfterBirth
not_using |
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|---|
0.99654 |
0.000224019 |
5.84398e-06 |
0.00180189 |
5.06478e-05 |
0.000210383 |
0.000718809 |
1.1688e-05 |
0.000105192 |
0.000181163 |
0.000149995 |
Discontinuation_ByMethod
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|
0.0496232 |
0.0111009 |
0.0333511 |
0.00627062 |
0.0503725 |
0 |
0.0332874 |
0.0422692 |
0.0423377 |
0.0497931 |
Discontinuation_ByAge
age |
r_discont_age |
---|---|
16 |
-0.628712 |
17 |
-0.438627 |
18 |
-0.29471 |
19 |
-0.185198 |
20 |
-0.101633 |
21 |
-0.037841 |
22 |
0.0107489 |
23 |
0.0475587 |
24 |
0.0751794 |
Only first 10 rows of 35 are shown.
Prob_Switch_From
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|
0.0109093 |
0.00145124 |
0.0030322 |
0.000862686 |
0.0114341 |
0 |
0.00265503 |
0.00751371 |
0.0137878 |
0.027214 |
Prob_Switch_From_And_To
switchfrom |
pill |
IUD |
injections |
implant |
male_condom |
female_sterilization |
other_modern |
periodic_abstinence |
withdrawal |
other_traditional |
---|---|---|---|---|---|---|---|---|---|---|
pill |
0 |
0 |
0.540323 |
0.217742 |
0.104839 |
0.0564516 |
0.0241935 |
0.00806452 |
0.0403226 |
0.00806452 |
IUD |
0.125 |
0 |
0.375 |
0.25 |
0.125 |
0.125 |
0 |
0 |
0 |
0 |
injections |
0.262806 |
0.0267261 |
0 |
0.447661 |
0.106904 |
0.0757238 |
0.00890869 |
0.00890869 |
0.0445434 |
0.0178174 |
implant |
0.205882 |
0.0294118 |
0.632353 |
0 |
0.102941 |
0.0294118 |
0 |
0 |
0 |
0 |
male_condom |
0.0829268 |
0.00487805 |
0.595122 |
0.22439 |
0 |
0.0292683 |
0.00487805 |
0.0097561 |
0.0487805 |
0 |
other_modern |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
periodic_abstinence |
0 |
0 |
0.333333 |
0.666667 |
0 |
0 |
0 |
0 |
0 |
0 |
withdrawal |
0.037037 |
0.0185185 |
0.518519 |
0.296296 |
0.111111 |
0.0185185 |
0 |
0 |
0 |
0 |
other_traditional |
0 |
0 |
0.73913 |
0.144928 |
0.057971 |
0.057971 |
0 |
0 |
0 |
0 |
age_specific_fertility_rates
Variant |
Period |
Age_Grp |
asfr |
---|---|---|---|
WPP_Estimates |
1955-1959 |
15-19 |
0.183883 |
WPP_Estimates |
1960-1964 |
15-19 |
0.186647 |
WPP_Estimates |
1965-1969 |
15-19 |
0.191979 |
WPP_Estimates |
1970-1974 |
15-19 |
0.197259 |
WPP_Estimates |
1975-1979 |
15-19 |
0.202538 |
WPP_Estimates |
1980-1984 |
15-19 |
0.202538 |
WPP_Estimates |
1985-1989 |
15-19 |
0.193211 |
WPP_Estimates |
1990-1994 |
15-19 |
0.159343 |
WPP_Estimates |
1995-1999 |
15-19 |
0.160904 |
Only first 10 rows of 434 are shown.
Copd
Name |
Description |
Type |
Value |
---|---|---|---|
prob_mod_exacerb |
probability of moderate exacerbation given lung function, for each lung function category. |
List |
[0, 0, 0, 0.01, 0.05, 0.2, 0.3] |
prob_sev_exacerb |
probability of severe exacerbation given lung function, for each lung function category. |
List |
[0, 0, 0, 0.0, 0.0, 0.05, 0.1] |
prob_progress_to_next_cat |
probability of changing from a lower lung function category to a higher lung function category |
Real |
0.015 |
prob_will_die_sev_exacerbation_ge80 |
probability that a person equal to or greater than 80 years will die of severe exacerbation |
Real |
0.95 |
prob_will_die_sev_exacerbation_7079 |
probability that a person between 70 to 79 years will die of severe exacerbation |
Real |
0.7 |
prob_will_die_sev_exacerbation_6069 |
probability that a person between 60 to 99 years will die of severe exacerbation |
Real |
0.5 |
prob_will_die_sev_exacerbation_5059 |
probability that a person between 50 to 59 years will die of severe exacerbation |
Real |
0.05 |
prob_will_die_sev_exacerbation_4049 |
probability that a person between 40 to 49 years will die of severe exacerbation |
Real |
0.02 |
prob_will_die_sev_exacerbation_3039 |
probability that a person between 30 to 39 years will die of severe exacerbation |
Real |
0.01 |
prob_will_die_sev_exacerbation_lt30 |
probability that a person less than 30 years will die of severe exacerbation |
Real |
0.0 |
eff_oxygen |
the effect of oxygen on individuals with severe exacerbation |
Real |
0.6 |
rel_risk_progress_per_higher_cat |
relative risk of progression to the next higher level of lung function for each higher level |
Real |
0.5 |
rel_risk_tob |
relative effect of tobacco on the rate of lung function progression |
Real |
7.0 |
rel_risk_wood_burn_stove |
relative risk of wood burn stove on the rate of lung function progression |
Real |
2.0 |
prob_not_tob_lung_func_15_39 |
probability of lung function categories in individuals aged 15-39 and do not smoke tobacco |
List |
[0.496396, 0.337947, 0.114555, 0.040078, 0.010086, 0.000938, 0.0] |
prob_not_tob_lung_func_40_59 |
probability of lung function categories in individuals aged 40-59 and do not smoke tobacco |
List |
[0.114194, 0.306129, 0.292286, 0.212143, 0.067501, 0.007387, 0.00036] |
prob_not_tob_lung_func_gr59 |
probability of lung function categories in individuals aged 60+ and do not smoke tobacco |
List |
[0.009201, 0.08707, 0.263341, 0.44523, 0.183632, 0.010073, 0.001453] |
prob_tob_lung_func_15_39 |
probability of lung function categories in individuals aged 15-39 who smoke tobacco |
List |
[0.06712, 0.199903, 0.259728, 0.241245, 0.148346, 0.071498, 0.01216] |
prob_tob_lung_func_40_59 |
probability of lung function categories in individuals aged 40-59 who smoke tobacco |
List |
[0.001499, 0.033733, 0.112819, 0.231259, 0.337331, 0.225637, 0.057722] |
prob_tob_lung_func_gr59 |
probability of lung function categories in individuals aged 60+ who smoke tobacco |
List |
[0.0, 0.0, 0.035366, 0.20122, 0.453659, 0.246341, 0.063414] |
Demography
Name |
Description |
Type |
Value |
---|---|---|---|
max_age_initial |
The oldest age (in whole years) in the initial population |
Integer |
120 |
pop_2010 |
Population in 2010 for initialising population |
Dataframe |
|
district_num_to_district_name |
Mapping from district_num to district name |
Dictionary |
|
district_num_to_region_name |
Mapping from district_num to region name |
Dictionary |
|
districts_in_region |
Set of districts (by name) that are within a region (by name) |
Dictionary |
|
all_cause_mortality_schedule |
All-cause age-specific mortality rates from WPP |
Dataframe |
|
fraction_of_births_male |
Birth Sex Ratio |
Series |
pop_2010
District |
District_Num |
Region |
Sex |
Age |
Count |
---|---|---|---|---|---|
Chitipa |
0 |
Northern |
M |
1 |
3673.51 |
Chitipa |
0 |
Northern |
M |
2 |
3538.09 |
Chitipa |
0 |
Northern |
M |
3 |
3410.42 |
Chitipa |
0 |
Northern |
M |
4 |
3289.97 |
Chitipa |
0 |
Northern |
M |
5 |
3176.2 |
Chitipa |
0 |
Northern |
M |
6 |
3068.58 |
Chitipa |
0 |
Northern |
M |
7 |
2966.6 |
Chitipa |
0 |
Northern |
M |
8 |
2869.74 |
Chitipa |
0 |
Northern |
M |
9 |
2777.45 |
Only first 10 rows of 6464 are shown.
district_num_to_district_name
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chitipa |
Karonga |
Nkhata Bay |
Rumphi |
Mzimba |
Likoma |
Mzuzu City |
Kasungu |
Nkhotakota |
Ntchisi |
Dowa |
Salima |
Lilongwe |
Mchinji |
Dedza |
Ntcheu |
Lilongwe City |
Mangochi |
Machinga |
Zomba |
Chiradzulu |
Blantyre |
Mwanza |
Thyolo |
Mulanje |
Phalombe |
Chikwawa |
Nsanje |
Balaka |
Neno |
Zomba City |
Blantyre City |
district_num_to_region_name
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Northern |
Northern |
Northern |
Northern |
Northern |
Northern |
Northern |
Central |
Central |
Central |
Central |
Central |
Central |
Central |
Central |
Central |
Central |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
Southern |
districts_in_region
Northern
0 |
1 |
2 |
3 |
4 |
5 |
6 |
---|---|---|---|---|---|---|
Chitipa |
Mzimba |
Likoma |
Mzuzu City |
Nkhata Bay |
Karonga |
Rumphi |
Central
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
---|---|---|---|---|---|---|---|---|---|
Mchinji |
Ntchisi |
Dedza |
Lilongwe |
Lilongwe City |
Dowa |
Nkhotakota |
Salima |
Ntcheu |
Kasungu |
Southern
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neno |
Chikwawa |
Zomba City |
Blantyre |
Phalombe |
Thyolo |
Mwanza |
Mangochi |
Machinga |
Mulanje |
Balaka |
Chiradzulu |
Zomba |
Blantyre City |
Nsanje |
all_cause_mortality_schedule
fallbackyear |
sex |
age_years |
death_rate |
---|---|---|---|
1950 |
M |
1 |
0.0572109 |
1950 |
M |
2 |
0.0572109 |
1950 |
M |
3 |
0.0572109 |
1950 |
M |
4 |
0.0572109 |
1950 |
M |
5 |
0.0139565 |
1950 |
M |
6 |
0.0139565 |
1950 |
M |
7 |
0.0139565 |
1950 |
M |
8 |
0.0139565 |
1950 |
M |
9 |
0.0139565 |
Only first 10 rows of 7200 are shown.
fraction_of_births_male
frac_births_male |
---|
0.50495 |
0.50495 |
0.50495 |
0.50495 |
0.50495 |
0.50495 |
0.50495 |
0.50495 |
0.50495 |
Only first 10 rows of 150 are shown.
Depression
Name |
Description |
Type |
Value |
---|---|---|---|
init_pr_depr_m_age1519_no_cc_wealth123 |
Initial probability of being depressed in male age1519 with no chronic condition with wealth level 1 or 2 or 3 |
Real |
0.06 |
init_rp_depr_f_not_rec_preg |
Initial relative prevalence of being depressed in females not recently pregnant |
Real |
1.5 |
init_rp_depr_f_rec_preg |
Initial relative prevalence of being depressed in females recently pregnant |
Real |
3.0 |
init_rp_depr_age2059 |
Initial relative prevalence of being depressed in 20-59 year olds vs 15-19 |
Real |
1.0 |
init_rp_depr_agege60 |
Initial relative prevalence of being depressed in 60+ year olds vs 15-19 |
Real |
3.0 |
init_rp_depr_cc |
Initial relative prevalence of being depressed in people with chronic condition |
Real |
1.0 |
init_rp_depr_wealth45 |
Initial relative prevalence of being depressed in people with wealth level 4 or 5 vs 1 or 2 or 3 |
Real |
1.0 |
init_rp_ever_depr_per_year_older_m |
Initial relative prevalence ever depression per year older in men |
Real |
0.004 |
init_rp_ever_depr_per_year_older_f |
Initial relative prevalence ever depression per year older in women |
Real |
0.006 |
init_pr_ever_talking_therapy_if_diagnosed |
Initial probability of ever having had talking therapy if ever diagnosed with depression |
Real |
1.0 |
init_pr_antidepr_curr_depr |
Initial probability of being on antidepressants if currently depressed |
Real |
0.11 |
init_rp_antidepr_ever_depr_not_curr |
Initial relative prevalence of being on antidepressants if ever depressed but not currently |
Real |
0.5 |
init_pr_ever_diagnosed_depression |
Initial probability of having ever been diagnosed with depression, amongst people with ever depression and not on antidepressants |
Real |
0.2 |
init_pr_ever_self_harmed_if_ever_depr |
Initial probability of having ever self harmed if ever depressed |
Real |
0.004 |
base_3m_prob_depr |
Probability of onset of depression in a 3 month period if male, wealth 1 2 or 3, no chronic condition and never previously depressed |
Real |
0.0021 |
rr_depr_wealth45 |
Relative rate of depression when in wealth level 4 or 5 vs 1 or 2 or 3 |
Real |
3.0 |
rr_depr_cc |
Relative rate of depression if has any chronic disease |
Real |
1.25 |
rr_depr_pregnancy |
Relative rate of depression when pregnant or recently pregnant |
Real |
3.0 |
rr_depr_female |
Relative rate of depression for females vs males |
Real |
1.5 |
rr_depr_prev_epis |
Relative rate of depression associated with previous depression vs never previously depressed |
Real |
50.0 |
rr_depr_on_antidepr |
Relative rate of depression episode if on antidepressants |
Real |
30.0 |
rr_depr_age1519 |
Relative rate of depression associated with 15-20 year olds |
Real |
1.0 |
rr_depr_agege60 |
Relative rate of depression associated with age > 60 |
Real |
3.0 |
rr_depr_hiv |
Relative rate of depression associated with HIV infection |
Real |
1.99 |
depr_resolution_rates |
Risk of depression resolving in 3 months if no chronic conditions and no treatments.Each individual is equally likely to be assigned each of these risks |
List |
[0.2, 0.3, 0.5, 0.7, 0.95] |
rr_resol_depr_cc |
Relative rate of resolving depression if has any chronic disease |
Real |
0.5 |
rr_resol_depr_on_antidepr |
Relative rate of resolving depression if on antidepressants |
Real |
1.5 |
rr_resol_depr_current_talk_ther |
Relative rate of resolving depression if has ever had talking therapy vs has never had talking therapy |
Real |
1.1 |
prob_3m_stop_antidepr |
Probability per 3 months of stopping antidepressants when not currently depressed. |
Real |
0.7 |
prob_3m_default_antidepr |
Probability per 3 months of stopping antidepressants when still depressed. |
Real |
0.2 |
prob_3m_suicide_depr_m |
Probability per 3 months of suicide in currently depressed men |
Real |
0.0005 |
rr_suicide_depr_f |
Relative risk of suicide in women compared with men |
Real |
0.333 |
prob_3m_selfharm_depr |
Probability per 3 months of non-fatal self harm in those currently depressed |
Real |
0.0005 |
sensitivity_of_assessment_of_depression |
The sensitivity of the clinical assessment in detecting the true current status of depression |
Real |
0.75 |
pr_assessed_for_depression_in_generic_appt_level1 |
Probability that a person is assessed for depression during a non-emergency generic appointmentlevel 1 |
Real |
0.01 |
anti_depressant_medication_item_code |
The item code used for one month of anti-depressant treatment |
Integer |
267 |
pr_assessed_for_depression_for_perinatal_female |
Probability that a perinatal female is assessed for depression during antenatal or postnatal services |
Real |
0.01 |
Diarrhoea
Name |
Description |
Type |
Value |
---|---|---|---|
base_inc_rate_diarrhoea_by_rotavirus |
incidence rate (per person-year) of diarrhoea caused by rotavirus in age groups 0-11, 12-23, 24-59 months |
List |
[0.175245863, 0.097007598, 0.009324] |
base_inc_rate_diarrhoea_by_shigella |
incidence rate (per person-year) of diarrhoea caused by shigella spp in age groups 0-11, 12-23, 24-59 months |
List |
[0.117936461999999, 0.078794104, 0.093018] |
base_inc_rate_diarrhoea_by_adenovirus |
incidence rate (per person-year) of diarrhoea caused by adenovirus 40/41 in age groups 0-11, 12-23, 24-59 months |
List |
[0.0586618, 0.058661803, 0.006438] |
base_inc_rate_diarrhoea_by_cryptosporidium |
incidence rate (per person-year) of diarrhoea caused by cryptosporidium in age groups 0-11, 12-23, 24-59 months |
List |
[0.030886699, 0.0117923629999999, 0.004662] |
base_inc_rate_diarrhoea_by_campylobacter |
incidence rate (per person-year) of diarrhoea caused by campylobacter spp in age groups 0-11, 12-23, 24-59 months |
List |
[0.098663257, 0.027915478, 0.004884] |
base_inc_rate_diarrhoea_by_ETEC |
incidence rate (per person-year) of diarrhoea caused by ETEC in age groups 0-11, 12-23, 24-59 months |
List |
[0.27925146, 0.170477152, 0.019758] |
base_inc_rate_diarrhoea_by_sapovirus |
incidence rate (per person-year) of diarrhoea caused by sapovirus in age groups 0-11, 12-23, 24-59 months |
List |
[0.100972179, 0.132603114, 0.00555] |
base_inc_rate_diarrhoea_by_norovirus |
incidence rate (per person-year) of diarrhoea caused by norovirus in age groups 0-11, 12-23, 24-59 months |
List |
[0.204864004, 0.066146727, 0.000888] |
base_inc_rate_diarrhoea_by_astrovirus |
incidence rate (per person-year) of diarrhoea caused by astrovirus in age groups 0-11, 12-23, 24-59 months |
List |
[0.054208352, 0.035974076, 0.001332] |
base_inc_rate_diarrhoea_by_tEPEC |
incidence rate (per person-year) of diarrhoea caused by tEPEC in age groups 0-11, 12-23, 24-59 months |
List |
[0.0608224569999999, 0.022716889, 0.001998] |
rr_diarrhoea_HHhandwashing |
relative rate of diarrhoea with household handwashing with soap |
Real |
0.7 |
rr_diarrhoea_improved_sanitation |
relative rate of diarrhoea for improved sanitation |
Real |
0.75 |
rr_diarrhoea_clean_water |
relative rate of diarrhoea for access to clean drinking water |
Real |
0.67 |
rr_diarrhoea_exclusive_vs_partial_breastfeeding_<6mo |
relative rate of diarrhoea for partial breastfeeding in <6 months old, compared to exclusive breastfeeding |
Real |
1.68 |
rr_diarrhoea_exclusive_vs_no_breastfeeding_<6mo |
relative rate of diarrhoea for no breastfeeding in <6 months old, compared to exclusive breastfeeding |
Real |
2.65 |
rr_diarrhoea_any_vs_no_breastfeeding_6_11mo |
relative rate of diarrhoea for no breastfeeding in 6 months old to 1 years old, compared to any breastfeeding at this age group |
Real |
1.32 |
rr_diarrhoea_untreated_HIV |
relative rate of diarrhoea for HIV positive status |
Real |
5.4 |
rr_diarrhoea_SAM |
relative rate of diarrhoea for severe malnutrition |
Real |
1.2 |
proportion_AWD_in_rotavirus |
acute diarrhoea type caused in rotavirus-attributed diarrhoea |
Real |
0.97668 |
proportion_AWD_in_shigella |
acute diarrhoea type caused in shigella-attributed diarrhoea |
Real |
0.861942 |
proportion_AWD_in_adenovirus |
acute diarrhoea type caused in adenovirus-attributed diarrhoea |
Real |
0.950061 |
proportion_AWD_in_cryptosporidium |
acute diarrhoea type caused in cryptosporidium-attributed diarrhoea |
Real |
0.970984 |
proportion_AWD_in_campylobacter |
acute diarrhoea type caused in campylobacter-attributed diarrhoea |
Real |
0.896768 |
proportion_AWD_in_ETEC |
acute diarrhoea type caused in ETEC-attributed diarrhoea |
Real |
0.950465 |
proportion_AWD_in_sapovirus |
acute diarrhoea type caused in sapovirus-attributed diarrhoea |
Real |
0.966385 |
proportion_AWD_in_norovirus |
acute diarrhoea type caused in norovirus-attributed diarrhoea |
Real |
0.961643 |
proportion_AWD_in_astrovirus |
acute diarrhoea type caused in astrovirus-attributed diarrhoea |
Real |
0.974147 |
proportion_AWD_in_tEPEC |
acute diarrhoea type in tEPEC-attributed diarrhoea |
Real |
0.961485 |
prob_dehydration_by_rotavirus |
probability of any dehydration caused by rotavirus |
Real |
0.153093 |
prob_dehydration_by_shigella |
probability of any dehydration caused by shigella |
Real |
0.102962 |
prob_dehydration_by_adenovirus |
probability of any dehydration caused by adenovirus |
Real |
0.079524 |
prob_dehydration_by_cryptosporidium |
probability of any dehydration caused by cryptosporidium |
Real |
0.121458 |
prob_dehydration_by_campylobacter |
probability of any dehydration caused by campylobacter |
Real |
0.072808 |
prob_dehydration_by_ETEC |
probability of any dehydration caused by ETEC |
Real |
0.075925 |
prob_dehydration_by_sapovirus |
probability of any dehydration caused by sapovirus |
Real |
0.10364 |
prob_dehydration_by_norovirus |
probability of any dehydration caused by norovirus |
Real |
0.090728 |
prob_dehydration_by_astrovirus |
probability of any dehydration caused by astrovirus |
Real |
0.122776 |
prob_dehydration_by_tEPEC |
probability of any dehydration caused by tEPEC |
Real |
0.113362 |
probability_of_severe_dehydration_if_some_dehydration |
probability that someone with diarrhoea and some dehydration develops severe dehydration |
Real |
0.167 |
prob_prolonged_diarr_rotavirus |
probability of prolonged episode in rotavirus-attributed diarrhoea |
Real |
0.117706 |
prob_prolonged_diarr_shigella |
probability of prolonged episode by shigella-attributed diarrhoea |
Real |
0.165342 |
prob_prolonged_diarr_adenovirus |
probability of prolonged episode by adenovirus-attributed diarrhoea |
Real |
0.116406 |
prob_prolonged_diarr_cryptosporidium |
probability of prolonged episode by cryptosporidium-attributed diarrhoea |
Real |
0.169134 |
prob_prolonged_diarr_campylobacter |
probability of prolonged episode by campylobacter-attributed diarrhoea |
Real |
0.152206 |
prob_prolonged_diarr_ETEC |
probability of prolonged episode by ETEC-attributed diarrhoea |
Real |
0.114177 |
prob_prolonged_diarr_sapovirus |
probability of prolonged episode by sapovirus-attributed diarrhoea |
Real |
0.133209 |
prob_prolonged_diarr_norovirus |
probability of prolonged episode by norovirus-attributed diarrhoea |
Real |
0.118223 |
prob_prolonged_diarr_astrovirus |
probability of prolonged episode by norovirus-attributed diarrhoea |
Real |
0.13511 |
prob_prolonged_diarr_tEPEC |
probability of prolonged episode by tEPEC-attributed diarrhoea |
Real |
0.190845 |
prob_prolonged_to_persistent_diarr |
probability of prolonged diarrhoea becoming persistent diarrhoea |
Real |
0.2866 |
rr_bec_persistent_age>6mo |
relative rate of acute diarrhoea becoming persistent diarrhoea for children over 6 months |
Real |
0.26 |
rr_bec_persistent_HIV |
relative rate of acute diarrhoea becoming persistent diarrhoea for HIV positive |
Real |
1.7 |
rr_bec_persistent_SAM |
relative rate of acute diarrhoea becoming persistent diarrhoea for severely acute malnutrition |
Real |
1.7 |
rr_bec_persistent_stunted |
relative rate of acute diarrhoea becoming persistent diarrhoea for stunted children |
Real |
33.3 |
min_dur_acute |
The minimum duration (in days) for an episode that is classified as an acute episode |
Integer |
1 |
min_dur_prolonged |
The minimum duration (in days) for an episode that is classified as a prolonged episode |
Integer |
5 |
min_dur_persistent |
The minimum duration (in days) for an episode that is classified as a persistent episode |
Integer |
13 |
max_dur_persistent |
The maximum duration (in days) for an episode that is classified as a persistent episode |
Integer |
30 |
prob_fever_by_rotavirus |
probability of fever caused by rotavirus |
Real |
0.384925 |
prob_fever_by_shigella |
probability of fever caused by shigella |
Real |
0.319876 |
prob_fever_by_adenovirus |
probability of fever caused by adenovirus |
Real |
0.271513 |
prob_fever_by_cryptosporidium |
probability of fever caused by cryptosporidium |
Real |
0.322385 |
prob_fever_by_campylobacter |
probability of fever caused by campylobacter |
Real |
0.312807 |
prob_fever_by_ETEC |
probability of fever caused by ETEC |
Real |
0.258931 |
prob_fever_by_sapovirus |
probability of fever caused by sapovirus |
Real |
0.292276 |
prob_fever_by_norovirus |
probability of fever caused by norovirus |
Real |
0.251071 |
prob_fever_by_astrovirus |
probability of fever caused by astrovirus |
Real |
0.195905 |
prob_fever_by_tEPEC |
probability of fever caused by tEPEC |
Real |
0.384547 |
prob_vomiting_by_rotavirus |
probability of vomiting caused by rotavirus |
Real |
0.471793 |
prob_vomiting_by_shigella |
probability of vomiting caused by shigella |
Real |
0.209852 |
prob_vomiting_by_adenovirus |
probability of vomiting caused by adenovirus |
Real |
0.308677 |
prob_vomiting_by_cryptosporidium |
probability of vomiting caused by cryptosporidium |
Real |
0.243581 |
prob_vomiting_by_campylobacter |
probability of vomiting caused by campylobacter |
Real |
0.218669 |
prob_vomiting_by_ETEC |
probability of vomiting caused by ETEC |
Real |
0.283139 |
prob_vomiting_by_sapovirus |
probability of vomiting caused by sapovirus |
Real |
0.303154 |
prob_vomiting_by_norovirus |
probability of vomiting caused by norovirus |
Real |
0.299343 |
prob_vomiting_by_astrovirus |
probability of vomiting caused by astrovirus |
Real |
0.276018 |
prob_vomiting_by_tEPEC |
probability of vomiting caused by tEPEC |
Real |
0.285661 |
adjustment_factor_on_cfr |
Factor by which fatality probabilities are multiplied (to be used in calibration) |
Real |
3.75 |
case_fatality_rate_AWD |
case fatality rate for acute watery diarrhoea cases |
Real |
0.0015 |
rr_diarr_death_bloody |
relative risk of diarrhoea death (compared to case_fatality_rate_AWD if the diarrhoea is of type “bloody” (i.e. dyssentry). |
Real |
7.6 |
rr_diarr_death_age24to59mo |
relative risk of diarrhoea death for ages 24 to 59 months |
Real |
0.38 |
rr_diarr_death_if_duration_longer_than_13_days |
relative risk of diarrhoea death if the duration episode is 13 days or longer |
Real |
0.0035 |
rr_diarr_death_severe_dehydration |
relative risk of diarrhoea death for cases with severe dehyadration |
Real |
3.45 |
rr_diarr_death_untreated_HIV |
relative risk of diarrhoea death for untreated HIV |
Real |
5.05 |
rr_diarr_death_SAM |
relative risk of diarrhoea death for severe acute malnutrition |
Real |
4.13 |
rr_diarr_death_alri |
relative risk of diarrhoea death if concurrent lower respiratory infection |
Real |
3.51 |
rr_diarr_death_cryptosporidium |
relative risk of diarrhoea death if caused by cryptosporidium |
Real |
2.14 |
rr_diarr_death_shigella |
relative risk of diarrhoea death if caused by shigella |
Real |
2.8 |
sensitivity_severe_dehydration_visual_inspection |
sensitivity of IMCI severe dehydration algorithm for dehydration >9% loss of body weight |
Real |
0.77 |
specificity_severe_dehydration_visual_inspection |
specificity of IMCI severe dehydration algorithm for dehydration >9% loss of body weight |
Real |
0.67 |
prob_hospitalization_on_danger_signs |
probability of hospitalisation when danger signs are detected in an initial consultation |
Real |
0.7 |
prob_WHOPlanC_cures_dehydration_if_severe_dehydration |
probability that severe dehydration is cured by Treatment Plan C |
Real |
0.9 |
prob_ORS_cures_dehydration_if_severe_dehydration |
probability that severe dehydration is cured by ORS |
Real |
0.721 |
prob_ORS_cures_dehydration_if_non_severe_dehydration |
probability that non-severe dehydration is cured by ORS |
Real |
0.93 |
prob_antibiotic_cures_dysentery |
probability that blood-in-stool is removed by the use of antibiotics |
Real |
0.99 |
number_of_days_reduced_duration_with_zinc |
number of days reduced duration with zinc |
Integer |
1 |
days_between_treatment_and_cure |
number of days between any treatment being given in an HSI and the cure occurring. |
Integer |
5 |
rr_severe_dehydration_due_to_rotavirus_with_R1_under1yo |
relative risk of severe dehydration with rotavirus vaccine, for under 1 years old. |
Real |
0.63 |
rr_severe_dehydration_due_to_rotavirus_with_R1_over1yo |
relative risk of severe dehydration with rotavirus vaccine, for those aged 1 year and older. |
Real |
0.35 |
Epi
Name |
Description |
Type |
Value |
---|---|---|---|
baseline_coverage |
baseline vaccination coverage (all vaccines) |
Dataframe |
|
vaccine_schedule |
vaccination schedule applicable from 2018 onwards |
Series |
|
prob_facility_level_for_vaccine |
The probability of going to each facility-level (0 / 1a / 1b / 2) for child having vaccines given through childhood immunisation schedule. The probabilities must sum to 1.0 |
List |
[0, 0.8, 0.1, 0.1] |
baseline_coverage
Year |
BCG |
DTP1 |
DTP3 |
HepB3 |
Hib3 |
MCV1 |
MCV2 |
PCV3 |
Pol3 |
RCV1 |
Rota |
IPV1 |
AgeOn01Jan2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1981 |
0.86 |
0.86 |
0.66 |
0 |
0 |
0.64 |
0 |
0 |
0.57 |
0 |
0 |
0 |
28 |
1982 |
0.87 |
0.84 |
0.64 |
0 |
0 |
0.64 |
0 |
0 |
0.58 |
0 |
0 |
0 |
27 |
1983 |
0.81 |
0.84 |
0.63 |
0 |
0 |
0.58 |
0 |
0 |
0.58 |
0 |
0 |
0 |
26 |
1984 |
0.74 |
0.8 |
0.58 |
0 |
0 |
0.5 |
0 |
0 |
0.56 |
0 |
0 |
0 |
25 |
1985 |
0.87 |
0.78 |
0.55 |
0 |
0 |
0.49 |
0 |
0 |
0.55 |
0 |
0 |
0 |
24 |
1986 |
0.87 |
0.8 |
0.57 |
0 |
0 |
0.6 |
0 |
0 |
0.53 |
0 |
0 |
0 |
23 |
1987 |
0.92 |
0.92 |
0.78 |
0 |
0 |
0.79 |
0 |
0 |
0.78 |
0 |
0 |
0 |
22 |
1988 |
0.9 |
0.94 |
0.82 |
0 |
0 |
0.82 |
0 |
0 |
0.72 |
0 |
0 |
0 |
21 |
1989 |
0.96 |
0.95 |
0.87 |
0 |
0 |
0.84 |
0 |
0 |
0.9 |
0 |
0 |
0 |
20 |
Only first 10 rows of 42 are shown.
vaccine_schedule
date_administration_days |
---|
1 |
42 |
70 |
98 |
42 |
70 |
98 |
42 |
70 |
Only first 10 rows of 21 are shown.
Epilepsy
Name |
Description |
Type |
Value |
---|---|---|---|
init_epil_seiz_status |
Proportions in each seizure status category at baseline |
List |
[0.974, 0.0175, 0.007, 0.0015] |
init_prop_antiepileptic_seiz_stat_1 |
initial proportions on antiepileptic by if seizure status = 1 |
Real |
0.15 |
init_prop_antiepileptic_seiz_stat_2 |
initial proportions on antiepileptic by if seizure status = 2 |
Real |
0.15 |
init_prop_antiepileptic_seiz_stat_3 |
initial proportions on antiepileptic by if seizure status = 3 |
Real |
0.2 |
base_3m_prob_epilepsy |
base probability of epilepsy per 3 month period if age < 20 |
Real |
0.000178 |
rr_epilepsy_age_ge20 |
relative rate of epilepsy if age over 20 |
Real |
0.3 |
prop_inc_epilepsy_seiz_freq |
proportion of incident epilepsy cases with frequent seizures |
Real |
0.1 |
base_prob_3m_seiz_stat_freq_infreq |
base probability per 3 months of seizure status frequent if current infrequent |
Real |
0.05 |
rr_effectiveness_antiepileptics |
relative rate of seizure status frequent if current infrequent if on antiepileptic |
Real |
3.0 |
base_prob_3m_seiz_stat_infreq_freq |
base probability per 3 months of seizure status infrequent if current frequent |
Real |
0.05 |
base_prob_3m_seiz_stat_infreq_none |
base probability per 3 months of seizure status infrequent if current nonenow |
Real |
0.05 |
base_prob_3m_seiz_stat_none_freq |
base probability per 3 months of seizure status nonenow if current frequent |
Real |
0.05 |
base_prob_3m_seiz_stat_none_infreq |
base probability per 3 months of seizure status nonenow if current infrequent |
Real |
0.05 |
base_prob_3m_stop_antiepileptic |
base probability per 3 months of stopping antiepileptic, if nonenow seizures |
Real |
0.1 |
rr_stop_antiepileptic_seiz_infreq_or_freq |
relative rate of stopping antiepileptic if infrequent or frequent seizures |
Real |
0.5 |
base_prob_3m_epi_death |
base probability per 3 months of epilepsy death |
Real |
0.000568 |
daly_wt_epilepsy_severe |
disability weight for severe epilepsycontrolled phase - code 860 |
Real |
0.552 |
daly_wt_epilepsy_less_severe |
disability weight for less severe epilepsycontrolled phase - code 861 |
Real |
0.263 |
daly_wt_epilepsy_seizure_free |
disability weight for less severe epilepsycontrolled phase - code 862 |
Real |
0.049 |
prob_start_anti_epilep_when_seizures_detected_in_generic_first_appt |
probability that someone who has had a seizure is started on anti-epileptics. This is calibrated to induce the correct proportion of persons with epilepsy currently receiving anti-epileptics. |
Real |
0.4 |
max_num_of_failed_attempts_before_defaulting |
maximum number of time an HSI can be repeated if the relevant essential consumables are not available. |
Integer |
2 |
HealthSeekingBehaviour
Name |
Description |
Type |
Value |
---|---|---|---|
force_any_symptom_to_lead_to_healthcareseeking |
Whether every symptom [except those that declare they should not lead to any healthcare seeking] should always lead to healthcare seeking immediately. |
Boolean |
False |
prob_non_emergency_care_seeking_by_level |
The probability of going to each facility-level when non-emergency care is sought. The values in the list are the probabilities of going to facility level 0 / 1a / 1b / 2, respectively, and these values must sum to 1.0. |
List |
[0.14, 0.66, 0.08, 0.12] |
baseline_odds_of_healthcareseeking_children |
odds of health-care seeking (children: 0-14) if male, 0-5 years-old, living in a rural setting in the Northern region, and not in the wealth categories 4 or 5 |
Real |
2.17 |
odds_ratio_children_sex_Female |
odds ratio for health-care seeking (children) if sex is Female |
Real |
1.12 |
odds_ratio_children_age_5to14 |
odds ratio for health-care seeking (children) if aged 5-14 |
Real |
0.5 |
odds_ratio_children_setting_urban |
odds ratio for health-care seeking (children) if setting is Urban |
Real |
1.75 |
odds_ratio_children_region_Central |
odds ratio for health-care seeking (children) if region is Central |
Real |
0.43 |
odds_ratio_children_region_Southern |
odds ratio for health-care seeking (children) if region is Southern |
Real |
0.56 |
odds_ratio_children_wealth_higher |
odds ratio for health-care seeking (children) if wealth is in categories 4 or 5 |
Real |
1.9 |
baseline_odds_of_healthcareseeking_adults |
odds of health-care seeking (adults: 15+) if male, 15-34 year-olds, living in a rural setting in the Northern region, and not in the wealth categories 4 or 5. |
Real |
1.27 |
odds_ratio_adults_sex_Female |
odds ratio for health-care seeking (adults) if sex is Female |
Real |
1.28 |
odds_ratio_adults_age_35to59 |
odds ratio for health-care seeking (adults) if aged 35-59 |
Real |
0.93 |
odds_ratio_adults_age_60plus |
odds ratio for health-care seeking (adults) if aged 60+ |
Real |
0.94 |
odds_ratio_adults_setting_urban |
odds ratio for health-care seeking (adults) if setting is Urban |
Real |
1.67 |
odds_ratio_adults_region_Central |
odds ratio for health-care seeking (adults) if region is Central |
Real |
0.6 |
odds_ratio_adults_region_Southern |
odds ratio for health-care seeking (adults) if region is Southern |
Real |
0.68 |
odds_ratio_adults_wealth_higher |
odds ratio for health-care seeking (adults) if wealth is in categories 4 or 5 |
Real |
1.56 |
max_days_delay_to_generic_HSI_after_symptoms |
Maximum days delay between symptom onset and firstgeneric HSI. Actual delay is sample between 0 and this value. |
Integer |
4 |
HealthSystem
Name |
Description |
Type |
Value |
---|---|---|---|
Master_Facilities_List |
Listing of all health facilities. |
Dataframe |
|
Officer_Types_Table |
The names of the types of health workers (“officers”) |
Dataframe |
|
Appt_Types_Table |
The names of the type of appointments with the health system |
Dataframe |
|
Appt_Offered_By_Facility_Level |
Table indicating whether or not each appointment is offered at each facility level. |
Dataframe |
|
Appt_Time_Table |
The time taken for each appointment, according to officer and facility type. |
Dataframe |
|
Daily_Capabilities_actual |
The capabilities (minutes of time available of each type of officer in each facility) based on the _estimated current_ number and distribution of staff estimated. |
Dataframe |
|
Daily_Capabilities_funded |
The capabilities (minutes of time available of each type of officer in each facility) based on the _potential_ number and distribution of staff estimated (i.e. those positions that can be funded). |
Dataframe |
|
Daily_Capabilities_funded_plus |
The capabilities (minutes of time available of each type of officer in each facility) based on the _potential_ number and distribution of staff estimated, with adjustments to permit each appointment type that should be run at facility level to do so in every district. |
Dataframe |
|
use_funded_or_actual_staffing |
If actual, then use the numbers and distribution of staff estimated to be available currently; If funded, then use the numbers and distribution of staff that are potentially available. If funded_plus, then use a dataset in which the allocation of staff to facilities is tweaked so as to allow each appointment type to run at each facility_level in each district for which it is defined. N.B. This parameter is over-ridden if an argument is provided to the module initialiser. |
String |
actual |
item_and_package_code_lookups |
Data imported from the OneHealth Tool on consumable items, packages and costs. |
Dataframe |
|
consumables_item_designations |
Look-up table for the designations of consumables (whether diagnostic, medicine, or other |
Dataframe |
|
availability_estimates |
Estimated availability of consumables in the LMIS dataset. |
Dataframe |
|
cons_availability |
Availability of consumables. If ‘default’ then use the availability specified in the ResourceFile; if ‘none’, then let no consumable be ever be available; if ‘all’, then all consumables are always available. When using ‘all’ or ‘none’, requests for consumables are not logged. NB. This parameter is over-riddenif an argument is provided to the module initialiser.Note that other options are also available: see the Consumables class. |
String |
default |
BedCapacity |
Data on the number of beds available of each type by facility_id |
Dataframe |
|
beds_availability |
Availability of beds. If ‘default’ then use the availability specified in the ResourceFile; if ‘none’, then let no beds be ever be available; if ‘all’, then all beds are always available. NB. This parameter is over-ridden if an argument is provided to the module initialiser. |
String |
default |
EquipmentCatalogue |
Data on equipment items and packages. |
Dataframe |
|
equipment_availability_estimates |
Data on the availability of equipment items and packages. |
Dataframe |
|
equip_availability |
What to assume about the availability of equipment. If ‘default’ then use the availability specified in the ResourceFile; if ‘none’, then let no equipment ever be available; if ‘all’, then all equipment is always available. NB. This parameter is over-ridden if an argument is provided to the module initialiser. |
String |
all |
equip_availability_postSwitch |
What to assume about the availability of equipment after the switch (see year_equip_availability_switch). The options for this are the same as equip_availability. |
String |
default |
year_equip_availability_switch |
Year in which the assumption for equip_availability changes (The change happens on 1st January of that year.) |
Integer |
2100 |
Service_Availability |
List of services to be available. NB. This parameter is over-ridden if an argument is provided to the module initialiser. |
List |
[‘*’] |
policy_name |
Name of priority policy adopted |
String |
Naive |
year_mode_switch |
Year in which mode switch is enforced |
Integer |
2100 |
scale_to_effective_capabilities |
In year in which mode switch takes place, will rescale available capabilities to match thosethat were effectively used (on average) in the past year if this is set to True. This way,we can approximate overtime and rushing of appts even in mode 2. |
Boolean |
False |
year_cons_availability_switch |
Year in which consumable availability switch is enforced. The change happenson 1st January of that year.) |
Integer |
2100 |
year_use_funded_or_actual_staffing_switch |
Year in which switch for use_funded_or_actual_staffing is enforced. (The change happenson 1st January of that year.) |
Integer |
2100 |
priority_rank |
Data on the priority ranking of each of the Treatment_IDs to be adopted by the queueing system under different policies, where the lower the number the higher the priority, and on which categories of individuals classify for fast-tracking for specific treatments |
Dictionary |
|
HR_scaling_by_level_and_officer_type_table |
Factors by which capabilities of medical officer types at different levels will bescaled at the start of the year specified by year_HR_scaling_by_level_and_officer_type. Thisserves to simulate a number of effects (e.g. absenteeism, boosting capabilities of specific medical cadres, etc). This is the imported from an Excel workbook: keys are the worksheet names and values are the worksheets in the format of pd.DataFrames. Additional scenarios can be added by adding worksheets to this workbook: the value of HR_scaling_by_level_and_officer_type_mode indicates which sheet is used. |
Dictionary |
|
year_HR_scaling_by_level_and_officer_type |
Year in which one-off constant HR scaling will take place. (The change happenson 1st January of that year.) |
Integer |
2100 |
HR_scaling_by_level_and_officer_type_mode |
Mode of HR scaling considered at the start of the simulation. This corresponds to the nameof the worksheet in ResourceFile_HR_scaling_by_level_and_officer_type.xlsx that should be used. Options are: default (capabilities are scaled by a constaint factor of 1); data (factors informed by survey data); and, custom (user can freely set these factors as parameters in the analysis). |
String |
default |
HR_scaling_by_district_table |
Factors by which daily capabilities in different districts will bescaled at the start of the year specified by year_HR_scaling_by_district to simulate(e.g., through catastrophic event disrupting delivery of services in particular district(s)).This is the import of an Excel workbook: keys are the worksheet names and values are the worksheets in the format of pd.DataFrames. Additional scenarios can be added by adding worksheets to this workbook: the value of HR_scaling_by_district_mode indicates whichsheet is used. |
Dictionary |
|
year_HR_scaling_by_district |
Year in which scaling of daily capabilities by district will take place. (The change happenson 1st January of that year.) |
Integer |
2100 |
HR_scaling_by_district_mode |
Mode of scaling of daily capabilities by district. This corresponds to the name of the worksheet in the file ResourceFile_HR_scaling_by_district.xlsx. |
String |
default |
yearly_HR_scaling |
Factors by which HR capabilities are scaled. Each sheet specifies a ‘mode’ for dynamic HR scaling. The mode to use is determined by the parameter yearly_HR_scaling_mode. Each sheet must have the same format, including the same column headers. On each sheet, the first row (for 2010, when the simulation starts) specifies the initial configuration: dynamic_HR_scaling_factor (float) is the factor by which all human resoucres capabilities and multiplied; scale_HR_by_popsize (bool) specifies whether the capabilities should (also) grow by the factor by which the population has grown in the last year. Each subsequent row specifies a year where there should be a CHANGE in the configuration. If there are no further rows, then there is no change. But, for example, an additional row of the form |
Dictionary |
|
yearly_HR_scaling_mode |
Specifies which of the policies in yearly_HR_scaling should be adopted. This corresponds toa worksheet of the file ResourceFile_dynamic_HR_scaling.xlsx. |
String |
no_scaling |
tclose_overwrite |
Decide whether to overwrite tclose variables assigned by disease modules |
Integer |
0 |
tclose_days_offset_overwrite |
Offset in days from topen at which tclose will be set by the healthsystem for all HSIsif tclose_overwrite is set to True. |
Integer |
7 |
mode_appt_constraints |
Integer code in {0, 1, 2} determining mode of constraints with regards to officer numbers and time - 0: no constraints, all HSI events run with no squeeze factor, 1: elastic constraints, all HSI events run with squeeze factor, 2: hard constraints, only HSI events with no squeeze factor run. N.B. This parameter is over-ridden if an argument is provided to the module initialiser. |
Integer |
1 |
mode_appt_constraints_postSwitch |
Mode considered after a mode switch in year_mode_switch. |
Integer |
1 |
cons_availability_postSwitch |
Consumables availability after switch in year_cons_availability_switch. Acceptable valuesare the same as those for Parameter cons_availability. |
String |
default |
use_funded_or_actual_staffing_postSwitch |
Staffing availability after switch in year_use_funded_or_actual_staffing_switch. Acceptable values are the same as those for Parameter use_funded_or_actual_staffing. |
String |
funded_plus |
Master_Facilities_List
District |
Facility_Level |
Region |
Facility_ID |
Facility_Name |
---|---|---|---|---|
Balaka |
1a |
Southern |
1 |
Facility_Level_1a_Balaka |
Balaka |
1b |
Southern |
2 |
Facility_Level_1b_Balaka |
Balaka |
2 |
Southern |
3 |
Facility_Level_2_Balaka |
Blantyre |
0 |
Southern |
4 |
Facility_Level_0_Blantyre |
Blantyre |
1a |
Southern |
5 |
Facility_Level_1a_Blantyre |
Blantyre |
1b |
Southern |
6 |
Facility_Level_1b_Blantyre |
Blantyre |
2 |
Southern |
7 |
Facility_Level_2_Blantyre |
Blantyre City |
0 |
Southern |
8 |
Facility_Level_0_Blantyre City |
Blantyre City |
1a |
Southern |
9 |
Facility_Level_1a_Blantyre City |
Only first 10 rows of 133 are shown.
Officer_Types_Table
Officer_Type |
Officer_Type_Code |
Officer_Category |
---|---|---|
Clinical Officer / Technician |
M02 |
Clinical |
Med. Assistant |
M03 |
Clinical |
Nurse Officer |
N01 |
Nursing_and_Midwifery |
Nurse Midwife Technician |
N02 |
Nursing_and_Midwifery |
Pharmacist |
P01 |
Pharmacy |
Pharm Technician |
P02 |
Pharmacy |
Pharm Assistant |
P03 |
Pharmacy |
Lab Officer |
L01 |
Laboratory |
Lab Technician |
L02 |
Laboratory |
Only first 10 rows of 21 are shown.
Appt_Types_Table
Appt_Type_Code |
Appt_Cat |
Appt_Type |
---|---|---|
IPAdmission |
GENERAL_INPATIENT_AND_OUTPATIENT_CARE |
Inpatient Admissions and Discharge Process |
Under5OPD |
GENERAL_INPATIENT_AND_OUTPATIENT_CARE |
Under 5 Outpatient Visit |
Over5OPD |
GENERAL_INPATIENT_AND_OUTPATIENT_CARE |
Over 5 Outpatient visit |
NormalDelivery |
RMNCH |
Normal Deliveries |
CompDelivery |
RMNCH |
Complicated Deliveries |
Csection |
RMNCH |
Caesarean Sections |
FamPlan |
RMNCH |
Family Planning |
AntenatalFirst |
RMNCH |
Antenatal Care - First Visit |
ANCSubsequent |
RMNCH |
Antenatal Care - Followup Visit |
Only first 10 rows of 50 are shown.
Appt_Offered_By_Facility_Level
Appt_Type_Code |
Facility_Level_0 |
Facility_Level_1a |
Facility_Level_1b |
Facility_Level_2 |
Facility_Level_3 |
Facility_Level_4 |
Facility_Level_5 |
---|---|---|---|---|---|---|---|
IPAdmission |
False |
True |
True |
True |
True |
False |
False |
Under5OPD |
False |
True |
True |
True |
True |
False |
False |
Over5OPD |
False |
True |
True |
True |
True |
False |
False |
NormalDelivery |
False |
True |
True |
True |
True |
False |
False |
CompDelivery |
False |
True |
True |
True |
True |
False |
False |
Csection |
False |
True |
True |
True |
True |
False |
False |
FamPlan |
False |
True |
True |
True |
False |
False |
False |
AntenatalFirst |
False |
True |
True |
True |
True |
False |
False |
ANCSubsequent |
False |
True |
True |
True |
True |
False |
False |
Only first 10 rows of 50 are shown.
Appt_Time_Table
Appt_Type_Code |
Facility_Level |
Officer_Category |
Time_Taken_Mins |
---|---|---|---|
ANCSubsequent |
2 |
Nursing_and_Midwifery |
18 |
ANCSubsequent |
2 |
Pharmacy |
1 |
ANCSubsequent |
3 |
Clinical |
3 |
ANCSubsequent |
3 |
Nursing_and_Midwifery |
15 |
ANCSubsequent |
3 |
Pharmacy |
5 |
ANCSubsequent |
1a |
Clinical |
1 |
ANCSubsequent |
1a |
Nursing_and_Midwifery |
11 |
ANCSubsequent |
1a |
Pharmacy |
0.4 |
ANCSubsequent |
1b |
Clinical |
2 |
Only first 10 rows of 345 are shown.
Daily_Capabilities_actual
Facility_ID |
Facility_Name |
Facility_Level |
District |
Region |
Officer_Category |
Total_Mins_Per_Day |
Staff_Count |
---|---|---|---|---|---|---|---|
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
DCSA |
17362.5 |
311 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Dental |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Laboratory |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Mental |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Nursing_and_Midwifery |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Nutrition |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Pharmacy |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Radiography |
0 |
0 |
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Clinical |
7764.57 |
35.9682 |
Only first 10 rows of 1197 are shown.
Daily_Capabilities_funded
Facility_ID |
Facility_Name |
Facility_Level |
District |
Region |
Officer_Category |
Total_Mins_Per_Day |
Staff_Count |
---|---|---|---|---|---|---|---|
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
DCSA |
13957 |
250 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Dental |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Laboratory |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Mental |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Nursing_and_Midwifery |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Nutrition |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Pharmacy |
0 |
0 |
0 |
Facility_Level_0_Balaka |
0 |
Balaka |
Southern |
Radiography |
0 |
0 |
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Clinical |
9786.98 |
47.0287 |
Only first 10 rows of 1197 are shown.
Daily_Capabilities_funded_plus
Facility_ID |
Facility_Name |
Facility_Level |
District |
Region |
Officer_Category |
Total_Mins_Per_Day |
Staff_Count |
---|---|---|---|---|---|---|---|
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Clinical |
9786.98 |
47.0287 |
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Dental |
2327.32 |
11.3933 |
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Laboratory |
5012.02 |
24.9123 |
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Nursing_and_Midwifery |
31874.9 |
150.48 |
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Nutrition |
110.791 |
0.542373 |
1 |
Facility_Level_1a_Balaka |
1a |
Balaka |
Southern |
Pharmacy |
4132.1 |
20.6361 |
2 |
Facility_Level_1b_Balaka |
1b |
Balaka |
Southern |
Clinical |
6470 |
31.8781 |
2 |
Facility_Level_1b_Balaka |
1b |
Balaka |
Southern |
Dental |
719.736 |
3.52345 |
2 |
Facility_Level_1b_Balaka |
1b |
Balaka |
Southern |
Laboratory |
1340.35 |
5.95697 |
Only first 10 rows of 733 are shown.
item_and_package_code_lookups
Intervention_Cat |
Intervention_Pkg |
Intervention_Pkg_Code |
Items |
Item_Code |
Expected_Units_Per_Case |
Unit_Cost |
---|---|---|---|---|---|---|
Maternal/Newborn and Reproductive Health |
Pill |
0 |
Levonorgestrel 0.15 mg + Ethinyl estradiol 30 mcg (Microgynon), cycle |
1 |
7.5 |
53.3501 |
Maternal/Newborn and Reproductive Health |
Male condom |
1 |
Condom, male |
2 |
120 |
20.9702 |
Maternal/Newborn and Reproductive Health |
Injectable |
2 |
Depot-Medroxyprogesterone Acetate 150 mg - 3 monthly |
3 |
4 |
50.9439 |
Maternal/Newborn and Reproductive Health |
Injectable |
2 |
Gloves, exam, latex, disposable, pair |
4 |
4 |
31.9087 |
Maternal/Newborn and Reproductive Health |
Injectable |
2 |
Povidone iodine, solution, 10 %, 5 ml per injection |
5 |
4 |
2.00634 |
Maternal/Newborn and Reproductive Health |
Injectable |
2 |
Syringe, Autodisable SoloShot IX |
6 |
4 |
5.4264 |
Maternal/Newborn and Reproductive Health |
IUD |
3 |
Gloves, exam, latex, disposable, pair |
4 |
3 |
31.9087 |
Maternal/Newborn and Reproductive Health |
IUD |
3 |
IUD, Copper T-380A |
7 |
1 |
19.3922 |
Maternal/Newborn and Reproductive Health |
Implant |
4 |
Gloves, exam, latex, disposable, pair |
4 |
2 |
31.9087 |
Only first 10 rows of 2444 are shown.
consumables_item_designations
is_diagnostic |
is_medicine |
is_other |
is_vital |
is_drug_or_vaccine |
---|---|---|---|---|
0 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
Only first 10 rows of 2016 are shown.
availability_estimates
Facility_ID |
month |
item_code |
available_prop |
---|---|---|---|
0 |
1 |
1 |
0.3825 |
0 |
1 |
2 |
0.555 |
0 |
1 |
3 |
0.33875 |
0 |
1 |
5 |
0.145161 |
0 |
1 |
6 |
0.609167 |
0 |
1 |
7 |
0.4 |
0 |
1 |
8 |
0 |
0 |
1 |
11 |
0.25 |
0 |
1 |
12 |
0.357143 |
Only first 10 rows of 307296 are shown.
BedCapacity
Facility_ID |
maternity_bed |
delivery_bed |
general_bed |
non_bed_space |
---|---|---|---|---|
1 |
134 |
29 |
14 |
1000 |
2 |
49 |
6 |
57 |
1000 |
3 |
35 |
4 |
54 |
1000 |
4 |
0 |
0 |
0 |
0 |
5 |
168 |
32 |
50 |
1000 |
6 |
61 |
7 |
195 |
1000 |
7 |
44 |
4 |
184 |
1000 |
8 |
0 |
0 |
0 |
0 |
9 |
168 |
32 |
50 |
1000 |
Only first 10 rows of 133 are shown.
EquipmentCatalogue
Item_Description |
Item_Code |
Pkg_Name |
Source_Equip_Item |
Alternative item names |
---|---|---|---|---|
Weighing scale |
1 |
ANC |
Malawi HSSPIII Equipment Costing 2023 |
‘Salter weighing scale’, ‘Waeighing Scale’ |
Autoclave |
2 |
nan |
Malawi HSSPIII Equipment Costing 2023 |
‘High pressure cooker sterilizer, complete with stove’, ‘Sterilization drums, medium’, ‘Sterilization drum’, ‘Sterilization buckets’, ‘Sterilization buckets (decontamination buckets)’, ‘Sterilization Buckets’, ‘Decontamination drums’, ‘Dressing drum medium’, ‘Dressing drum large’, ‘Dressing drum small’ |
Refrigerator |
3 |
nan |
Malawi HSSPIII Equipment Costing 2023 |
‘Vaccine refrigerator (solar)’, ‘Vaccine Refrigerator’ |
Cold box |
4 |
nan |
Malawi HSSPIII Equipment Costing 2023 |
‘Cold Chain Box-large’, ‘Cold Chain Box-medium’ |
Vaccine Carriers |
5 |
nan |
Malawi HSSPIII Equipment Costing 2023 |
nan |
Blood pressure machine |
6 |
Minor Surgery, Major Surgery, ICU |
Malawi HSSPIII Equipment Costing 2023 |
nan |
Thermometer |
7 |
nan |
Malawi HSSPIII Equipment Costing 2023 |
‘Thermometers, digital’ |
Push bike for mobility |
8 |
nan |
Malawi HSSPIII Equipment Costing 2023 |
nan |
Desk |
9 |
nan |
Malawi HSSPIII Equipment Costing 2023 |
‘Office desk’ |
Only first 10 rows of 404 are shown.
equipment_availability_estimates
Facility_ID |
Item_Code |
Pr_Available |
---|---|---|
0 |
1 |
0.75 |
0 |
2 |
1 |
0 |
3 |
1 |
0 |
4 |
0.226281 |
0 |
5 |
0.226281 |
0 |
6 |
0.25 |
0 |
7 |
0.75 |
0 |
8 |
0.226281 |
0 |
9 |
0.226281 |
Only first 10 rows of 53732 are shown.
priority_rank
Default
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
0 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
0 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
0 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
0 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
0 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
0 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
Test
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
0 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
0 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
0 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
0 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
0 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
0 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
Naive
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
1 |
0 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
2 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
2 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
2 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
2 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
2 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
2 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
2 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
2 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
Test Mode 1
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
4 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
0 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
4 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
4 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
0 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
4 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
0 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
4 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
ClinicallyVulnerable
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
1 |
0 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
3 |
2 |
2 |
2 |
2 |
Alri_Pneumonia_Treatment_Inpatient |
3 |
2 |
2 |
2 |
2 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
3 |
2 |
2 |
2 |
2 |
BladderCancer_Investigation |
3 |
2 |
2 |
2 |
2 |
BladderCancer_PalliativeCare |
3 |
2 |
2 |
2 |
2 |
BladderCancer_Treatment |
3 |
2 |
2 |
2 |
2 |
BreastCancer_Investigation |
3 |
2 |
2 |
2 |
2 |
BreastCancer_PalliativeCare |
3 |
2 |
2 |
2 |
2 |
Only first 10 rows of 87 are shown.
VerticalProgrammes
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
1 |
0 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
3 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
3 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
3 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
3 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
3 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
3 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
3 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
3 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
RMNCH
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
1 |
0 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
5 |
3 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
5 |
3 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
5 |
3 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
5 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
5 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
5 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
5 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
5 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
EHP_III
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
1 |
0 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
2 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
2 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
2 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
4 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
4 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
4 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
4 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
4 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
LCOA_EHP
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
1 |
0 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
2 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
3 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
3 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
4 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
4 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
4 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
4 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
4 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
CVD
Treatment |
Priority |
FT_if_5orUnder |
FT_if_pregnant |
FT_if_tbdiagnosed |
FT_if_Hivdiagnosed |
---|---|---|---|---|---|
FirstAttendance_SpuriousEmergencyCare |
1 |
0 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Outpatient |
3 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient |
3 |
-1 |
-1 |
-1 |
-1 |
Alri_Pneumonia_Treatment_Inpatient_Followup |
3 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Investigation |
3 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_PalliativeCare |
3 |
-1 |
-1 |
-1 |
-1 |
BladderCancer_Treatment |
3 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_Investigation |
3 |
-1 |
-1 |
-1 |
-1 |
BreastCancer_PalliativeCare |
3 |
-1 |
-1 |
-1 |
-1 |
Only first 10 rows of 87 are shown.
HR_scaling_by_level_and_officer_type_table
default
Officer_Category |
L0_factor |
L1a_factor |
L1b_factor |
L2_factor |
L3_factor |
L4_factor |
L5_factor |
---|---|---|---|---|---|---|---|
Clinical |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
DCSA |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Dental |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Laboratory |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Mental |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Nursing_and_Midwifery |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Nutrition |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Pharmacy |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Radiography |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
data
Officer_Category |
L0_factor |
L1a_factor |
L1b_factor |
L2_factor |
L3_factor |
L4_factor |
L5_factor |
---|---|---|---|---|---|---|---|
Clinical |
1 |
0.795927 |
0.836783 |
1.00678 |
1 |
1 |
1 |
DCSA |
2.13327 |
1 |
1 |
1 |
1 |
1 |
1 |
Dental |
1 |
1.46777 |
1.46777 |
1.46777 |
1 |
1 |
1 |
Laboratory |
1 |
1.0149 |
0.997807 |
1.14721 |
1 |
1 |
1 |
Mental |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Nursing_and_Midwifery |
1 |
0.605695 |
0.615689 |
0.799333 |
1 |
1 |
1 |
Nutrition |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Pharmacy |
1 |
1.02347 |
1.06089 |
1.30115 |
1 |
1 |
1 |
Radiography |
1 |
1 |
0.275236 |
0.277971 |
1 |
1 |
1 |
custom
Officer_Category |
L0_factor |
L1a_factor |
L1b_factor |
L2_factor |
L3_factor |
L4_factor |
L5_factor |
---|---|---|---|---|---|---|---|
Clinical |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
DCSA |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Dental |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Laboratory |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Mental |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Nursing_and_Midwifery |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Nutrition |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Pharmacy |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Radiography |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
x2_fac0&1
Officer_Category |
L0_factor |
L1a_factor |
L1b_factor |
L2_factor |
L3_factor |
L4_factor |
L5_factor |
---|---|---|---|---|---|---|---|
Clinical |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
DCSA |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
Dental |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
Laboratory |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
Mental |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
Nursing_and_Midwifery |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
Nutrition |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
Pharmacy |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
Radiography |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
HR_scaling_by_district_table
default
District |
Factor |
---|---|
Blantyre |
1 |
Blantyre City |
1 |
Chikwawa |
1 |
Chiradzulu |
1 |
Chitipa |
1 |
Dedza |
1 |
Dowa |
1 |
Karonga |
1 |
Kasungu |
1 |
Only first 10 rows of 32 are shown.
yearly_HR_scaling
no_scaling
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
scaling_by_population_growth
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1 |
True |
GDP_growth
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1.042 |
False |
GDP_growth_fHE_case1
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1.01074 |
False |
GDP_growth_fHE_case2
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1.02116 |
False |
GDP_growth_fHE_case3
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1.02637 |
False |
GDP_growth_fHE_case4
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1.05763 |
False |
GDP_growth_fHE_case5
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1.06284 |
False |
GDP_growth_fHE_case6
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2019 |
1.07326 |
False |
GDP_growth_FL_case1_const_tot_i
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2018 |
1.1 |
False |
2019 |
1.042 |
False |
2032 |
0.861157 |
False |
2033 |
1.042 |
False |
GDP_growth_FL_case2_const_tot_i
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2018 |
1.3 |
False |
2019 |
1.042 |
False |
2031 |
0.616568 |
False |
2032 |
1.042 |
False |
GDP_growth_FL_case1_vary_tot_in
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2018 |
1.1 |
False |
2019 |
1.042 |
False |
GDP_growth_FL_case2_vary_tot_in
year |
dynamic_HR_scaling_factor |
scale_HR_by_popsize |
---|---|---|
2010 |
1 |
False |
2018 |
1.3 |
False |
2019 |
1.042 |
False |
Hiv
Name |
Description |
Type |
Value |
---|---|---|---|
time_inf |
prob of time since infection for baseline adult pop |
Dataframe |
|
art_coverage |
coverage of ART at baseline |
Dataframe |
|
treatment_cascade |
spectrum estimates of treatment cascade |
Dataframe |
|
beta |
Transmission rate |
Real |
0.14379 |
unaids_prevalence_adjustment_factor |
adjustment for baseline age-specific prevalence values to give correct population prevalence |
Real |
1.1 |
prob_mtct_untreated |
Probability of mother to child transmission |
Real |
0.22 |
prob_mtct_treated |
Probability of mother to child transmission, mother on ART |
Real |
0.0 |
prob_mtct_incident_preg |
Probability of mother to child transmission, mother infected during pregnancy |
Real |
0.3 |
monthly_prob_mtct_bf_untreated |
Probability of mother to child transmission during breastfeeding |
Real |
0.01 |
monthly_prob_mtct_bf_treated |
Probability of mother to child transmission, mother infected during breastfeeding |
Real |
0.0 |
rr_fsw |
Relative risk of HIV with female sex work |
Real |
25.0 |
rr_circumcision |
Relative risk of HIV with circumcision |
Real |
0.4 |
rr_rural |
Relative risk of HIV in rural location |
Real |
0.52 |
rr_windex_poorer |
Relative risk of HIV with wealth level poorer |
Real |
0.96 |
rr_windex_middle |
Relative risk of HIV with wealth level middle |
Real |
1.18 |
rr_windex_richer |
Relative risk of HIV with wealth level richer |
Real |
1.19 |
rr_windex_richest |
Relative risk of HIV with wealth level richest |
Real |
1.56 |
rr_sex_f |
Relative risk of HIV if female |
Real |
1.43 |
rr_edlevel_primary |
Relative risk of HIV with primary education |
Real |
1.18 |
rr_edlevel_secondary |
Relative risk of HIV with secondary education |
Real |
1.15 |
rr_edlevel_higher |
Relative risk of HIV with higher education |
Real |
1.0 |
rr_schisto |
Relative risk of HIV with high intensity S. haematobium infection |
Real |
2.3 |
rr_behaviour_change |
Relative risk of HIV with behaviour modification |
Real |
0.75 |
proportion_reduction_in_risk_of_hiv_aq_if_on_prep |
Proportion reduction in risk of HIV acquisition if on PrEP. 0 for no efficacy; 1.0 for perfect efficacy. |
Real |
0.9 |
mean_months_between_aids_and_death |
Mean number of months (distributed exponentially) for the time between AIDS and AIDS Death |
Real |
18.0 |
mean_months_between_aids_and_death_infant |
Mean number of months for the time between AIDS and AIDS Death for infants |
Real |
6.0 |
infection_to_death_weibull_shape_1519 |
Shape parameter for Weibull describing time between infection and death for 15-19 yo (units: years) |
Real |
2.0 |
infection_to_death_weibull_shape_2024 |
Shape parameter for Weibull describing time between infection and death for 20-24 yo (units: years) |
Real |
2.0 |
infection_to_death_weibull_shape_2529 |
Shape parameter for Weibull describing time between infection and death for 25-29 yo (units: years) |
Real |
2.0 |
infection_to_death_weibull_shape_3034 |
Shape parameter for Weibull describing time between infection and death for 30-34 yo (units: years) |
Real |
2.0 |
infection_to_death_weibull_shape_3539 |
Shape parameter for Weibull describing time between infection and death for 35-39 yo (units: years) |
Real |
2.0 |
infection_to_death_weibull_shape_4044 |
Shape parameter for Weibull describing time between infection and death for 40-44 yo (units: years) |
Real |
2.0 |
infection_to_death_weibull_shape_4549 |
Shape parameter for Weibull describing time between infection and death for 45-49 yo (units: years) |
Real |
2.0 |
infection_to_death_weibull_scale_1519 |
Scale parameter for Weibull describing time between infection and death for 15-19 yo (units: years) |
Real |
16.0 |
infection_to_death_weibull_scale_2024 |
Scale parameter for Weibull describing time between infection and death for 20-24 yo (units: years) |
Real |
15.4 |
infection_to_death_weibull_scale_2529 |
Scale parameter for Weibull describing time between infection and death for 25-29 yo (units: years) |
Real |
14.1 |
infection_to_death_weibull_scale_3034 |
Scale parameter for Weibull describing time between infection and death for 30-34 yo (units: years) |
Real |
12.1 |
infection_to_death_weibull_scale_3539 |
Scale parameter for Weibull describing time between infection and death for 35-39 yo (units: years) |
Real |
11.0 |
infection_to_death_weibull_scale_4044 |
Scale parameter for Weibull describing time between infection and death for 40-44 yo (units: years) |
Real |
10.01 |
infection_to_death_weibull_scale_4549 |
Scale parameter for Weibull describing time between infection and death for 45-49 yo (units: years) |
Real |
7.9 |
art_default_to_aids_mean_years |
Mean years between when a person (any change) stops being on treatment to when AIDS is onset (if the absence of resuming treatment). |
Real |
5.0 |
prop_delayed_aids_onset |
Proportion of PLHIV that will have delayed AIDS onset to compensate for AIDS-TB |
Real |
0.3 |
mean_survival_for_infants_infected_prior_to_birth |
Exponential rate parameter for mortality in infants who are infected before birth |
Real |
1.08 |
infection_to_death_infant_infection_after_birth_weibull_scale |
Weibull scale parameter for mortality in infants who are infected after birth |
Real |
16.0 |
infection_to_death_infant_infection_after_birth_weibull_shape |
Weibull shape parameter for mortality in infants who are infected after birth |
Real |
2.7 |
hiv_testing_rates |
annual rates of testing for children and adults |
Dataframe |
|
rr_test_hiv_positive |
relative likelihood of having HIV test for people with HIV |
Real |
1.1 |
hiv_testing_rate_adjustment |
adjustment to current testing rates to account for multiple routes into HIV testing |
Real |
0.75 |
treatment_initiation_adjustment |
adjustment to current ART coverage levels to account for defaulters |
Real |
1.0 |
vs_adjustment |
adjustment to current viral suppression levels to account for defaulters |
Real |
1.0 |
prob_hiv_test_at_anc_or_delivery |
probability of a women having hiv test at anc or following delivery |
Real |
0.95 |
prob_hiv_test_for_newborn_infant |
probability of a newborn infant having HIV test pre-discharge |
Real |
0.95 |
prob_start_art_or_vs |
Probability that a person will start treatment and be virally suppressed following testing |
Dataframe |
|
prob_behav_chg_after_hiv_test |
Probability that a person will change risk behaviours, if HIV-negative, following testing |
Real |
0.5 |
prob_prep_for_fsw_after_hiv_test |
Probability that a FSW will start PrEP, if HIV-negative, following testing |
Real |
0.05 |
prob_prep_for_agyw |
Probability that adolescent girls / young women will start PrEP |
Real |
0.0 |
prob_circ_after_hiv_test |
Probability that a male will be circumcised, if HIV-negative, following testing |
Real |
0.05 |
prob_circ_for_child_before_2020 |
Probability that a male aging <15 yrs will be circumcised before year 2020 |
Real |
0.0128 |
prob_circ_for_child_from_2020 |
Probability that a male aging <15 yrs will be circumcised from year 2020, which is different from before 2020 as children vmmc policy/fund/cases has changed, according to PEPFAR 2020 Country Operational Plan and DHIS2 data |
Real |
0.0008 |
probability_of_being_retained_on_prep_every_3_months |
Probability that someone who has initiated on prep will attend an appointment and be on prep for the next 3 months, until the next appointment. |
Real |
0.5 |
probability_of_being_retained_on_art_every_3_months |
Probability that someone who has initiated on treatment will attend an appointment and be on treatment for next 3 months, until the next appointment. |
Real |
0.95 |
probability_of_seeking_further_art_appointment_if_drug_not_available |
Probability that a person who ‘should’ be on art will seek another appointment (the following day and try for each of the next 7 days) if drugs were not available. |
Real |
0.9 |
probability_of_seeking_further_art_appointment_if_appointment_not_available |
Probability that a person who ‘should’ be on art will seek another appointment if the health-system has not been able to provide them with an appointment |
Real |
0.9 |
prep_start_year |
Year from which PrEP is available |
Real |
2018.0 |
ART_age_cutoff_young_child |
Age cutoff for ART regimen for young children |
Integer |
1 |
ART_age_cutoff_older_child |
Age cutoff for ART regimen for older children |
Integer |
10 |
rel_probability_art_baseline_aids |
relative probability of person with HIV infection over 10 years being on ART at baseline |
Real |
10.0 |
aids_tb_treatment_adjustment |
probability of death if aids and tb, person on treatment for tb |
Real |
0.5 |
hiv_healthseekingbehaviour_cap |
number of repeat visits assumed for healthcare services |
Integer |
5 |
dispensation_period_months |
length of prescription for ARVs in months, same for all PLHIV |
Real |
3.0 |
length_of_inpatient_stay_if_terminal |
length in days of inpatient stay for end-of-life HIV patients: list has two elements [low-bound-inclusive, high-bound-exclusive] |
List |
[14, 20] |
type_of_scaleup |
argument to determine type scale-up of program which will be implemented, can be ‘none’, ‘target’ or ‘max’ |
String |
none |
scaleup_start_year |
the year when the scale-up starts (it will occur on 1st January of that year) |
Integer |
2025 |
scaleup_parameters |
the parameters and values changed in scenario analysis |
Dataframe |
time_inf
year |
probability_infection |
scaled_prob |
Unnamed: 3 |
Unnamed: 4 |
Unnamed: 5 |
Distribution by CD4 count - HIV+ not on ART (15+) - (Male+Female) |
Unnamed: 7 |
Unnamed: 8 |
Unnamed: 9 |
Unnamed: 10 |
Unnamed: 11 |
Unnamed: 12 |
Unnamed: 13 |
Unnamed: 14 |
Unnamed: 15 |
Unnamed: 16 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
20 |
0.0145011 |
0.0167087 |
nan |
nan |
nan |
malawi_2021_v14_aim_v6.07 |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
19 |
0.018403 |
0.0212047 |
nan |
nan |
nan |
2010 |
150189.14229 |
134383.22199 |
114415.4995 |
52950.4893 |
77739.93484 |
28957.76557 |
20245.60225 |
578882 |
276528 |
0.350438 |
18 |
0.022511 |
0.0259382 |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
17 |
0.0264052 |
0.0304252 |
nan |
nan |
nan |
Distribution by CD4 count - HIV+ on ART (15+) - (Male+Female) |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
16 |
0.0305511 |
0.0352023 |
nan |
nan |
nan |
nan |
> 500 |
350 - 500 |
250 - 349 |
200 - 249 |
100 - 199 |
50 - 99 |
< 50 |
nan |
nan |
nan |
15 |
0.0338398 |
0.0389916 |
nan |
nan |
nan |
malawi_2021_v14_aim_v6.07 |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
14 |
0.0383583 |
0.044198 |
nan |
nan |
nan |
2010 |
6268.17276 |
5523.92113 |
4618.85403 |
44214.79861 |
77016.22359 |
36469.29667 |
36098.98313 |
210210 |
nan |
nan |
13 |
0.0423454 |
0.0487921 |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
12 |
0.0452294 |
0.0521152 |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
nan |
Only first 10 rows of 21 are shown.
art_coverage
year |
age |
single_age |
sex |
art_coverage |
prop_coverage |
---|---|---|---|---|---|
2009 |
0_4 |
1 |
F |
10.69 |
0.1069 |
2009 |
0_4 |
2 |
F |
10.69 |
0.1069 |
2009 |
0_4 |
3 |
F |
10.69 |
0.1069 |
2009 |
0_4 |
4 |
F |
10.69 |
0.1069 |
2009 |
5_9 |
5 |
F |
7.6 |
0.076 |
2009 |
5_9 |
6 |
F |
7.6 |
0.076 |
2009 |
5_9 |
7 |
F |
7.6 |
0.076 |
2009 |
5_9 |
8 |
F |
7.6 |
0.076 |
2009 |
5_9 |
9 |
F |
7.6 |
0.076 |
Only first 10 rows of 1662 are shown.
treatment_cascade
year |
age |
plhiv |
know_status |
on_art |
plhiv_virally_suppressed |
prob_art_if_dx |
virally_suppressed_on_art |
vs_assumed_value |
---|---|---|---|---|---|---|---|---|
2011 |
adults |
100 |
73.2277 |
37.6375 |
nan |
0.513979 |
80 |
yes |
2012 |
adults |
100 |
76.423 |
46.3159 |
42.1013 |
0.606046 |
91 |
no |
2013 |
adults |
100 |
78.7843 |
52.9497 |
47.6735 |
0.672084 |
90 |
no |
2014 |
adults |
100 |
80.8733 |
59.2378 |
51.5664 |
0.732477 |
87 |
no |
2015 |
adults |
100 |
82.7952 |
64.1071 |
57.269 |
0.774285 |
89 |
no |
2016 |
adults |
100 |
85.3839 |
71.6873 |
65.3256 |
0.839588 |
91 |
no |
2017 |
adults |
100 |
88.3281 |
78.056 |
69.322 |
0.883705 |
89 |
no |
2018 |
adults |
100 |
90.6581 |
84.2257 |
76.8029 |
0.929047 |
91 |
no |
2019 |
adults |
100 |
92.1484 |
85.4227 |
79.9867 |
0.927012 |
94 |
no |
Only first 10 rows of 32 are shown.
hiv_testing_rates
year |
adults_15plus |
children0_14 |
total |
pop_size_children0_14 |
pop_size_adults15plus |
annual_testing_rate_children |
annual_testing_rate_adults |
annual_testing_rate_all_ages |
testing_yield |
---|---|---|---|---|---|---|---|---|---|
2011 |
1.47766e+06 |
147536 |
1.62766e+06 |
6.84823e+06 |
8.2137e+06 |
0.0215437 |
0.179902 |
0.108065 |
nan |
2012 |
1.54915e+06 |
149514 |
1.70682e+06 |
6.94965e+06 |
8.51109e+06 |
0.0215139 |
0.182016 |
0.110397 |
nan |
2013 |
1.56574e+06 |
136888 |
1.70263e+06 |
7.04596e+06 |
8.8196e+06 |
0.0194279 |
0.177529 |
0.107316 |
nan |
2014 |
1.73309e+06 |
161964 |
1.89506e+06 |
7.13959e+06 |
9.13714e+06 |
0.0226853 |
0.189676 |
0.116427 |
nan |
2015 |
2.01048e+06 |
215807 |
2.22629e+06 |
7.23293e+06 |
9.46126e+06 |
0.0298367 |
0.212496 |
0.133357 |
nan |
2016 |
2.91753e+06 |
483515 |
3.40104e+06 |
7.32839e+06 |
9.79171e+06 |
0.0659783 |
0.297959 |
0.198658 |
nan |
2017 |
3.62603e+06 |
539283 |
4.16531e+06 |
7.42836e+06 |
1.01303e+07 |
0.0725978 |
0.35794 |
0.237223 |
0.023 |
2018 |
4.09092e+06 |
544240 |
4.63516e+06 |
7.53526e+06 |
1.04771e+07 |
0.0722257 |
0.390464 |
0.257332 |
0.01925 |
2019 |
3.64886e+06 |
418104 |
4.06697e+06 |
7.66667e+06 |
1.09056e+07 |
0.0545353 |
0.334586 |
0.218981 |
0.01425 |
Only first 10 rows of 41 are shown.
prob_start_art_or_vs
year |
age |
plhiv |
know_status |
on_art |
plhiv_virally_suppressed |
prob_art_if_dx |
virally_suppressed_on_art |
vs_assumed_value |
---|---|---|---|---|---|---|---|---|
2011 |
adults |
100 |
73.2277 |
37.6375 |
nan |
0.513979 |
80 |
yes |
2012 |
adults |
100 |
76.423 |
46.3159 |
42.1013 |
0.606046 |
91 |
no |
2013 |
adults |
100 |
78.7843 |
52.9497 |
47.6735 |
0.672084 |
90 |
no |
2014 |
adults |
100 |
80.8733 |
59.2378 |
51.5664 |
0.732477 |
87 |
no |
2015 |
adults |
100 |
82.7952 |
64.1071 |
57.269 |
0.774285 |
89 |
no |
2016 |
adults |
100 |
85.3839 |
71.6873 |
65.3256 |
0.839588 |
91 |
no |
2017 |
adults |
100 |
88.3281 |
78.056 |
69.322 |
0.883705 |
89 |
no |
2018 |
adults |
100 |
90.6581 |
84.2257 |
76.8029 |
0.929047 |
91 |
no |
2019 |
adults |
100 |
92.1484 |
85.4227 |
79.9867 |
0.927012 |
94 |
no |
Only first 10 rows of 32 are shown.
scaleup_parameters
parameter |
target_value |
min_value |
max_value |
---|---|---|---|
reduction_in_hiv_beta |
0.9 |
1 |
0 |
prob_prep_for_fsw_after_hiv_test |
0.5 |
0 |
1 |
prob_prep_for_agyw |
0.1 |
0 |
1 |
probability_of_being_retained_on_prep_every_3_months |
0.75 |
0 |
1 |
probability_of_being_retained_on_art_every_3_months |
1 |
0 |
1 |
prob_circ_after_hiv_test |
0.25 |
0 |
1 |
annual_testing_rate_adults |
0.4 |
0 |
1 |
prob_hiv_test_at_anc_or_delivery |
0.95 |
0 |
1 |
prob_hiv_test_for_newborn_infant |
0.95 |
0 |
1 |
virally_suppressed_on_art |
95 |
0 |
100 |
Labour
Name |
Description |
Type |
Value |
---|---|---|---|
intercept_parity_lr2010 |
intercept value for linear regression equation predicating womens parity at 2010 baseline |
List |
[-2.81, -2.81] |
effect_age_parity_lr2010 |
effect of an increase in age by 1 year in the linear regression equation predicating womens parity at 2010 baseline |
List |
[0.21, 0.21] |
effect_mar_stat_2_parity_lr2010 |
effect of a change in marriage status from comparison (level 1) in the linear regression equation predicating womans parity at 2010 baseline |
List |
[0.84, 0.84] |
effect_mar_stat_3_parity_lr2010 |
effect of a change in marriage status from comparison (level 1) in the linear regression equation predicating womans parity at 2010 baseline |
List |
[0.14, 0.14] |
effect_wealth_lev_4_parity_lr2010 |
effect of an increase in wealth level in the linear regression equation predicating womans parity at 2010 base line |
List |
[-0.09, -0.09] |
effect_wealth_lev_3_parity_lr2010 |
effect of an increase in wealth level in the linear regression equation predicating womans parity at 2010 base line |
List |
[-0.18, -0.18] |
effect_wealth_lev_2_parity_lr2010 |
effect of an increase in wealth level in the linear regression equation predicating womans parity at 2010 base line |
List |
[-0.22, -0.22] |
effect_wealth_lev_1_parity_lr2010 |
effect of an increase in wealth level in the linear regression equation predicating womans parity at 2010 base line |
List |
[-0.48, -0.48] |
effect_edu_lev_2_parity_lr2010 |
effect of an increase in education level in the linear regression equation predicating womans parity at 2010 base line |
List |
[-0.33, -0.33] |
effect_edu_lev_3_parity_lr2010 |
effect of an increase in education level in the linear regression equation predicating womans parity at 2010 base line |
List |
[-1, -1] |
effect_rural_parity_lr2010 |
effect of rural living in the linear regression equation predicating womans parity at 2010 base line |
List |
[0.19, 0.19] |
prob_previous_caesarean_at_baseline |
probability of previously having delivered via caesarean section at baseline |
List |
[0.046, 0.046] |
risk_post_term_labour |
risk of remaining pregnant past 42 weeks |
List |
[0.077, 0.077] |
rr_potl_bmi_30_35 |
effect of maternal BMI being between 30 and 35 on risk of post term labour |
List |
[1.42, 1.42] |
rr_potl_bmi_35+ |
effect of maternal BMI being between above 35 on risk of post term labour |
List |
[1.55, 1.55] |
list_limits_for_defining_term_status |
List of number of days of gestation used to define term, early preterm, late preterm and post term delivery |
List |
[[259, 293, 148, 230, 231, 258, 294], [259, 293, 148, 230, 231, 258, 294]] |
allowed_interventions |
list of interventions allowed to run, used in analysis |
List |
[[‘prophylactic_labour_interventions’, ‘assessment_and_treatment_of_severe_pre_eclampsia’, ‘assessment_and_treatment_of_obstructed_labour’, ‘assessment_and_treatment_of_maternal_sepsis’, ‘assessment_and_treatment_of_hypertension’, ‘assessment_and_treatment_of_eclampsia’, ‘assessment_and_plan_for_referral_antepartum_haemorrhage’, ‘assessment_and_plan_for_referral_uterine_rupture’, ‘active_management_of_the_third_stage_of_labour’, ‘assessment_and_treatment_of_pph_retained_placenta’, ‘assessment_and_treatment_of_pph_uterine_atony’], [‘prophylactic_labour_interventions’, ‘assessment_and_treatment_of_severe_pre_eclampsia’, ‘assessment_and_treatment_of_obstructed_labour’, ‘assessment_and_treatment_of_maternal_sepsis’, ‘assessment_and_treatment_of_hypertension’, ‘assessment_and_treatment_of_eclampsia’, ‘assessment_and_plan_for_referral_antepartum_haemorrhage’, ‘assessment_and_plan_for_referral_uterine_rupture’, ‘active_management_of_the_third_stage_of_labour’, ‘assessment_and_treatment_of_pph_retained_placenta’, ‘assessment_and_treatment_of_pph_uterine_atony’]] |
mean_birth_weights |
list of mean birth weights from gestational age at birth 24-41 weeks |
List |
[[657, 746, 851, 966, 1096, 1240, 1440, 1641, 1841, 2041, 2242, 2442, 2736, 2856, 2995, 3036, 3117, 3136], [657, 746, 851, 966, 1096, 1240, 1440, 1641, 1841, 2041, 2242, 2442, 2736, 2856, 2995, 3036, 3117, 3136]] |
standard_deviation_birth_weights |
list of standard deviations associated with mean birth weights from gestational age at birth 24-41 weeks |
List |
[[113, 140, 169, 196, 218, 235, 274, 312, 351, 390, 428, 460, 467, 398, 356, 351, 396, 351], [113, 140, 169, 196, 218, 235, 274, 312, 351, 390, 428, 460, 467, 398, 356, 351, 396, 351]] |
residual_prob_of_macrosomia |
probability that those allocated to be normal birth weight and above will be macrosomic (>4kg) |
List |
[0.057, 0.057] |
prob_obstruction_cpd |
risk of a woman developing obstructed labour secondary to cephalopelvic disproportion |
List |
[0.012, 0.022] |
rr_obstruction_cpd_stunted_mother |
relative risk of obstruction secondary to CPD in mothers who are stunted |
List |
[2.4, 2.4] |
rr_obstruction_foetal_macrosomia |
relative risk of obstruction secondary to CPD in mothers who are carrying a macrosomic foetus |
List |
[3.3, 3.3] |
prob_obstruction_malpos_malpres |
risk of a woman developing obstructed labour secondary to malposition or malpresentation |
List |
[0.005, 0.009] |
prob_obstruction_other |
risk of a woman developing obstructed labour secondary to other causes |
List |
[0.0015, 0.0027] |
prob_placental_abruption_during_labour |
probability of a woman developing placental abruption during labour |
List |
[0.0005, 0.0005] |
prob_aph_placenta_praevia_labour |
probability of a woman with placenta praevia experiencing an APH during labour |
List |
[0.25, 0.25] |
prob_aph_placental_abruption_labour |
probability of a woman with placental abruption experiencing an APH during labour |
List |
[0.9, 0.9] |
rr_placental_abruption_hypertension |
Relative risk of placental abruption in women with hypertension |
List |
[2.2, 2.2] |
rr_placental_abruption_previous_cs |
Relative risk of placental abruption in women who delivered previously via caesarean section |
List |
[1.3, 1.3] |
severity_maternal_haemorrhage |
probability a maternal hemorrhage is non-severe (<1000mls) or severe (>1000mls) |
List |
[[0.8, 0.2], [0.8, 0.2]] |
cfr_aph |
case fatality rate for antepartum haemorrhage during labour |
List |
[0.11, 0.04] |
prob_sepsis_chorioamnionitis |
risk of sepsis following chorioamnionitis infection |
List |
[0.0002, 0.00018] |
rr_sepsis_chorio_prom |
relative risk of chorioamnionitis following PROM |
List |
[1.76, 1.76] |
prob_sepsis_endometritis |
risk of sepsis following endometritis |
List |
[6.9e-05, 6.2e-05] |
rr_sepsis_endometritis_post_cs |
relative risk of endometritis following caesarean delivery |
List |
[12.1, 12.1] |
prob_sepsis_urinary_tract |
risk of sepsis following urinary tract infection |
List |
[5.4e-05, 5.4e-05] |
prob_sepsis_skin_soft_tissue |
risk of sepsis following skin or soft tissue infection |
List |
[3.9e-05, 3.5e-05] |
rr_sepsis_sst_post_cs |
relative risk of skin/soft tissue sepsis following caesarean delivery |
List |
[3.9, 3.9] |
cfr_sepsis |
case fatality rate for sepsis during labour |
List |
[0.75, 0.49] |
cfr_pp_sepsis |
case fatality rate for sepsis following delivery |
List |
[0.75, 0.49] |
prob_uterine_rupture |
probability of a uterine rupture during labour |
List |
[0.0011, 0.0005] |
rr_ur_parity_2 |
relative risk of uterine rupture in women who have delivered 2 times previously |
List |
[2.74, 2.74] |
rr_ur_parity_3_or_4 |
relative risk of uterine rupture in women who have delivered 3-4 times previously |
List |
[4.89, 4.89] |
rr_ur_parity_5+ |
relative risk of uterine rupture in women who have delivered > 5 times previously |
List |
[7.57, 7.57] |
rr_ur_prev_cs |
relative risk of uterine rupture in women who have previously delivered via caesarean section |
List |
[2.02, 2.02] |
rr_ur_obstructed_labour |
relative risk of uterine rupture in women who have been in obstructed labour |
List |
[23.6, 23.6] |
cfr_uterine_rupture |
case fatality rate for uterine rupture in labour |
List |
[0.65, 0.5] |
prob_progression_gest_htn |
probability of gestational hypertension progressing to severe gestational hypertensionduring/after labour |
List |
[0.036, 0.036] |
prob_progression_severe_gest_htn |
probability of severe gestational hypertension progressing to severe pre-eclampsia during/after labour |
List |
[0.13, 0.13] |
prob_progression_mild_pre_eclamp |
probability of mild pre-eclampsia progressing to severe pre-eclampsia during/after labour |
List |
[0.14, 0.14] |
prob_progression_severe_pre_eclamp |
probability of severe pre-eclampsia progressing to eclampsia during/after labour |
List |
[0.29, 0.29] |
cfr_eclampsia |
case fatality rate for eclampsia during labours |
List |
[0.028, 0.03] |
cfr_severe_pre_eclamp |
case fatality rate for severe pre eclampsia during labour |
List |
[0.018, 0.018] |
prob_ip_still_birth |
baseline probability of intrapartum still birth |
List |
[0.006, 0.005] |
rr_still_birth_maternal_death |
relative risk of still birth in mothers who have died during labour |
List |
[180, 180] |
rr_still_birth_ur |
relative risk of still birth in mothers experiencing uterine rupture |
List |
[56.6, 56.6] |
rr_still_birth_ol |
relative risk of still birth in mothers experiencing obstructed labour |
List |
[4.5, 4.5] |
rr_still_birth_aph |
relative risk of still birth in mothers experiencing antepartum haemorrhage |
List |
[2.1, 2.1] |
rr_still_birth_hypertension |
relative risk of still birth in mothers experiencing hypertension |
List |
[4.5, 4.5] |
rr_still_birth_sepsis |
relative risk of still birth in mothers experiencing intrapartum sepsis |
List |
[2, 2] |
rr_still_birth_multiple_pregnancy |
relative risk of still birth in mothers pregnant with twins |
List |
[3, 3] |
prob_both_twins_ip_still_birth |
probability that if this mother will experience still birth, and she is pregnant with twins, that neither baby will survive |
List |
[0.8, 0.8] |
prob_pph_uterine_atony |
risk of pph after experiencing uterine atony |
List |
[0.006, 0.011] |
rr_pph_ua_hypertension |
relative risk risk of pph after secondary to uterine atony in hypertensive women |
List |
[1.84, 1.84] |
rr_pph_ua_multiple_pregnancy |
relative risk risk of pph after secondary to uterine atony in women pregnant with twins |
List |
[2.16, 2.16] |
rr_pph_ua_placental_abruption |
relative risk risk of pph after secondary to uterine atony in women with placental abruption |
List |
[2.74, 2.74] |
rr_pph_ua_macrosomia |
relative risk risk of pph after secondary to uterine atony in women with macrosomic foetus |
List |
[1.46, 1.46] |
rr_pph_ua_diabetes |
risk of pph after experiencing uterine atony |
List |
[1.22, 1.22] |
prob_pph_retained_placenta |
risk of pph after experiencing retained placenta |
List |
[0.001, 0.0016] |
prob_pph_other_causes |
risk of pph after experiencing other pph causes |
List |
[0.0007, 0.001] |
cfr_pp_pph |
case fatality rate for postpartum haemorrhage |
List |
[0.22, 0.08] |
rr_death_from_haem_with_anaemia |
relative risk increase of death in women who are anaemic at time of PPH |
List |
[1.5, 1.5] |
odds_deliver_in_health_centre |
odds of a woman delivering in a health centre compared to a hospital |
List |
[0.69, 1.08] |
rrr_hc_delivery_age_20_24 |
relative risk ratio for a woman aged 20-24 delivering in a health centre compared to a hospital |
List |
[0.79, 1] |
rrr_hc_delivery_age_25_29 |
relative risk ratio for a woman aged 25-29 delivering in a health centre compared to a hospital |
List |
[0.5, 0.56] |
rrr_hc_delivery_age_30_34 |
relative risk ratio for a woman aged 30-34 delivering in a health centre compared to a hospital |
List |
[0.27, 0.32] |
rrr_hc_delivery_age_35_39 |
relative risk ratio for a woman aged 35-39 delivering in a health centre compared to a hospital |
List |
[0.13, 0.14] |
rrr_hc_delivery_age_40_44 |
relative risk ratio for a woman aged 40-44 delivering in a health centre compared to a hospital |
List |
[0.06, 0.07] |
rrr_hc_delivery_age_45_49 |
relative risk ratio for a woman aged 45-49 delivering in a health centre compared to a hospital |
List |
[0.02, 0.03] |
rrr_hc_delivery_wealth_4 |
relative risk ratio of a woman at wealth level 4 delivering at health centre compared to a hospital |
List |
[0.82, 0.79] |
rrr_hc_delivery_wealth_3 |
relative risk ratio of a woman at wealth level 3 delivering at health centre compared to a hospital |
List |
[0.77, 0.73] |
rrr_hc_delivery_wealth_2 |
relative risk ratio of a woman at wealth level 2 delivering at health centre compared to a hospital |
List |
[0.62, 0.58] |
rrr_hc_delivery_wealth_1 |
relative risk ratio of a woman at wealth level 1 delivering at health centre compared to a hospital |
List |
[0.55, 0.43] |
rrr_hc_delivery_parity_3_to_4 |
relative risk ratio for a woman with a parity of 3-4 delivering in a health centre compared toa hospital |
List |
[2, 1.85] |
rrr_hc_delivery_parity_>4 |
relative risk ratio of a woman with a parity >4 delivering in health centre compared to a hospital |
List |
[3.9, 3.8] |
rrr_hc_delivery_rural |
relative risk ratio of a married woman delivering in a health centre compared to a hospital |
List |
[1.99, 1.81] |
rrr_hc_delivery_married |
relative risk ratio of a married woman delivering in a health centre compared to a hospital |
List |
[1.3, 1.42] |
odds_deliver_at_home |
odds of a woman delivering at home compared to a hospital |
List |
[0.37, 0.09] |
rrr_hb_delivery_age_20_24 |
relative risk ratio for a woman aged 20-24 delivering at home compared to a hospital |
List |
[1.42, 1] |
rrr_hb_delivery_age_25_29 |
relative risk ratio for a woman aged 25-29 delivering at home compared to a hospital |
List |
[1, 0.58] |
rrr_hb_delivery_age_30_34 |
relative risk ratio for a woman aged 30-34 delivering at home compared to a hospital |
List |
[0.42, 0.25] |
rrr_hb_delivery_age_35_39 |
relative risk ratio for a woman aged 35-39 delivering at home compared to a hospital |
List |
[0.24, 0.16] |
rrr_hb_delivery_age_40_44 |
relative risk ratio for a woman aged 40-44 delivering at home compared to a hospital |
List |
[0.12, 0.07] |
rrr_hb_delivery_age_45_49 |
relative risk ratio for a woman aged 45-49 delivering at home compared to a hospital |
List |
[0.05, 0.04] |
rrr_hb_delivery_rural |
relative risk ratio of a rural delivering at home compared to a hospital |
List |
[1.73, 1] |
rrr_hb_delivery_primary_education |
relative risk ratio of a woman with a primary education delivering at home compared to a hospital |
List |
[0.76, 0.79] |
rrr_hb_delivery_secondary_education |
relative risk ratio of a woman with a secondary education delivering at home compared to a hospital |
List |
[0.46, 0.51] |
rrr_hb_delivery_wealth_4 |
relative risk ratio of a woman at wealth level 4 delivering at home compared to a hospital |
List |
[0.82, 0.74] |
rrr_hb_delivery_wealth_3 |
relative risk ratio of a woman at wealth level 3 delivering at home compared to a hospital |
List |
[0.72, 0.68] |
rrr_hb_delivery_wealth_2 |
relative risk ratio of a woman at wealth level 2 delivering at home compared to a hospital |
List |
[0.41, 0.49] |
rrr_hb_delivery_wealth_1 |
relative risk ratio of a woman at wealth level 1 delivering at home compared to a hospital |
List |
[0.2, 0.17] |
rrr_hb_delivery_parity_3_to_4 |
relative risk ratio for a woman with a parity of 3-4 delivering at home compared toa hospital |
List |
[2.4, 1] |
rrr_hb_delivery_parity_>4 |
relative risk ratio of a woman with a parity >4 delivering at home compared to a hospital |
List |
[5.25, 1] |
rrr_hb_delivery_married |
relative risk ratio of a married woman delivering in a home compared to a hospital |
List |
[0.63, 1] |
probability_delivery_hospital |
probability of delivering in a hospital |
List |
[0.32, 0.4] |
prob_timings_pnc |
probabilities that a woman who will receive a PNC check will receive care <48hrs post birth or > 48hrs post birth |
List |
[[0.85, 0.15], [0.88, 0.12]] |
odds_will_attend_pnc |
baseline odss a woman will seek PNC for her and her newborn following delivery |
List |
[0.9, 0.9] |
or_pnc_age_30_35 |
odds ratio for women aged 30-35 attending PNC |
List |
[1.75, 1.75] |
or_pnc_age_>35 |
odds ratio for women aged > 35 attending PNC |
List |
[1.86, 1.86] |
or_pnc_rural |
odds ratio for women who live rurally attending PNC |
List |
[0.55, 0.55] |
or_pnc_wealth_level_1 |
odds ratio for women from the highest wealth level attending PNC |
List |
[0.72, 0.72] |
or_pnc_anc4+ |
odds ratio for women who attended ANC4+ attending PNC |
List |
[1.2, 1.2] |
or_pnc_caesarean_delivery |
odds ratio for women who delivered by caesarean attending PNC |
List |
[1.93, 1.93] |
or_pnc_facility_delivery |
odds ratio for women who delivered in a health facility attending PNC |
List |
[1.91, 1.91] |
or_pnc_parity_>4 |
odds ratio for women with a parity of >4 attending PNC |
List |
[0.03, 0.03] |
probs_of_attending_pn_event_by_day |
probabilities used in a weighted random draw to determine when a woman will attend the postnatal event |
List |
[[0.4, 0.3, 0.2, 0.05, 0.05], [0.4, 0.3, 0.2, 0.05, 0.05]] |
prob_careseeking_for_complication |
probability of a woman seeking skilled assistance after developing a complication at a home birth |
List |
[0.782, 0.782] |
prob_careseeking_for_complication_pn |
probability of a woman seeking skilled assistance after developing a postnatal complication following a home birth |
List |
[0.782, 0.782] |
test_care_seeking_probs |
dummy probabilities of delivery care seeking used in testing |
List |
[[0.33, 0.33, 0.34], [0.33, 0.33, 0.34]] |
prob_delivery_modes_ec |
probabilities that a woman admitted with eclampsia will deliver normally, via caesarean or via assisted vaginal delivery |
List |
[[0, 0, 1], [0, 0, 1]] |
prob_delivery_modes_spe |
probabilities that a woman admitted with severe pre-eclampsia will deliver normally, via caesarean or via assisted vaginal delivery |
List |
[[0.05, 0.05, 0.9], [0.05, 0.05, 0.9]] |
residual_prob_avd |
probabilities that a woman will deliver via assisted vaginal delivery for an indication not explicitly modelled |
List |
[0.128, 0.128] |
residual_prob_caesarean |
probabilities that a woman will deliver via caesarean section for an indication not explicitly modelled |
List |
[0.0188, 0.022] |
prob_adherent_ifa |
probability that a woman started on postnatal IFA will be adherent |
List |
[0.37, 0.34] |
effect_of_ifa_for_resolving_anaemia |
relative effect of iron and folic acid on anaemia status |
List |
[0.7, 0.7] |
number_ifa_tablets_required_postnatally |
total number of iron and folic acid tablets required during postnatal period |
List |
[93, 93] |
treatment_effect_maternal_infection_clean_delivery |
Effect of clean delivery practices on risk of maternal infection |
List |
[0.4, 0.4] |
treatment_effect_maternal_chorio_abx_prom |
Relative effect of antibiotics for premature rupture of membranes on maternal risk of chorioamnionitis prior to birth |
List |
[0.66, 0.66] |
treatment_effect_amtsl |
relative risk of severe postpartum haemorrhage following active management of the third stage of labour |
List |
[0.34, 0.34] |
prob_haemostatis_uterotonics |
probability of uterotonics stopping a postpartum haemorrhage due to uterine atony |
List |
[0.57, 0.57] |
prob_successful_manual_removal_placenta |
probability of manual removal of retained products arresting a post partum haemorrhage |
List |
[0.75, 0.75] |
success_rate_pph_surgery |
probability of surgery for postpartum haemorrhage being successful |
List |
[0.79, 0.79] |
pph_treatment_effect_surg_md |
effect of surgery on maternal death due to postpartum haemorrhage |
List |
[0.25, 0.25] |
pph_treatment_effect_hyst_md |
effect of hysterectomy on maternal death due to postpartum haemorrhage |
List |
[0.25, 0.25] |
pph_bt_treatment_effect_md |
effect of blood transfusion treatment for postpartum haemorrhage on risk of maternal death |
List |
[0.4, 0.4] |
sepsis_treatment_effect_md |
effect of treatment for sepsis on risk of maternal death |
List |
[0.2, 0.2] |
success_rate_uterine_repair |
probability repairing a ruptured uterus surgically |
List |
[0.83, 0.83] |
prob_successful_assisted_vaginal_delivery |
probability of successful assisted vaginal delivery |
List |
[0.7, 0.7] |
ur_repair_treatment_effect_md |
effect of surgical uterine repair treatment for uterine rupture on risk of maternal death |
List |
[0.25, 0.25] |
ur_treatment_effect_bt_md |
effect of blood transfusion treatment for uterine rupture on risk of maternal death |
List |
[0.4, 0.4] |
ur_hysterectomy_treatment_effect_md |
effect of blood hysterectomy for uterine rupture on risk of maternal death |
List |
[0.25, 0.25] |
eclampsia_treatment_effect_severe_pe |
effect of treatment for severe pre eclampsia on risk of eclampsia |
List |
[0.41, 0.41] |
eclampsia_treatment_effect_md |
effect of treatment for eclampsia on risk of maternal death |
List |
[0.4, 0.4] |
anti_htns_treatment_effect_md |
effect of IV anti hypertensive treatment on risk of death secondary to severe pre-eclampsia/eclampsia stillbirth |
List |
[0.5, 0.5] |
anti_htns_treatment_effect_progression |
effect of IV anti hypertensive treatment on risk of progression from mild to severe gestational hypertension |
List |
[0.49, 0.49] |
aph_bt_treatment_effect_md |
effect of blood transfusion treatment for antepartum haemorrhage on risk of maternal death |
List |
[0.4, 0.4] |
treatment_effect_blood_transfusion_anaemia |
effect of blood transfusion treatment for severe anaemia |
List |
[0.9, 0.9] |
aph_cs_treatment_effect_md |
effect of caesarean section for antepartum haemorrhage on risk of maternal death |
List |
[0.25, 0.25] |
treatment_effect_avd_still_birth |
effect of assisted vaginal delivery on risk of intrapartum still birth |
List |
[0.55, 0.55] |
treatment_effect_cs_still_birth |
effect of caesarean section delivery on risk of intrapartum still birth |
List |
[0.25, 0.25] |
prob_hcw_avail_iv_abx |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - parenteral antibiotics |
List |
[0.99, 0.99] |
prob_hcw_avail_uterotonic |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - parenteral uterotonics |
List |
[0.99, 0.99] |
prob_hcw_avail_anticonvulsant |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - parenteral anticonvulsants |
List |
[0.93, 0.93] |
prob_hcw_avail_man_r_placenta |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - manual removal of retained placenta |
List |
[0.82, 0.82] |
prob_hcw_avail_avd |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - assisted vaginal delivery |
List |
[0.46, 0.46] |
prob_hcw_avail_blood_tran |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - blood transfusion |
List |
[0.86, 0.86] |
prob_hcw_avail_surg |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - obstetric surgery |
List |
[0.74, 0.74] |
prob_hcw_avail_retained_prod |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - removal of retained products of conception |
List |
[0.49, 0.49] |
prob_hcw_avail_neo_resus |
average probability that a health facility providing EmONC care has a HCW available that can delivery signal function - neonatal resuscitation |
List |
[0.98, 0.98] |
mean_hcw_competence_hc |
mean competence of HCW at delivering EmONC care at a health centre. A draw below this level prevents intervention delivery |
List |
[[0.602, 0.602], [0.602, 0.602]] |
mean_hcw_competence_hp |
mean competence of HCW at delivering EmONC care at a hospital. A draw below this level prevents intervention delivery |
List |
[[0.662, 0.662], [0.662, 0.662]] |
prob_intervention_delivered_anaemia_assessment_pnc |
probability a woman will have their Hb levels checked during PNC given that the HSI has ran and the consumables are available (proxy for clinical quality) |
List |
[0.14, 0.18] |
analysis_year |
Year on which changes in parameters as part of analysis should be enacted (1st day, 1st month) |
Integer |
2023 |
la_analysis_in_progress |
Used within the pregnancy_helper_function to signify that labour/postnatal analysis is currently being conducted |
Boolean |
False |
alternative_bemonc_availability |
parameter used in analysis to allow manipulation of coverage of BEmONC interventions |
Boolean |
False |
alternative_cemonc_availability |
parameter used in analysis to allow manipulation of coverage of CEmONC interventions |
Boolean |
False |
bemonc_availability |
set probability of BEmONC intervention being delivered during analysis |
Real |
1.0 |
cemonc_availability |
set probability of CEmONC intervention being delivered during analysis |
Real |
1.0 |
bemonc_cons_availability |
set probability of BEmONC consumables being available |
Real |
1.0 |
cemonc_cons_availability |
set probability of CEmONC consumables being available |
Real |
1.0 |
alternative_pnc_coverage |
Signals within the analysis event that an alternative level of PNC coverage has been determined following the events run |
Boolean |
False |
alternative_pnc_quality |
Signals within the analysis event that an alternative level of PNC quality has been determined following the events run |
Boolean |
False |
pnc_availability_odds |
Target odds of maternal PNC coverage when analysis is being conducted - only applied ifalternative_pnc_coverage is true |
Real |
3.0 |
pnc_availability_probability |
Target probability of quality/consumables when analysis is being conducted - only applied if alternative_pnc_coverage is true |
Real |
1.0 |
sba_sens_analysis_max |
Signals that max coverage of SBA is being forced for sensitivity analysis |
Boolean |
False |
pnc_sens_analysis_max |
Signals that max coverage of PNC is being forced for sensitivity analysis |
Boolean |
False |
pnc_sens_analysis_min |
Signals that min coverage of SBA is being forced for sensitivity analysis |
Boolean |
False |
Lifestyle
Name |
Description |
Type |
Value |
---|---|---|---|
init_p_urban |
initial proportion urban |
Dictionary |
|
init_p_wealth_urban |
List of probabilities of category given urban |
List |
[0.75, 0.16, 0.05, 0.02, 0.02] |
init_p_wealth_rural |
List of probabilities of category given rural |
List |
[0.11, 0.21, 0.22, 0.23, 0.23] |
init_p_bmi_urban_m_not_high_sugar_age1529_not_tob_wealth1 |
List of probabilities of bmi categories for urban men age 15-29 with not high sugar, not tobacco, wealth level 1 |
List |
[0.06, 0.8, 0.12, 0.01, 0.01] |
init_or_higher_bmi_f |
odds ratio higher BMI if female |
Real |
3.0 |
init_or_higher_bmi_rural |
odds ratio higher BMI if rural |
Real |
0.6 |
init_or_higher_bmi_high_sugar |
odds ratio higher BMI if high sugar intake |
Real |
1.1 |
init_or_higher_bmi_age3049 |
odds ratio higher BMI if age 30-49 |
Real |
1.8 |
init_or_higher_bmi_agege50 |
odds ratio higher BMI if age ge 50 |
Real |
2.7 |
init_or_higher_bmi_tob |
odds ratio higher BMI if use tobacco |
Real |
0.7 |
init_or_higher_bmi_per_higher_wealth_level |
odds ratio for higher initial bmi category per higher wealth level |
Real |
0.85 |
init_p_high_sugar |
initital proportion with high sugar intake |
Real |
0.4 |
init_p_high_salt_urban |
initital proportion with high salt intake |
Real |
0.2 |
init_or_high_salt_rural |
odds ratio high salt if rural |
Real |
1.5 |
init_p_ex_alc_m |
initital proportion of men with excess alcohol use |
Real |
0.15 |
init_p_ex_alc_f |
initital proportion of women with excess alcohol use |
Real |
0.01 |
init_p_low_ex_urban_m |
initital proportion of men with low exercise urban |
Real |
0.32 |
init_or_low_ex_rural |
odds ratio low exercise rural |
Real |
0.4 |
init_or_low_ex_f |
odds ratio low exercise female |
Real |
0.6 |
init_p_tob_age1519_m_wealth1 |
initial proportion of 15-19 year old men using tobacco, wealth level 1 |
Real |
0.01 |
init_or_tob_f |
odds ratio tobacco use females |
Real |
0.2 |
init_or_tob_age2039_m |
odds ratio tobacco use age2039 in men |
Real |
4.0 |
init_or_tob_agege40_m |
odds ratio tobacco use age40+ in men |
Real |
6.0 |
init_or_tob_wealth2 |
odds ratio tobacco use wealth level 2 |
Real |
2.0 |
init_or_tob_wealth3 |
odds ratio tobacco use wealth level 3 |
Real |
3.0 |
init_or_tob_wealth4 |
odds ratio tobacco use wealth level 4 |
Real |
4.0 |
init_or_tob_wealth5 |
odds ratio tobacco use wealth level 5 |
Real |
5.0 |
init_dist_mar_stat_age1520 |
proportions never, current, div_wid age 15-20 baseline |
List |
[0.7, 0.3, 0] |
init_dist_mar_stat_age2030 |
proportions never, current, div_wid age 20-30 baseline |
List |
[0.15, 0.8, 0.05] |
init_dist_mar_stat_age3040 |
proportions never, current, div_wid age 30-40 baseline |
List |
[0.05, 0.7, 0.25] |
init_dist_mar_stat_age4050 |
proportions never, current, div_wid age 40-50 baseline |
List |
[0.03, 0.5, 0.47] |
init_dist_mar_stat_age5060 |
proportions never, current, div_wid age 50-60 baseline |
List |
[0.03, 0.3, 0.67] |
init_dist_mar_stat_agege60 |
proportions never, current, div_wid age 60+ baseline |
List |
[0.03, 0.2, 0.77] |
init_age2030_w5_some_ed |
proportions of low wealth 20-30 year olds with some education at baseline |
Real |
0.97 |
init_prop_age2030_w5_some_ed_sec |
proportion of low wealth aged 20-30 with some education who have secondary education at baseline |
Real |
0.1 |
init_p_unimproved_sanitation_urban |
initial probability of unimproved_sanitation given urban |
Real |
0.04 |
init_or_unimproved_sanitation_rural |
initial odds ratio of unimproved_sanitation if rural |
Real |
4.5 |
init_p_no_clean_drinking_water_urban |
initial probability of no_clean_drinking_water given urban |
Real |
0.017 |
init_or_no_clean_drinking_water_rural |
initial odds ratio of no clean drinking_water if rural |
Real |
8.6 |
init_p_wood_burn_stove_urban |
initial probability of wood_burn_stove given urban |
Real |
0.257 |
init_or_wood_burn_stove_rural |
initial odds ratio of wood_burn_stove if rural |
Real |
40.0 |
init_p_no_access_handwashing_wealth1 |
initial probability of no_access_handwashing given wealth 1 |
Real |
0.478 |
init_or_no_access_handwashing_per_lower_wealth |
initial odds ratio of no_access_handwashing per lower wealth level |
Real |
1.06 |
init_prop_primary_edu |
proportion of starting primary education at baseline age 5-12 |
Real |
0.5 |
init_rp_some_ed_age0513 |
relative prevalence of some education at baseline age 5-13 |
Real |
1.01 |
init_rp_some_ed_age1320 |
relative prevalence of some education at baseline age 13-20 |
Real |
1.0 |
init_rp_some_ed_age2030 |
relative prevalence of some education at baseline age 20-30 |
Real |
1.0 |
init_rp_some_ed_age3040 |
relative prevalence of some education at baseline age 30-40 |
Real |
1.0 |
init_rp_some_ed_age4050 |
relative prevalence of some education at baseline age 40-50 |
Real |
0.9 |
init_rp_some_ed_age5060 |
relative prevalence of some education at baseline age 50-60 |
Real |
0.9 |
init_rp_some_ed_per_higher_wealth |
relative prevalence of some education at baseline per higher wealth level |
Real |
1.005 |
init_rp_some_ed_sec_age1320 |
relative prevalence of secondary education age 15-20 |
Real |
1.0 |
init_rp_some_ed_sec_age3040 |
relative prevalence of secondary education age 30-40 |
Real |
0.8 |
init_rp_some_ed_sec_age4050 |
relative prevalence of secondary education age 40-50 |
Real |
0.6 |
init_rp_some_ed_sec_age5060 |
relative prevalence of secondary education age 50-60 |
Real |
0.4 |
init_rp_some_ed_sec_agege60 |
relative prevalence of secondary education age 60+ |
Real |
0.2 |
init_rp_some_ed_agege60 |
relative prevalence of some education at baseline age age 60+ |
Real |
0.9 |
init_rp_some_ed_sec_per_higher_wealth |
relative prevalence of secondary education per higher wealth level |
Real |
1.48 |
r_urban |
probability per 3 months of change from rural to urban |
Real |
0.0005 |
r_rural |
probability per 3 months of change from urban to rural |
Real |
1e-05 |
r_higher_bmi |
probability per 3 months of increase in bmi category if rural male age15-29 not using tobacoo with wealth level 1 with not high sugar intake |
Real |
0.0005 |
rr_higher_bmi_urban |
probability per 3 months of increase in bmi category if |
Real |
1.5 |
rr_higher_bmi_f |
rate ratio for increase in bmi category for females |
Real |
3.0 |
rr_higher_bmi_age3049 |
rate ratio for increase in bmi category for age 30-49 |
Real |
1.8 |
rr_higher_bmi_agege50 |
rate ratio for increase in bmi category for age ge 50 |
Real |
2.7 |
rr_higher_bmi_tob |
rate ratio for increase in bmi category for tobacco users |
Real |
0.7 |
rr_higher_bmi_per_higher_wealth |
rate ratio for increase in bmi category per higher wealth level |
Real |
0.85 |
rr_higher_bmi_high_sugar |
rate ratio for increase in bmi category for high sugar intake |
Real |
1.2 |
r_lower_bmi |
probability per 3 months of decrease in bmi category in non tobacco users |
Real |
0.001 |
rr_lower_bmi_tob |
rate ratio for lower bmi category for tobacco users |
Real |
1.4 |
rr_lower_bmi_pop_advice_weight |
probability per 3 months of decrease in bmi category given population advice/campaign on weight |
Real |
1.1 |
r_high_salt_urban |
probability per 3 months of high salt intake if urban |
Real |
0.003 |
rr_high_salt_rural |
rate ratio for high salt if rural |
Real |
1.5 |
r_not_high_salt |
probability per 3 months of not high salt intake |
Real |
0.0001 |
rr_not_high_salt_pop_advice_salt |
probability per 3 months of not high salt given population advice/campaign on salt |
Real |
1.1 |
r_high_sugar |
probability per 3 months of high sugar intake |
Real |
0.0001 |
r_not_high_sugar |
probability per 3 months of not high sugar intake |
Real |
0.0001 |
rr_not_high_sugar_pop_advice_sugar |
probability per 3 months of not high sugar given population advice/campaign on sugar |
Real |
1.1 |
r_low_ex |
probability per 3 months of change from not low exercise to low exercise |
Real |
0.001 |
r_not_low_ex |
probability per 3 months of change from low exercise to not low exercie |
Real |
0.0001 |
rr_not_low_ex_pop_advice_exercise |
probability per 3 months of not low exercise population advice/campaign on exercise |
Real |
1.1 |
rr_low_ex_f |
risk ratio for becoming low exercise if female rather than male |
Real |
0.6 |
rr_low_ex_urban |
risk ratio for becoming low exercise if urban rather than rural |
Real |
2.0 |
r_tob |
probability per 3 months of change from not using tobacco to using tobacco if male age 15-19 wealth level 1 |
Real |
0.0004 |
r_not_tob |
probability per 3 months of change from tobacco using to not tobacco using |
Real |
0.0001 |
rr_tob_f |
rate ratio tobacco if female |
Real |
0.1 |
rr_tob_age2039 |
risk ratio for tobacco using if age 20-39 compared with 15-19 |
Real |
1.2 |
rr_tob_agege40 |
risk ratio for tobacco using if age >= 40 compared with 15-19 |
Real |
1.5 |
rr_tob_wealth |
risk ratio for tobacco using per 1 higher wealth level (higher wealth level = lower wealth) |
Real |
1.3 |
rr_not_tob_pop_advice_tobacco |
probability per 3 months of quitting tobacco given population advice/campaign on tobacco |
Real |
1.1 |
r_ex_alc |
probability per 3 months of change from not excess alcohol to excess alcohol |
Real |
0.003 |
r_not_ex_alc |
probability per 3 months of change from excess alcohol to not excess alcohol |
Real |
0.0001 |
rr_ex_alc_f |
risk ratio for becoming excess alcohol if female rather than male |
Real |
0.07 |
rr_not_ex_alc_pop_advice_alcohol |
probability per 3 months of not excess alcohol given population advice/campaign on alcohol |
Real |
1.1 |
r_mar |
probability per 3 months of marriage when age 15-30 |
Real |
0.03 |
r_div_wid |
probability per 3 months of becoming divorced or widowed, amongst those married |
Real |
0.01 |
r_stop_ed |
probabilities per 3 months of stopping education if wealth level 5 |
Real |
0.007 |
rr_stop_ed_lower_wealth |
relative rate of stopping education per 1 lower wealth quantile |
Real |
1.5 |
p_ed_primary |
probability at age 5 that start primary education if wealth level 5 |
Real |
0.9 |
rp_ed_primary_higher_wealth |
relative probability of starting school per 1 higher wealth level |
Real |
1.1 |
p_ed_secondary |
probability at age 13 that start secondary education at 13 if in primary education and wealth level 5 |
Real |
0.8 |
rp_ed_secondary_higher_wealth |
relative probability of starting secondary school per 1 higher wealth level |
Real |
1.05 |
r_improved_sanitation |
probability per 3 months of change from unimproved_sanitation true to false |
Real |
0.001 |
r_clean_drinking_water |
probability per 3 months of change from drinking_water true to false |
Real |
0.001 |
r_non_wood_burn_stove |
probability per 3 months of change from wood_burn_stove true to false |
Real |
0.001 |
r_access_handwashing |
probability per 3 months of change from no access hand washing true to false |
Real |
0.001 |
start_date_campaign_exercise_increase |
Date of campaign start for increased exercise |
Date |
2010-07-01 00:00:00 |
start_date_campaign_quit_smoking |
Date of campaign start to quit smoking |
Date |
2010-07-01 00:00:00 |
start_date_campaign_alcohol_reduction |
Date of campaign start for alcohol reduction |
Date |
2010-07-01 00:00:00 |
proportion_of_men_that_are_assumed_to_be_circumcised_at_birth |
Proportion of men that are assumed to be circumcised at birth.The men are assumed to be circumcised at birth. |
Real |
0.2128 |
proportion_of_men_circumcised_at_initiation |
Proportion of men (of all ages) that are assumed to be circumcised at the initiation of thesimulation. |
Real |
0.2128 |
proportion_female_sex_workers |
proportion of women aged 15-49 years who are sex workers |
Real |
0.0069 |
fsw_transition |
proportion of sex workers that stop being a sex worker each year |
Real |
0.18181818181818182 |
init_p_urban
prop_urban
Chitipa |
Karonga |
Nkhata Bay |
Rumphi |
Mzimba |
Likoma |
Mzuzu |
Mzuzu City |
Kasungu |
Nkhotakota |
Ntchisi |
Dowa |
Salima |
Lilongwe |
Lilongwe City |
Mchinji |
Dedza |
Ntcheu |
Mangochi |
Machinga |
Zomba |
Zomba City |
Chiradzulu |
Blantyre |
Blantyre City |
Mwanza |
Thyolo |
Mulanje |
Phalombe |
Chikwawa |
Nsanje |
Balaka |
Neno |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.1846 |
0.2644 |
0.1716 |
0.2188 |
0.0386 |
0.1503 |
0 |
1 |
0.2029 |
0.1372 |
0.1372 |
0.1379 |
0.1924 |
0 |
1 |
0.1486 |
0.1383 |
0.1118 |
0.1642 |
0.1499 |
0 |
1 |
0.0635 |
0 |
1 |
0.2536 |
0.1111 |
0.1149 |
0.0897 |
0.1171 |
0.2053 |
0.1836 |
0.1015 |
Malaria
Name |
Description |
Type |
Value |
---|---|---|---|
interv |
data frame of intervention coverage by year |
Dataframe |
|
clin_inc |
data frame of clinical incidence by age, district, intervention coverage |
Dataframe |
|
inf_inc |
data frame of infection incidence by age, district, intervention coverage |
Dataframe |
|
sev_inc |
data frame of severe case incidence by age, district, intervention coverage |
Dataframe |
|
itn_district |
data frame of ITN usage rates by district |
Dataframe |
|
irs_district |
data frame of IRS usage rates by district |
Dataframe |
|
sev_symp_prob |
probabilities of each symptom for severe malaria cases |
Dataframe |
|
sensitivity_rdt |
Sensitivity of rdt |
Real |
0.95 |
cfr |
case-fatality rate for severe malaria |
Real |
0.15 |
dur_asym |
duration (days) of asymptomatic malaria |
Real |
110.0 |
dur_clin |
duration (days) of clinical symptoms of malaria |
Real |
5.0 |
dur_clin_para |
duration (days) of parasitaemia for clinical malaria cases |
Real |
195.0 |
treatment_adjustment |
probability of death from severe malaria if on treatment |
Real |
0.5 |
p_sev_anaemia_preg |
probability of severe anaemia in pregnant women with clinical malaria |
Real |
0.075 |
mortality_adjust |
adjustment of case-fatality rate to match WHO/MAP |
Real |
10.0 |
data_end |
final year of ICL malaria model outputs, after 2018 = projections |
Real |
2018.0 |
irs_rates_boundary |
threshold for indoor residual spraying coverage |
Real |
0.5 |
irs_rates_upper |
indoor residual spraying high coverage |
Real |
0.8 |
irs_rates_lower |
indoor residual spraying low coverage |
Real |
0.0 |
prob_malaria_case_tests |
probability that a malaria case will have a scheduled rdt |
Real |
0.4 |
itn |
projected future itn coverage |
Real |
0.6 |
rdt_testing_rates |
per capita rdt testing rate of general population |
Dataframe |
|
scaling_factor_for_rdt_availability |
scaling factor applied to the reports of rdt usage to compensate fornon-availability of rdts at some facilities |
Real |
1.2 |
duration_iptp_protection_weeks |
duration of protection against clinical malaria conferred by each dose of IPTp |
Real |
6.0 |
rr_clinical_malaria_hiv_under5 |
relative risk of clinical malaria if HIV+ and aged under 5 years |
Real |
1.7 |
rr_clinical_malaria_hiv_over5 |
relative risk of clinical malaria if HIV+ and aged over 5 years |
Real |
2.6 |
rr_clinical_malaria_hiv_pregnant |
relative risk of clinical malaria if HIV+ and pregnant |
Real |
3.96 |
rr_clinical_malaria_cotrimoxazole |
relative risk of clinical malaria if on cotrimoxazole |
Real |
0.58 |
rr_clinical_malaria_art |
relative risk of clinical malaria if HIV+ and on ART and virally suppressed |
Real |
0.74 |
rr_clinical_malaria_iptp |
relative risk of clinical malaria with each dose of IPTp |
Real |
0.54 |
rr_severe_malaria_hiv_under5 |
relative risk of severe malaria if HIV+ and aged under 5 years |
Real |
9.69 |
rr_severe_malaria_hiv_over5 |
relative risk of severe malaria if HIV+ and aged over 5 years |
Real |
2.68 |
rr_severe_malaria_hiv_pregnant |
relative risk of clinical malaria if HIV+ and pregnant |
Real |
2.8 |
rr_severe_malaria_iptp |
relative risk of severe malaria with each dose of IPTp |
Real |
0.6 |
prob_of_treatment_success |
probability that treatment will clear malaria symptoms |
Real |
1.0 |
type_of_scaleup |
argument to determine type scale-up of program which will be implemented, can be ‘none’, ‘target’ or ‘max’ |
String |
none |
scaleup_start_year |
the year when the scale-up starts (it will occur on 1st January of that year) |
Integer |
2025 |
scaleup_parameters |
the parameters and values changed in scenario analysis |
Dataframe |
interv
Year |
ITN_coverage |
IRS_coverage |
ACT_coverage |
MIS_sleptUnderITN |
MIS_IPTp_1dose |
MIS_IPTp_2dose |
MIS_IPTp_3dose |
---|---|---|---|---|---|---|---|
2001 |
0 |
0 |
0 |
nan |
nan |
nan |
nan |
2002 |
0 |
0 |
0 |
nan |
nan |
nan |
nan |
2003 |
0.0337 |
0 |
0 |
0.02022 |
nan |
nan |
nan |
2004 |
0.1149 |
0 |
0.011 |
0.06894 |
nan |
nan |
nan |
2005 |
0.2636 |
0 |
0.0269 |
0.15816 |
nan |
nan |
nan |
2006 |
0.2405 |
0 |
0.0538 |
0.1443 |
nan |
nan |
nan |
2007 |
0.2865 |
0.00712375 |
0.0898 |
0.1719 |
nan |
nan |
nan |
2008 |
0.3185 |
0.00698449 |
0.1382 |
0.1911 |
nan |
nan |
nan |
2009 |
0.2908 |
0.0198598 |
0.2082 |
0.17448 |
nan |
nan |
nan |
Only first 10 rows of 26 are shown.
clin_inc
Unnamed: 0 |
admin |
llin |
irs |
month |
inc_age_gp |
clin_incidence |
age |
monthly_inc_clin |
monthly_prob_clin |
---|---|---|---|---|---|---|---|---|---|
1 |
Balaka |
0.1 |
0.8 |
2 |
clin_inc_0_0.5 |
0.616651 |
0 |
0.0513875 |
0.0500895 |
2 |
Balaka |
0.1 |
0.8 |
3 |
clin_inc_0_0.5 |
0.724266 |
0 |
0.0603555 |
0.0585702 |
3 |
Balaka |
0.1 |
0.8 |
4 |
clin_inc_0_0.5 |
0.487449 |
0 |
0.0406208 |
0.0398068 |
4 |
Balaka |
0.1 |
0.8 |
5 |
clin_inc_0_0.5 |
0.221309 |
0 |
0.0184424 |
0.0182734 |
5 |
Balaka |
0.1 |
0.8 |
6 |
clin_inc_0_0.5 |
0.0654417 |
0 |
0.00545347 |
0.00543863 |
6 |
Balaka |
0.1 |
0.8 |
7 |
clin_inc_0_0.5 |
0.00924685 |
0 |
0.000770571 |
0.000770274 |
7 |
Balaka |
0.1 |
0.8 |
8 |
clin_inc_0_0.5 |
0.0258359 |
0 |
0.00215299 |
0.00215068 |
8 |
Balaka |
0.1 |
0.8 |
9 |
clin_inc_0_0.5 |
0.0592395 |
0 |
0.00493663 |
0.00492446 |
9 |
Balaka |
0.1 |
0.8 |
10 |
clin_inc_0_0.5 |
0.0234651 |
0 |
0.00195542 |
0.00195351 |
Only first 10 rows of 497664 are shown.
inf_inc
Unnamed: 0 |
admin |
llin |
irs |
month |
inf_inc_age_gp |
inf_incidence |
age |
monthly_inc_inf |
monthly_prob_inf |
---|---|---|---|---|---|---|---|---|---|
1 |
Balaka |
0.1 |
0.8 |
2 |
inf_inc_0_0.5 |
1.19984 |
0 |
0.0999865 |
0.0951504 |
2 |
Balaka |
0.1 |
0.8 |
3 |
inf_inc_0_0.5 |
1.42709 |
0 |
0.118924 |
0.112125 |
3 |
Balaka |
0.1 |
0.8 |
4 |
inf_inc_0_0.5 |
0.955087 |
0 |
0.0795906 |
0.0765057 |
4 |
Balaka |
0.1 |
0.8 |
5 |
inf_inc_0_0.5 |
0.464054 |
0 |
0.0386712 |
0.037933 |
5 |
Balaka |
0.1 |
0.8 |
6 |
inf_inc_0_0.5 |
0.122824 |
0 |
0.0102353 |
0.0101831 |
6 |
Balaka |
0.1 |
0.8 |
7 |
inf_inc_0_0.5 |
0.0174689 |
0 |
0.00145575 |
0.00145469 |
7 |
Balaka |
0.1 |
0.8 |
8 |
inf_inc_0_0.5 |
0.0559292 |
0 |
0.00466077 |
0.00464993 |
8 |
Balaka |
0.1 |
0.8 |
9 |
inf_inc_0_0.5 |
0.110247 |
0 |
0.00918724 |
0.00914517 |
9 |
Balaka |
0.1 |
0.8 |
10 |
inf_inc_0_0.5 |
0.0416001 |
0 |
0.00346667 |
0.00346067 |
Only first 10 rows of 497664 are shown.
sev_inc
Unnamed: 0 |
admin |
llin |
irs |
month |
sev_inc_age_gp |
sev_incidence |
age |
monthly_inc_sev |
monthly_prob_sev |
---|---|---|---|---|---|---|---|---|---|
1 |
Balaka |
0.1 |
0.8 |
2 |
sev_inc_0_0.5 |
0.039965 |
0 |
0.00333041 |
0.00332487 |
2 |
Balaka |
0.1 |
0.8 |
3 |
sev_inc_0_0.5 |
0.0449733 |
0 |
0.00374778 |
0.00374076 |
3 |
Balaka |
0.1 |
0.8 |
4 |
sev_inc_0_0.5 |
0.0293607 |
0 |
0.00244672 |
0.00244373 |
4 |
Balaka |
0.1 |
0.8 |
5 |
sev_inc_0_0.5 |
0.0133483 |
0 |
0.00111236 |
0.00111174 |
5 |
Balaka |
0.1 |
0.8 |
6 |
sev_inc_0_0.5 |
0.00411232 |
0 |
0.000342693 |
0.000342634 |
6 |
Balaka |
0.1 |
0.8 |
7 |
sev_inc_0_0.5 |
0.000551552 |
0 |
4.59627e-05 |
4.59616e-05 |
7 |
Balaka |
0.1 |
0.8 |
8 |
sev_inc_0_0.5 |
0.00155992 |
0 |
0.000129993 |
0.000129985 |
8 |
Balaka |
0.1 |
0.8 |
9 |
sev_inc_0_0.5 |
0.00409992 |
0 |
0.00034166 |
0.000341602 |
9 |
Balaka |
0.1 |
0.8 |
10 |
sev_inc_0_0.5 |
0.00162945 |
0 |
0.000135787 |
0.000135778 |
Only first 10 rows of 497664 are shown.
itn_district
District |
Year |
itn_rate |
---|---|---|
Balaka |
2011 |
0.3 |
Balaka |
2012 |
0.5 |
Balaka |
2013 |
0.7 |
Balaka |
2014 |
0.6 |
Balaka |
2015 |
0.4 |
Balaka |
2016 |
0.6 |
Balaka |
2017 |
0.6 |
Balaka |
2018 |
0.6 |
Blantyre |
2010 |
0.5 |
Only first 10 rows of 288 are shown.
irs_district
District |
Year |
irs_rate |
---|---|---|
Balaka |
2011 |
0 |
Balaka |
2012 |
0 |
Balaka |
2013 |
0 |
Balaka |
2014 |
0 |
Balaka |
2015 |
0 |
Balaka |
2016 |
0 |
Balaka |
2017 |
0 |
Balaka |
2018 |
0 |
Blantyre |
2010 |
0 |
Only first 10 rows of 288 are shown.
sev_symp_prob
symptom |
age_group |
prop_lower |
prop_upper |
---|---|---|---|
acidosis |
0_5 |
0.4 |
0.45 |
coma_convulsions |
0_5 |
0.3 |
0.4 |
renal_failure |
0_5 |
0.05 |
0.15 |
severe_anaemia |
0_5 |
0.4 |
0.5 |
shock |
0_5 |
0.05 |
0.15 |
jaundice |
5_60 |
0.1 |
0.6 |
acidosis |
5_60 |
0.45 |
0.6 |
coma_convulsions |
5_60 |
0.38 |
0.45 |
renal_failure |
5_60 |
0.1 |
0.5 |
Only first 10 rows of 12 are shown.
rdt_testing_rates
Year |
NumSuspectedCasesTestedByRDT |
NumPositiveCasesTestedByRDT |
NumSuspectedCasesTestedByMicroscopy |
NumPositiveCasesTestedByMicroscopy |
NumTreated |
NumMalariaCases |
TreatmentCoverage |
Population |
Rate_rdt_testing |
---|---|---|---|---|---|---|---|---|---|
2011 |
580708 |
253973 |
166959 |
50526 |
nan |
5.46033e+06 |
nan |
1.51461e+07 |
0.0383404 |
2012 |
2.76399e+06 |
1.28185e+06 |
103754 |
283138 |
nan |
4.92953e+06 |
nan |
1.55813e+07 |
0.177392 |
2013 |
3.02902e+06 |
1.23639e+06 |
129575 |
44501 |
nan |
4.5475e+06 |
nan |
1.60248e+07 |
0.189021 |
2014 |
5.34472e+06 |
2.82768e+06 |
127752 |
77635 |
nan |
4.26516e+06 |
nan |
1.6478e+07 |
0.324356 |
2015 |
7.03008e+06 |
3.58532e+06 |
240212 |
75923 |
nan |
4.03294e+06 |
nan |
1.69389e+07 |
0.415025 |
2016 |
8.66124e+06 |
4.73084e+06 |
216643 |
96538 |
nan |
3.86857e+06 |
nan |
1.74056e+07 |
0.497611 |
2017 |
9.41394e+06 |
4.90134e+06 |
198534 |
46099 |
nan |
3.85109e+06 |
nan |
1.78812e+07 |
0.526473 |
2018 |
1.13841e+07 |
5.83074e+06 |
132475 |
34735 |
7.04301e+06 |
3.78227e+06 |
1.86211 |
1.83679e+07 |
0.619783 |
2019 |
1.08613e+07 |
5.15378e+06 |
406907 |
30328 |
5.08972e+06 |
3.83515e+06 |
1.32712 |
1.88673e+07 |
0.575668 |
Only first 10 rows of 15 are shown.
scaleup_parameters
parameter |
target_value |
min_value |
max_value |
---|---|---|---|
prob_malaria_case_tests |
1 |
0 |
1 |
rdt_testing_rates |
0.8 |
0 |
1 |
prob_of_treatment_success |
1 |
0 |
1 |
irs_district |
0.8 |
0 |
0.8 |
itn_district |
0.7 |
0 |
0.7 |
itn |
0.7 |
0 |
0.7 |
Measles
Name |
Description |
Type |
Value |
---|---|---|---|
beta_baseline |
Baseline measles transmission probability |
Real |
0.00216 |
beta_scale |
Scale value for measles transmission probability sinusoidal function |
Real |
1.0 |
phase_shift |
Phase shift for measles transmission probability sinusoidal function |
Real |
5.0 |
period |
Period for measles transmission probability sinusoidal function |
Real |
12.0 |
vaccine_efficacy_1 |
Efficacy of first measles vaccine dose against measles infection |
Real |
0.85 |
vaccine_efficacy_2 |
Efficacy of second measles vaccine dose against measles infection |
Real |
0.99 |
prob_severe |
Probability of severe measles infection, requiring hospitalisation |
Real |
0.05 |
risk_death_on_treatment |
Risk of scheduled death occurring if on treatment for measles complications |
Real |
0.38 |
symptom_prob |
Probability of each symptom with measles infection |
Dataframe |
|
case_fatality_rate |
Probability that case of measles will result in death if not treated |
Dictionary |
symptom_prob
age |
symptom |
probability |
---|---|---|
1 |
rash |
1 |
2 |
rash |
1 |
3 |
rash |
1 |
4 |
rash |
1 |
5 |
rash |
1 |
6 |
rash |
1 |
7 |
rash |
1 |
8 |
rash |
1 |
9 |
rash |
1 |
Only first 10 rows of 217 are shown.
case_fatality_rate
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
0.00333333 |
NewbornOutcomes
Name |
Description |
Type |
Value |
---|---|---|---|
prob_care_seeking_for_complication |
baseline probability that a mother will seek care for an unwell neonate following delivery |
List |
[0.782, 0.782] |
prob_day_reaches_week_one_event |
Probabilities for day of attendance at postnatal week one event |
List |
[[0.4, 0.3, 0.2, 0.05, 0.05], [0.4, 0.3, 0.2, 0.05, 0.05]] |
prob_early_onset_neonatal_sepsis_day_0 |
baseline probability of a neonate developing early onset sepsis between birth and 24hrs |
List |
[0.02, 0.017] |
rr_eons_maternal_chorio |
relative risk of EONS in newborns whose mothers have chorioamnionitis |
List |
[6.6, 6.6] |
rr_eons_maternal_prom |
relative risk of EONS in newborns whose mothers have PROM |
List |
[4.9, 4.9] |
rr_eons_preterm_neonate |
relative risk of EONS in preterm newborns |
List |
[3.36, 3.36] |
cfr_early_onset_sepsis |
case fatality rate for a neonate due to neonatal sepsis |
List |
[0.064, 0.056] |
cfr_late_onset_sepsis |
case fatality rate for a neonate due to neonatal sepsis |
List |
[0.064, 0.056] |
prob_mild_impairment_post_sepsis |
probability of the mild neurodevelopmental impairment in survivors of sepsis |
List |
[0.12, 0.12] |
prob_mod_severe_impairment_post_sepsis |
probability of the moderate or severe neurodevelopmental impairment in survivors of sepsis |
List |
[0.23, 0.23] |
prob_failure_to_transition |
baseline probability of a neonate developing intrapartum related complications (previously birth asphyxia) following delivery |
List |
[0.01, 0.01] |
prob_enceph_no_resus |
Probability of a newborn who was not breathing at birth, and didnt receive resuscitation, developing encephalopathy |
List |
[0.5, 0.5] |
cfr_failed_to_transition |
case fatality rate for a neonate following failure to transition |
List |
[0.2, 0.2] |
prob_encephalopathy |
baseline odds of a neonate developing encephalopathy of any severity following birth |
List |
[0.0097, 0.0097] |
rr_enceph_neonatal_sepsis |
relative risk of neonatal encephalopathy if the neonate is also septic |
List |
[8.67, 8.67] |
rr_enceph_obstructed_labour |
relative risk for encephalopathy if the mothers labour was obstructed |
List |
[3.8, 3.8] |
rr_enceph_acute_hypoxic_event |
relative risk for encephalopathy if the mothers experience an acute event in labour |
List |
[8.74, 8.74] |
prob_enceph_severity |
probability of the severity of encephalopathy in a newborn who is encephalopathic |
List |
[[0.422, 0.338, 0.24], [0.422, 0.338, 0.24]] |
prob_mild_impairment_post_enceph |
probability of the mild neurodevelopmental impairment in survivors of encephalopathy |
List |
[0.21, 0.21] |
prob_mod_severe_impairment_post_enceph |
probability of the moderate or severe neurodevelopmental impairment in survivors of encephalopathy |
List |
[0.269, 0.269] |
cfr_enceph |
case fatality rate for a neonate due to mild encephalopathy |
List |
[0.48, 0.28] |
cfr_multiplier_severe_enceph |
multiplier for risk of death in a neonate with severe encephalopathy |
List |
[1.91, 3.28] |
prob_respiratory_distress_preterm |
probability that a preterm infant will experience respiratory distress at birth |
List |
[0.12, 0.12] |
rr_rds_early_preterm |
relative risk of RDS in a preterm newborn born before 34 weeks |
List |
[2.64, 2.64] |
rr_rds_maternal_diabetes_mellitus |
relative risk of RDS in a preterm newborn whose mother has DM |
List |
[2.66, 2.66] |
rr_rds_maternal_gestational_diab |
relative risk of RDS in a preterm newborn whose mother has gestational diabetes |
List |
[1.57, 1.57] |
cfr_respiratory_distress_syndrome |
case fatality rate for respiratory distress syndrome of prematurity |
List |
[0.29, 0.2] |
prob_mild_disability_preterm_<32weeks |
probability of mild long term neurodevelopmental disability in preterm infants born at less than 32 weeks gestation |
List |
[0.324, 0.324] |
prob_mod_severe_disability_preterm_<32weeks |
probability of moderate/severe longterm neurodevelopmental disability in preterm infants born at less than 32 weeks gestation |
List |
[0.246, 0.246] |
prob_mild_disability_preterm_32_36weeks |
probability of mild long term neurodevelopmental disability in preterm infants born between 32 and 36 weeks gestation |
List |
[0.034, 0.034] |
prob_mod_severe_disability_preterm_32_36weeks |
probability of moderate/severe long term neurodevelopmental disability in preterm infants born between 32 and 36 weeks gestation |
List |
[0.018, 0.018] |
prob_retinopathy_preterm_early |
Probability that a neonate born at less than 32 weeks who survives the neonatal period will develop retinopathy |
List |
[0.365, 0.365] |
prob_retinopathy_preterm_late |
Probability that a neonate born at less than 32 weeks who survives the neonatal period will develop retinopathy |
List |
[0.077, 0.077] |
prob_retinopathy_severity_no_treatment |
Probabilities that a preterm neonate who developed retinopathy will experience the following vision impairments: none, mild, moderate or blindness |
List |
[[0.28, 0.03, 0.1, 0.12, 0.47], [0.28, 0.03, 0.1, 0.12, 0.47]] |
cfr_preterm_birth |
case fatality rate for a neonate born prematurely |
List |
[0.0227, 0.0187] |
rr_preterm_death_early_preterm |
relative risk of preterm death in early preterm neonates |
List |
[1.66, 1.66] |
prob_preterm_death_by_day |
probability of death due to preterm complications occurring on days 0-14 |
List |
[[0.4, 0.2, 0.15, 0.05, 0.02, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018], [0.4, 0.2, 0.15, 0.05, 0.02, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018, 0.018]] |
prob_congenital_heart_anomaly |
Probability of a congenital heart anomaly in the newborn |
List |
[0.009, 0.009] |
prob_limb_musc_skeletal_anomaly |
Probability of a congenital limb or musculoskeletal anomaly in the newborn |
List |
[0.008, 0.008] |
prob_urogenital_anomaly |
Probability of a congenital urogenital anomaly in the newborn |
List |
[0.003, 0.003] |
prob_digestive_anomaly |
Probability of a congenital digestive anomaly in the newborn |
List |
[0.0007, 0.0007] |
prob_other_anomaly |
Probability of a other congenital anomalies in the newborn |
List |
[0.0004, 0.0004] |
cfr_congenital_heart_anomaly |
case fatality rate for newborns with congenital heart anomalies |
List |
[0.062, 0.062] |
cfr_limb_or_musculoskeletal_anomaly |
case fatality rate for newborns with congenital limb/musculoskeletal anomalies |
List |
[0.0069, 0.0069] |
cfr_urogenital_anomaly |
case fatality rate for newborns with congenital urogenital anomalies |
List |
[0.0085, 0.0085] |
cfr_digestive_anomaly |
case fatality rate for newborns with congenital digestive anomalies |
List |
[0.2829, 0.2829] |
cfr_other_anomaly |
case fatality rate for newborns with other congenital anomalies |
List |
[0.131, 0.131] |
prob_cba_death_by_age_group |
probabilities that death from a congenital birth anomaly will occur once the individual reaches the following age groups: early neonatal, late neonatal, post neonatal 1-4 years, 5-9 years, 10 -14 years or 15-69 years |
List |
[[0.27, 0.08, 0.38, 0.2, 0.02, 0.01, 0.04], [0.3, 0.09, 0.35, 0.18, 0.03, 0.02, 0.03]] |
prob_early_breastfeeding_hb |
probability that a neonate will be breastfed within the first hour following birth when delivered at home |
List |
[0.94, 0.67] |
prob_breastfeeding_type |
probabilities that a woman is 1.) not breastfeeding 2.) non-exclusively breastfeeding 3.)exclusively breastfeeding at birth (until 6 months) |
List |
[[0.005, 0.277, 0.718], [0.101, 0.289, 0.61]] |
prob_early_breastfeeding_hf |
probability that a neonate will be breastfed within the first hour following birth when delivered at a health facility |
List |
[0.94, 0.77] |
prob_pnc_check_newborn |
probability that a neonate will receive a full postnatal check |
List |
[0.6, 0.6] |
prob_timings_pnc_newborns |
probabilities that a postnatal check will happen before or after 48 hours alive |
List |
[[0.97, 0.03], [0.97, 0.03]] |
prob_kmc_available |
probability that KMC can be delivered in a given hospital |
List |
[0.62, 0.62] |
treatment_effect_inj_abx_sep |
effect of injectable antibiotics treatment on reducing mortality from sepsis |
List |
[0.35, 0.35] |
treatment_effect_supp_care_sep |
effect of full supportive care treatment on reducing mortality from sepsis |
List |
[0.2, 0.2] |
treatment_effect_cord_care |
effect of full supportive care treatment on reducing incidence of sepsis |
List |
[0.77, 0.77] |
treatment_effect_clean_birth |
effect of clean birth practices on reducing incidence of sepsis |
List |
[0.73, 0.73] |
treatment_effect_early_init_bf |
effect of early initiation of breastfeeding on reducing incidence of sepsis |
List |
[0.55, 0.55] |
treatment_effect_resuscitation |
effect of resuscitation on newborn mortality associated with encephalopathy |
List |
[0.63, 0.63] |
treatment_effect_resuscitation_preterm |
effect of resuscitation on newborn mortality associated with prematurity |
List |
[0.81, 0.81] |
treatment_effect_abx_prom |
effect of antibiotics given to mothers experience PROM on risk of newborn sepsis |
List |
[0.67, 0.67] |
treatment_effect_steroid_preterm |
relative risk of death for preterm neonates following administration of antenatal corticosteroids |
List |
[0.71, 0.71] |
treatment_effect_kmc |
treatment effect of kangaroo mother care on preterm mortality |
List |
[0.49, 0.49] |
OesophagealCancer
Name |
Description |
Type |
Value |
---|---|---|---|
init_prop_oes_cancer_stage |
initial proportions in dysplasia/cancer categories for man aged 20 with no excess alcohol and no tobacco |
List |
[0.0003, 0.0001, 5e-06, 3e-05, 5e-05, 1e-05] |
init_prop_dysphagia_oes_cancer_by_stage |
initial proportions of those with dysplasia/cancer categories that have the symptom dysphagia |
List |
[0.01, 0.03, 0.1, 0.2, 0.3, 0.8] |
init_prop_with_dysphagia_diagnosed_oes_cancer_by_stage |
initial proportions of people that have symptom of dysphagia that have been diagnosed |
List |
[0.8, 0.85, 0.9, 0.95, 0.98, 0.9] |
init_prop_treatment_status_oes_cancer |
initial proportions of people with oesophageal dysplasia/cancer that had initiated treatment |
List |
[0.01, 0.01, 0.05, 0.05, 0.05, 0.05] |
init_prob_palliative_care |
initial probability of being under palliative care if in stage 4 |
Real |
0.5 |
r_low_grade_dysplasia_none |
probabilty per 3 months of incident low grade oesophageal dysplasia, amongst people with no oesophageal dysplasia (men, age20, no excess alcohol, no tobacco) |
Real |
5e-07 |
rr_low_grade_dysplasia_none_female |
rate ratio for low grade oesophageal dysplasia for females |
Real |
1.3 |
rr_low_grade_dysplasia_none_per_year_older |
rate ratio for low grade oesophageal dysplasia per year older from age 20 |
Real |
1.1 |
rr_low_grade_dysplasia_none_tobacco |
rate ratio for low grade oesophageal dysplasia for tobacco smokers |
Real |
2.0 |
rr_low_grade_dysplasia_none_ex_alc |
rate ratio for low grade oesophageal dysplasia for no excess alcohol |
Real |
1.0 |
r_high_grade_dysplasia_low_grade_dysp |
probabilty per 3 months of high grade oesophageal dysplasia, amongst people with low grade dysplasia |
Real |
0.03 |
rr_high_grade_dysp_undergone_curative_treatment |
rate ratio for high grade dysplasia for people with low grade dysplasia if had curative treatment at low grade dysplasia stage |
Real |
0.1 |
r_stage1_high_grade_dysp |
probabilty per 3 months of stage 1 oesophageal cancer amongst people with high grade dysplasia |
Real |
0.01 |
rr_stage1_undergone_curative_treatment |
rate ratio for stage 1 oesophageal cancer for people with high grade dysplasia if had curative treatment at high grade dysplasia stage |
Real |
0.1 |
r_stage2_stage1 |
probabilty per 3 months of stage 2 oesophageal cancer amongst people with stage 1 |
Real |
0.05 |
rr_stage2_undergone_curative_treatment |
rate ratio for stage 2 oesophageal cancer for people with stage 1 oesophageal cancer if had curative treatment at stage 1 |
Real |
0.1 |
r_stage3_stage2 |
probabilty per 3 months of stage 3 oesophageal cancer amongst people with stage 2 |
Real |
0.05 |
rr_stage3_undergone_curative_treatment |
rate ratio for stage 3 oesophageal cancer for people with stage 2 oesophageal cancer if had curative treatment at stage 2 |
Real |
0.1 |
r_stage4_stage3 |
probabilty per 3 months of stage 4 oesophageal cancer amongst people with stage 3 |
Real |
0.05 |
rr_stage4_undergone_curative_treatment |
rate ratio for stage 4 oesophageal cancer for people with stage 3 oesophageal cancer if had curative treatment at stage 3 |
Real |
0.3 |
rate_palliative_care_stage4 |
prob palliative care this 3 month period if stage4 |
Real |
0.5 |
r_death_oesoph_cancer |
probabilty per 3 months of death from oesophageal cancer mongst people with stage 4 oesophageal cancer |
Real |
0.4 |
rr_dysphagia_low_grade_dysp |
probability per 3 months of dysphagia in a person with low grade oesophageal dysplasia |
Real |
1.0 |
rr_dysphagia_high_grade_dysp |
rate ratio for dysphagia if have high grade oesophageal dysplasia |
Real |
1.0 |
r_dysphagia_stage1 |
rate ratio for dysphagia if have stage 1 oesophageal cancer |
Real |
0.01 |
rr_dysphagia_stage2 |
rate ratio for dysphagia if have stage 2 oesophageal cancer |
Real |
2.0 |
rr_dysphagia_stage3 |
rate ratio for dysphagia if have stage 3 oesophageal cancer |
Real |
50.0 |
rr_dysphagia_stage4 |
rate ratio for dysphagia if have stage 4 oesophageal cancer |
Real |
100.0 |
rp_oes_cancer_female |
relative prevalence at baseline of oesophageal dysplasia/cancer if female |
Real |
1.3 |
rp_oes_cancer_per_year_older |
relative prevalence at baseline of oesophageal dysplasia/cancer per year older than 20 |
Real |
1.1 |
rp_oes_cancer_tobacco |
relative prevalence at baseline of oesophageal dysplasia/cancer if tobacco |
Real |
2.0 |
rp_oes_cancer_ex_alc |
relative prevalence at baseline of oesophageal dysplasia/cancer |
Real |
1.0 |
sensitivity_of_endoscopy_for_oes_cancer_with_dysphagia |
sensitivity of endoscopy_for diagnosis of oesophageal cancer for those with dysphagia |
Real |
1.0 |
OtherAdultCancer
Name |
Description |
Type |
Value |
---|---|---|---|
init_prop_early_other_adult_ca_symptom_other_adult_cancer_by_stage |
initial proportions of those with other adult cancer categories that have other adult_ca_symptom |
List |
[0.3, 0.5, 0.8] |
in_prop_other_adult_cancer_stage |
initial proportions in other adult cancer stages for person aged 15-29 |
List |
[0.0002, 0.0002, 0.0004] |
init_prop_with_early_other_adult_ca_symptom_diagnosed_by_stage |
initial proportions of people that have symptom of other_adult_ca_symptom that have been diagnosed |
List |
[0.3, 0.4, 0.5] |
init_prop_treatment_status_other_adult_cancer |
initial proportions of people with other_adult cancer previously given treatment |
List |
[0.1, 0.1, 0.1] |
init_prob_palliative_care |
initial probability of being under palliative care if in metastatic |
Real |
0.95 |
r_site_confined_none |
probabilty per 3 months of incident site_confined other_adult cancer amongst people age 15-29 with no other adult cancer |
Real |
1e-05 |
rr_site_confined_age3049 |
rate ratio for site-confined other_adult cancer for age 30-49 |
Real |
5.0 |
rr_site_confined_age5069 |
rate ratio for site-confined other_adult cancer for age 50-69 |
Real |
21.0 |
rr_site_confined_agege70 |
rate ratio for site-confined other_adult cancer for age ge 70 |
Real |
60.0 |
rr_site_confined_hiv |
rate ratio for site-confined other_adult_cancer if infected with HIV |
Real |
4.13 |
r_local_ln_site_confined_other_adult_ca |
probabilty per 3 months of local ln other_adult cancer amongst people with site confined |
Real |
0.15 |
rr_local_ln_other_adult_ca_undergone_curative_treatment |
rate ratio for local_ln for people with site_confined if had curative treatment at site_confined stage |
Real |
0.1 |
r_metastatic_local_ln |
probabilty per 3 months of metastatic other_adult cancer amongst people with local_ln |
Real |
0.15 |
rr_metastatic_undergone_curative_treatment |
rate ratio for metastatic Other_adult cancer for people with local_lnOther_adult cancer if had curative treatment at local_ln |
Real |
0.2 |
r_death_other_adult_cancer |
probabilty per 3 months of death from other adult cancer mongst people with metastatic other_adult cancer |
Real |
0.2 |
r_early_other_adult_ca_symptom_site_confined_other_adult_ca |
probability per 3 months of other_adult_ca_symptom in a person with site confined other_adult cancer |
Real |
0.02 |
rr_early_other_adult_ca_symptom_local_ln_other_adult_ca |
rate ratio for other_adult_ca_symptom if have high grade other_adult cancer |
Real |
3.0 |
rr_early_other_adult_ca_symptom_metastatic_other_adult_ca |
rate ratio for other_adult_ca_symptom if have metastatic other_adult cancer |
Real |
10.0 |
rp_other_adult_cancer_age3049 |
relative prevalence at baseline of bladder cancer/cancer age 30-49 |
Real |
1.5 |
rp_other_adult_cancer_age5069 |
relative prevalence at baseline of bladder cancer/cancer age 50-69 |
Real |
2.0 |
rp_other_adult_cancer_agege70 |
relative prevalence at baseline of bladder cancer/cancer age 70+ |
Real |
4.0 |
sensitivity_of_diagnostic_device_for_other_adult_cancer_with_other_adult_ca_site_confined |
sensitivity of diagnostic_device_for diagnosis of other_adult cancer for those with other_adult_ca_site-confined |
Real |
0.8 |
sensitivity_of_diagnostic_device_for_other_adult_cancer_with_other_adult_ca_local_ln |
sensitivity of diagnostic_device_for diagnosis of other_adult cancer for those with other_adult_local_ln |
Real |
0.95 |
sensitivity_of_diagnostic_device_for_other_adult_cancer_with_other_adult_ca_metastatic |
sensitivity of diagnostic_device_for diagnosis of other_adult cancer for those with other_adult_ca metastatic |
Real |
0.95 |
PostnatalSupervisor
Name |
Description |
Type |
Value |
---|---|---|---|
prob_obstetric_fistula |
probability of a woman developing an obstetric fistula after birth |
List |
[0.00426, 0.00426] |
rr_obstetric_fistula_obstructed_labour |
relative risk of obstetric fistula in women who experienced obstructed labour |
List |
[14.8, 14.8] |
prevalence_type_of_fistula |
prevalence of 1.) vesicovaginal 2.)rectovaginal fistula |
List |
[[0.924, 0.076], [0.924, 0.076]] |
prob_secondary_pph |
baseline probability of secondary PPH |
List |
[0.0002, 0.00034] |
rr_secondary_pph_endometritis |
relative risk of secondary postpartum haemorrhage in women with sepsis secondary to endometritis |
List |
[1, 1] |
prob_secondary_pph_severity |
probability of mild, moderate or severe secondary PPH |
List |
[[0.33, 0.33, 0.34], [0.33, 0.33, 0.34]] |
cfr_secondary_postpartum_haemorrhage |
case fatality rate for secondary pph |
List |
[0.22, 0.08] |
prob_htn_resolves |
Weekly probability of resolution of hypertension |
List |
[0.167, 0.167] |
weekly_prob_gest_htn_pn |
weekly probability of a woman developing gestational hypertension during the postnatal period |
List |
[0.0025, 0.0025] |
rr_gest_htn_obesity |
Relative risk of gestational hypertension for women who are obese |
List |
[3.31, 3.31] |
weekly_prob_pre_eclampsia_pn |
weekly probability of a woman developing mild pre-eclampsia during the postnatal period |
List |
[0.0017, 0.0017] |
rr_pre_eclampsia_obesity |
Relative risk of pre-eclampsia for women who are obese |
List |
[3.2, 3.2] |
rr_pre_eclampsia_chronic_htn |
Relative risk of pre-eclampsia in women who are chronically hypertensive |
List |
[2.26, 2.26] |
rr_pre_eclampsia_diabetes_mellitus |
Relative risk of pre-eclampsia in women who have diabetes mellitus |
List |
[3.7, 3.7] |
probs_for_mgh_matrix_pn |
probability of mild gestational hypertension moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0.918, 0.032, 0.05, 0, 0], [0.918, 0.032, 0.05, 0, 0]] |
probs_for_sgh_matrix_pn |
probability of severe gestational hypertension moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0.92, 0, 0.08, 0], [0, 0.92, 0, 0.08, 0]] |
probs_for_mpe_matrix_pn |
probability of mild pre-eclampsia moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0, 0.95, 0.05, 0], [0, 0, 0.95, 0.05, 0]] |
probs_for_spe_matrix_pn |
probability of severe pre-eclampsia moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0, 0, 0.95, 0.05], [0, 0, 0, 0.95, 0.05]] |
probs_for_ec_matrix_pn |
probability of eclampsia moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0, 0, 0, 1], [0, 0, 0, 0, 1]] |
cfr_eclampsia |
case fatality rate of eclampsia in the postnatal period |
List |
[0.028, 0.03] |
cfr_severe_pre_eclampsia |
case fatality rate of severe pre-eclampsia in the postnatal period |
List |
[0.018, 0.018] |
weekly_prob_death_severe_gest_htn |
weekly risk of death from severe hypertension in the postnatal period |
List |
[2e-05, 2e-05] |
baseline_prob_anaemia_per_week |
Weekly probability of anaemia in pregnancy |
List |
[0.017, 0.024] |
rr_anaemia_maternal_malaria |
relative risk of anaemia secondary to malaria infection |
List |
[1.45, 1.45] |
rr_anaemia_recent_haemorrhage |
relative risk of anaemia secondary to recent haemorrhage |
List |
[1.93, 1.93] |
rr_anaemia_hiv_no_art |
relative risk of anaemia for a woman with HIV not on ART |
List |
[4.19, 4.19] |
prob_type_of_anaemia_pn |
probability of a woman with anaemia having mild, moderate or severe anaemia |
List |
[[0.52, 0.475, 0.005], [0.52, 0.475, 0.005]] |
prob_late_sepsis_endometritis |
probability of developing sepsis following postpartum endometritis infection |
List |
[6.9e-05, 6.2e-05] |
rr_sepsis_endometritis_post_cs |
relative risk of endometritis following caesarean delivery |
List |
[12.1, 12.1] |
prob_late_sepsis_urinary_tract |
probability of developing sepsis following postpartum UTI |
List |
[5.4e-05, 5.4e-05] |
prob_late_sepsis_skin_soft_tissue |
probability of developing sepsis following postpartum skin/soft tissue infection |
List |
[3.9e-05, 3.5e-05] |
rr_sepsis_sst_post_cs |
relative risk of skin/soft tissue sepsis following caesarean delivery |
List |
[3.9, 3.9] |
cfr_postpartum_sepsis |
case fatality rate for postnatal sepsis |
List |
[0.75, 0.49] |
prob_early_onset_neonatal_sepsis_week_1 |
Baseline probability of a newborn developing sepsis in week one of life |
List |
[0.02, 0.017] |
rr_eons_maternal_chorio |
relative risk of EONS in newborns whose mothers have chorioamnionitis |
List |
[6.6, 6.6] |
rr_eons_maternal_prom |
relative risk of EONS in newborns whose mothers have PROM |
List |
[4.9, 4.9] |
rr_eons_preterm_neonate |
relative risk of EONS in preterm newborns |
List |
[3.36, 3.36] |
cfr_early_onset_neonatal_sepsis |
case fatality for early onset neonatal sepsis |
List |
[0.064, 0.056] |
prob_late_onset_neonatal_sepsis |
probability of late onset neonatal sepsis (all cause) |
List |
[0.0045, 0.0038] |
cfr_late_neonatal_sepsis |
Risk of death from late neonatal sepsis |
List |
[0.064, 0.056] |
prob_sepsis_disabilities |
Probabilities of varying disability levels after neonatal sepsis |
List |
[[0.4, 0.1, 0.3, 0.1, 0.1], [0.4, 0.1, 0.3, 0.1, 0.1]] |
prob_care_seeking_postnatal_emergency |
baseline probability of emergency care seeking for women in the postnatal period |
List |
[0.782, 0.782] |
prob_care_seeking_postnatal_emergency_neonate |
baseline probability care will be sought for a neonate with a complication |
List |
[0.782, 0.782] |
odds_care_seeking_fistula_repair |
odds of a woman seeking care for treatment of obstetric fistula |
List |
[1.5, 1.5] |
aor_cs_fistula_age_15_19 |
odds ratio for care seeking for treatment of obstetric fistula in 15-19 year olds |
List |
[0.31, 0.31] |
aor_cs_fistula_age_lowest_education |
odds ratio for care seeking for treatment of obstetric fistula in women in the lowest education quantile |
List |
[0.69, 0.69] |
treatment_effect_early_init_bf |
effect of early initiation of breastfeeding on neonatal sepsis rates |
List |
[0.55, 0.55] |
treatment_effect_iron_folic_acid_anaemia |
effect of iron and folic acid supplementation on anaemia risk |
List |
[0.3, 0.3] |
treatment_effect_abx_prom |
effect of early antibiotics given to a mother with PROM on neonatal sepsis rates |
List |
[0.67, 0.67] |
treatment_effect_clean_birth |
Treatment effect of clean birth practices on early onset neonatal sepsis risk |
List |
[0.73, 0.73] |
treatment_effect_cord_care |
Treatment effect of chlorhexidine cord care on early onset neonatal sepsis risk |
List |
[0.77, 0.77] |
treatment_effect_anti_htns_progression_pn |
Treatment effect of oral anti hypertensives on progression from mild/mod to severe gestationalhypertension |
List |
[0.49, 0.49] |
PregnancySupervisor
Name |
Description |
Type |
Value |
---|---|---|---|
prob_ectopic_pregnancy |
probability of ectopic pregnancy |
List |
[0.01, 0.01] |
prob_care_seeking_ectopic_pre_rupture |
probability a woman will seek care for ectopic pregnancy prior to rupture |
List |
[0.08, 0.08] |
prob_ectopic_pregnancy_death |
probability of a woman dying from a ruptured ectopic pregnancy |
List |
[0.02, 0.012] |
prob_multiples |
probability that a woman is currently carrying more than one pregnancy |
List |
[0.0399, 0.0399] |
prob_placenta_praevia |
probability that this womans pregnancy will be complicated by placenta praevia |
List |
[0.005, 0.0058] |
rr_placenta_praevia_previous_cs |
relative risk of placenta praevia in a woman who has previously delivered via caesarean section |
List |
[1.47, 1.47] |
prob_syphilis_during_pregnancy |
probability that this womans will develop syphilis during her pregnancy |
List |
[0.028, 0.028] |
prob_previous_miscarriage_at_baseline |
probability that a woman at baseline will have previously experienced a miscarriage |
Real |
0.047 |
prob_spontaneous_abortion_per_month |
underlying risk of spontaneous abortion per month |
List |
[[0.025, 0.037, 0.05, 0.037, 0.025], [0.025, 0.037, 0.05, 0.037, 0.025]] |
rr_spont_abortion_age_35 |
relative risk of spontaneous abortion in women aged 35 years or older |
List |
[4, 4] |
rr_spont_abortion_age_31_34 |
relative risk of spontaneous abortion in women aged 31-34 years old |
List |
[2.31, 2.31] |
rr_spont_abortion_prev_sa |
relative risk of spontaneous abortion in women who have previously experiences spontaneous abortion |
List |
[2.23, 2.23] |
prob_complicated_sa |
probability that a woman who experiences spontaneous abortion with experience any complications |
List |
[0.11, 0.11] |
prob_induced_abortion_per_month |
underlying risk of induced abortion per month |
List |
[0.038, 0.038] |
prob_complicated_ia |
probability that a woman who experiences induced abortion with experience any complications |
List |
[0.37, 0.37] |
prob_haemorrhage_post_abortion |
probability of haemorrhage following an abortion |
List |
[0.23, 0.23] |
prob_sepsis_post_abortion |
probability of sepsis following an abortion |
List |
[0.137, 0.137] |
prob_injury_post_abortion |
probability of injury following an abortion |
List |
[0.056, 0.056] |
prob_induced_abortion_death |
underlying risk of death following an induced abortion |
List |
[0.005, 0.0025] |
prob_spontaneous_abortion_death |
underlying risk of death following an spontaneous abortion |
List |
[0.01, 0.005] |
baseline_prob_anaemia_per_month |
baseline risk of a woman developing anaemia secondary only to pregnant |
List |
[0.1, 0.12] |
rr_anaemia_maternal_malaria |
relative risk of anaemia secondary to malaria infection |
List |
[1.45, 1.45] |
rr_anaemia_hiv_no_art |
relative risk of anaemia for a woman with HIV not on ART |
List |
[4.19, 4.19] |
prob_mild_mod_sev_anaemia |
probabilities that a womans anaemia will be mild, moderate or severe |
List |
[[0.52, 0.475, 0.005], [0.5, 0.46, 0.04]] |
prob_gest_diab_per_month |
underlying risk of gestational diabetes per month without the impact of risk factors |
List |
[0.0056, 0.0056] |
rr_gest_diab_obesity |
Relative risk of gestational diabetes for women who are obese |
List |
[3.97, 3.97] |
prob_gest_htn_per_month |
underlying risk of gestational hypertension per month without the impact of risk factors |
List |
[0.0073, 0.0073] |
rr_gest_htn_obesity |
Relative risk of gestational hypertension for women who are obese |
List |
[3.31, 3.31] |
prob_pre_eclampsia_per_month |
underlying risk of pre-eclampsia per month without the impact of risk factors |
List |
[0.0065, 0.0065] |
rr_pre_eclampsia_obesity |
Relative risk of pre-eclampsia for women who are obese |
List |
[3.2, 3.2] |
rr_pre_eclampsia_multiple_pregnancy |
Relative risk of pre-eclampsia for women who are pregnant with twins |
List |
[4.07, 4.07] |
rr_pre_eclampsia_chronic_htn |
Relative risk of pre-eclampsia in women who are chronically hypertensive |
List |
[2.26, 2.26] |
rr_pre_eclampsia_diabetes_mellitus |
Relative risk of pre-eclampsia in women who have diabetes mellitus |
List |
[3.7, 3.7] |
probs_for_mgh_matrix |
probability of mild gestational hypertension moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0.918, 0.032, 0.05, 0, 0], [0.918, 0.032, 0.05, 0, 0]] |
probs_for_sgh_matrix |
probability of severe gestational hypertension moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0.87, 0, 0.13, 0], [0, 0.87, 0, 0.13, 0]] |
probs_for_mpe_matrix |
probability of mild pre-eclampsia moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0, 0.78, 0.22, 0], [0, 0, 0.78, 0.22, 0]] |
probs_for_spe_matrix |
probability of severe pre-eclampsia moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0, 0, 0.16, 0.84], [0, 0, 0, 0.16, 0.84]] |
probs_for_ec_matrix |
probability of eclampsia moving between states: gestational hypertension, severe gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, eclampsia |
List |
[[0, 0, 0, 0, 1], [0, 0, 0, 0, 1]] |
prob_severe_pre_eclampsia_death |
probability of death for a woman experiencing acute severe pre-eclampsia |
List |
[0.018, 0.018] |
prob_eclampsia_death |
probability of death for a woman experiencing eclampsia |
List |
[0.028, 0.03] |
prob_monthly_death_severe_htn |
monthly risk of death for a woman with severe hypertension |
List |
[0.0001, 0.0001] |
prob_placental_abruption_per_month |
monthly probability that a woman will develop placental abruption |
List |
[0.0005, 0.0005] |
rr_placental_abruption_hypertension |
Relative risk of placental abruption in women with hypertension |
List |
[2.2, 2.2] |
rr_placental_abruption_previous_cs |
Relative risk of placental abruption in women who delivered previously via caesarean section |
List |
[1.3, 1.3] |
prob_aph_placenta_praevia |
risk of antepartum haemorrhage due to ongoing placenta praevia |
List |
[0.09, 0.09] |
prob_aph_placental_abruption |
risk of antepartum haemorrhage due to placental abruption |
List |
[0.9, 0.9] |
prob_mod_sev_aph |
probabilities that APH is mild/moderate or severe |
List |
[[0.8, 0.2], [0.8, 0.2]] |
prob_antepartum_haemorrhage_death |
probability of death for a woman suffering acute antepartum haemorrhage |
List |
[0.11, 0.04] |
prob_prom_per_month |
monthly probability that a woman will experience premature rupture of membranes |
List |
[0.0064, 0.0064] |
prob_chorioamnionitis |
monthly probability of a women developing chorioamnionitis |
List |
[0.015, 0.013] |
prob_antenatal_sepsis_death |
case fatality rate for chorioamnionitis |
List |
[0.75, 0.49] |
baseline_prob_early_labour_onset |
monthly baseline risk of labour onsetting before term |
List |
[[0.0008, 0.0033, 0.017, 0.04], [0.0008, 0.0033, 0.017, 0.04]] |
rr_preterm_labour_post_prom |
relative risk of early labour onset following PROM |
List |
[5.9, 5.9] |
rr_preterm_labour_anaemia |
relative risk of early labour onset in women with anaemia |
List |
[4.58, 4.58] |
rr_preterm_labour_malaria |
relative risk of early labour onset in women with malaria |
List |
[3.08, 3.08] |
rr_preterm_labour_multiple_pregnancy |
relative risk of early labour onset in women pregnant with twins |
List |
[3.44, 3.44] |
prob_still_birth_per_month |
underlying risk of stillbirth per month without the impact of risk factors |
List |
[0.0031, 0.0026] |
rr_still_birth_ga_41 |
relative risk of still birth in women with gestational age 41 weeks |
List |
[2.24, 2.24] |
rr_still_birth_ga_42 |
relative risk of still birth in women with gestational age 42 weeks |
List |
[3.88, 3.88] |
rr_still_birth_ga_>42 |
relative risk of still birth in women with gestational age > 42 weeks |
List |
[6.94, 6.94] |
rr_still_birth_gest_diab |
relative risk of still birth in women with gestational diabetes |
List |
[3.91, 3.91] |
rr_still_birth_diab_mellitus |
relative risk of still birth in women with diabetes mellitus |
List |
[3.52, 3.52] |
rr_still_birth_maternal_malaria |
relative risk of still birth in women with malaria |
List |
[1.81, 1.81] |
rr_still_birth_maternal_syphilis |
relative risk of still birth in women with syphilis |
List |
[6.87, 6.87] |
rr_still_birth_pre_eclampsia |
relative risk of still birth in women with pre-eclampsia |
List |
[4.15, 4.15] |
rr_still_birth_eclampsia |
relative risk of still birth in women with eclampsia |
List |
[4.15, 4.15] |
rr_still_birth_gest_htn |
relative risk of still birth in women with mild gestational hypertension |
List |
[1.21, 1.21] |
rr_still_birth_chronic_htn |
relative risk of still birth in women with chronic hypertension |
List |
[2.32, 2.23] |
rr_still_birth_aph |
relative risk of still birth in women with antepartum haemorrhage |
List |
[2.1, 2.1] |
rr_still_birth_chorio |
relative risk of still birth in women with chorioamnionitis |
List |
[2, 2] |
prob_seek_care_pregnancy_complication |
Probability that a woman who is pregnant will seek care in the event of a complication |
List |
[0.782, 0.782] |
prob_seek_care_pregnancy_loss |
Probability that a woman who has developed complications post pregnancy loss will seek care |
List |
[0.782, 0.782] |
prob_seek_care_induction |
Probability that a woman who is post term will seek care for induction of labour |
List |
[0.2, 0.2] |
prob_anc1_months_2_to_4 |
list of probabilities that a woman will attend her first ANC visit at either month 2, 3 or 4 of pregnancy |
List |
[[0.165, 0.165, 0.67], [0.165, 0.364, 0.471]] |
prob_anc1_months_5_to_9 |
list of probabilities that a woman will attend her first ANC visit on months 5-10 |
List |
[[0.345, 0.245, 0.28, 0.015, 0.015, 0.1], [0.41, 0.25, 0.21, 0.015, 0.015, 0.1]] |
odds_early_init_anc4 |
probability of a woman undergoing 4 or more basic ANC visits with the first visit occurring prior or during month 4 of pregnancy (EANC4+) |
List |
[0.32, 0.58] |
aor_early_anc4_20_24 |
adjusted odds ratio of EANC4+ in women aged 20-24 |
List |
[1.26, 1.26] |
aor_early_anc4_25_29 |
adjusted odds ratio of EANC4+ in women aged 25-29 |
List |
[1.44, 1.44] |
aor_early_anc4_30_34 |
adjusted odds ratio of EANC4+ in women aged 30-34 |
List |
[1.49, 1.49] |
aor_early_anc4_35_39 |
adjusted odds ratio of EANC4+ in women aged 35-39 |
List |
[1.64, 1.64] |
aor_early_anc4_40_44 |
adjusted odds ratio of EANC4+ in women aged 40-44 |
List |
[1.51, 1.51] |
aor_early_anc4_45_49 |
adjusted odds ratio of EANC4+ in women aged 45-49 |
List |
[1.91, 1.91] |
aor_early_anc4_2010 |
adjusted odds ratio of EANC4+ in 2010 |
List |
[1.51, 1.51] |
aor_early_anc4_2015 |
adjusted odds ratio of EANC4+ in 2015 |
List |
[2.03, 2.03] |
aor_early_anc4_parity_2_3 |
adjusted odds ratio of EANC4+ in women with a parity of 2-3 |
List |
[0.74, 0.74] |
aor_early_anc4_parity_4_5 |
adjusted odds ratio of EANC4+ in women with a parity of 4-5 |
List |
[0.65, 0.65] |
aor_early_anc4_parity_6+ |
adjusted odds ratio of EANC4+ in women with a parity of 6+ |
List |
[0.61, 0.61] |
aor_early_anc4_secondary_edu |
adjusted odds ratio of EANC4+ in women with secondary education |
List |
[1.24, 1.24] |
aor_early_anc4_tertiary_edu |
adjusted odds ratio of EANC4+ in women with tertiary education |
List |
[2.64, 2.64] |
aor_early_anc4_richest_wealth |
adjusted odds ratio of EANC4+ in women in the richest wealth quintile |
List |
[1.32, 1.32] |
prob_late_initiation_anc4 |
probability a woman will undertake 4 or more ANC visits with the first being after 4 months |
List |
[0.3, 0.29] |
prob_early_initiation_anc_below4 |
probabilities a woman will attend fewer than 4 ANC visits but the first visit will occur before month 4 |
List |
[0.115, 0.101] |
prob_early_anc_at_facility_level_1_2 |
probabilities a woman will attend ANC 1 at facility levels 1 or 2 |
List |
[[0.5, 0.5], [0.5, 0.5]] |
treatment_effect_ectopic_pregnancy_treatment |
Treatment effect of ectopic pregnancy case management |
List |
[0.1, 0.1] |
treatment_effect_post_abortion_care |
Treatment effect of post abortion care |
List |
[0.2, 0.2] |
treatment_effect_iron_folic_acid_anaemia |
relative effect of daily iron and folic acid treatment on risk of maternal anaemia |
List |
[0.3, 0.3] |
treatment_effect_calcium_pre_eclamp |
risk reduction of pre-eclampsia for women taking daily calcium supplementation |
List |
[0.45, 0.45] |
treatment_effect_gest_htn_calcium |
Effect of calcium supplementation on risk of developing gestational hypertension |
List |
[0.65, 0.65] |
treatment_effect_anti_htns_progression |
Effect of anti hypertensive medication in reducing the risk of progression from mild to severe hypertension |
List |
[0.49, 0.49] |
prob_glycaemic_control_diet_exercise |
probability a womans GDM is controlled by diet and exercise during the first month of treatment |
List |
[0.5, 0.5] |
prob_glycaemic_control_orals |
probability a womans GDM is controlled by oral anti-diabetics during the first month of treatment |
List |
[0.936, 0.936] |
treatment_effect_gdm_case_management |
Treatment effect of GDM case management on mothers risk of stillbirth |
List |
[0.9, 0.9] |
treatment_effect_still_birth_food_sups |
risk reduction of still birth for women receiving nutritional supplements |
List |
[0.6, 0.6] |
anc_service_structure |
stores type of ANC service being delivered in the model (anc4 or anc8) and is used in analysisscripts to change ANC structure |
Integer |
8 |
analysis_year |
Year on which the pregnancy analysis event is scheduled to update any relevant parameters for analysis (1st day 1st month) |
Integer |
2023 |
ps_analysis_in_progress |
Used within the pregnancy_helper_function to signify that analysis is currently being conducted |
Boolean |
False |
alternative_anc_coverage |
Signals within the analysis event that an alternative level of ANC coverage has been determined following the events run |
Boolean |
False |
alternative_anc_quality |
Signals within the analysis event that an alternative level of ANC quality has been determined following the events run |
Boolean |
False |
anc_availability_odds |
Target odds of early initiation of ANC4+ when analysis is being conducted - only applied ifalternative_anc_coverage is true |
Real |
9.0 |
anc_availability_probability |
Target probability of quality/consumables when analysis is being conducted - only applied if alternative_anc_quality is true |
Real |
0.9 |
alternative_ip_anc_quality |
Signals within the analysis event that an alternative level of inpatient ANC quality has been determined following the events run |
Boolean |
False |
ip_anc_availability_probability |
Target probability of quality/consumables when analysis is being conducted - only applied if alternative_ip_anc_quality is true |
Real |
0.9 |
sens_analysis_min |
Signals within the analysis event and code that sensitivity analysis is being undertaken in which ANC is blocked from occurring |
Boolean |
False |
sens_analysis_max |
Signals within the analysis event and code that sensitivity analysis is being undertaken in which the maximum coverage of ANC is enforced |
Boolean |
False |
ProstateCancer
Name |
Description |
Type |
Value |
---|---|---|---|
init_prop_prostate_ca_stage |
initial proportions in prostate cancer stages for men aged 35-49 |
List |
[0.0001, 0.0001, 5e-05] |
init_prop_urinary_symptoms_by_stage |
initial proportions of those in prostate ca stages that have urinary symptoms |
List |
[0.3, 0.5, 0.7] |
init_prop_pelvic_pain_symptoms_by_stage |
initial proportions of those in prostate ca stages that have pelvic pain symptoms |
List |
[0.0, 0.3, 0.7] |
init_prop_with_urinary_symptoms_diagnosed_prostate_ca_by_stage |
initial proportions of people with prostate ca and urinary symptoms that have been diagnosed |
List |
[0.3, 0.4, 0.5] |
init_prop_with_pelvic_pain_symptoms_diagnosed_prostate_ca_by_stage |
initial proportions of people with prostate ca and pelvic pain symptoms that have been diagnosed |
List |
[0.3, 0.4, 0.5] |
init_prop_treatment_status_prostate_ca |
initial proportions of people with prostate ca that had received treatment |
List |
[0.1, 0.1, 0.1] |
init_prob_palliative_care |
initial probability of being under palliative care if at metastatic stage |
Real |
0.95 |
r_prostate_confined_prostate_ca_none |
probabilty per 3 months of incident (prostate confined) prostate cancer amongst people with no prostate ca (men, age35-49) |
Real |
4e-05 |
rr_prostate_confined_prostate_ca_age5069 |
rate ratio for incident (prostate confined) prostate cancer amongst men aged 50-69 |
Real |
2.0 |
rr_prostate_confined_prostate_ca_agege70 |
rate ratio for incident (prostate confined) prostate cancer amongst men aged ge 70 |
Real |
4.0 |
r_local_ln_prostate_ca_prostate_confined |
probabilty per 3 months of local lymph node involved prostate ca amongst people with prostate confined prostate ca |
Real |
0.15 |
rr_local_ln_prostate_ca_undergone_curative_treatment |
rate ratio for local lymph node involved prostate ca for people with prostate confined prostate cadue to undergoing curative treatment |
Real |
0.1 |
r_metastatic_prostate_ca_local_ln |
probabilty per 3 months of metastatic prostate cancer amongst people with local lymph nodeinvolved prostate ca |
Real |
0.15 |
rr_metastatic_prostate_ca_undergone_curative_treatment |
rate ratio for metastatic prostate cancer stage 1 for people with lymph node involved prostate ca due toundergoing curative treatment |
Real |
0.2 |
r_death_metastatic_prostate_cancer |
probabilty per 3 months of death from prostate cancer mongst people with metastatic prostate cancer |
Real |
0.2 |
r_urinary_symptoms_prostate_ca |
rate of urinary symptoms if have prostate confined prostate ca |
Real |
0.05 |
rr_urinary_symptoms_local_ln_or_metastatic_prostate_cancer |
rate ratio of urinary symptoms in a person with local lymph node or metastatuc prostate cancer compared with prostate confined prostate ca |
Real |
1.5 |
r_pelvic_pain_symptoms_local_ln_prostate_ca |
rate of pelvic pain or numbness symptoms if have local lymph node involved prostate cancer |
Real |
0.05 |
rr_pelvic_pain_metastatic_prostate_cancer |
rate ratio of pelvic pain or numbness in a person with metastatic prostate cancer compared with lymph node involved prostate cancer |
Real |
1.5 |
rp_prostate_cancer_age5069 |
stage-specific relative prevalence at baseline of prostate cancer for age 50-69 |
Real |
2.0 |
rp_prostate_cancer_agege70 |
stage-specific relative prevalence at baseline of prostate cancer for age 70+ |
Real |
4.0 |
sensitivity_of_psa_test_for_prostate_ca |
sensitivity of psa test for prostate cancer |
Real |
0.9 |
sensitivity_of_biopsy_for_prostate_ca |
sensitivity of biopsy for prostate cancer |
Real |
0.95 |
RTI
Name |
Description |
Type |
Value |
---|---|---|---|
base_rate_injrti |
Base rate of RTI per year |
Real |
0.00420322902234662 |
rr_injrti_age04 |
risk ratio of RTI in age 0-4 compared to base rate of RTI |
Real |
0.145533 |
rr_injrti_age59 |
risk ratio of RTI in age 5-9 compared to base rate of RTI |
Real |
0.551895 |
rr_injrti_age1017 |
risk ratio of RTI in age 10-17 compared to base rate of RTI |
Real |
0.967017 |
rr_injrti_age1829 |
risk ratio of RTI in age 18-29 compared to base rate of RTI |
Real |
1.184184 |
rr_injrti_age3039 |
risk ratio of RTI in age 30-39 compared to base rate of RTI |
Real |
1.052843 |
rr_injrti_age4049 |
risk ratio of RTI in age 40-49 compared to base rate of RTI |
Real |
1.074376 |
rr_injrti_age5059 |
risk ratio of RTI in age 50-59 compared to base rate of RTI |
Real |
1.336449 |
rr_injrti_age6069 |
risk ratio of RTI in age 60-69 compared to base rate of RTI |
Real |
2.308514 |
rr_injrti_age7079 |
risk ratio of RTI in age 70-79 compared to base rate of RTI |
Real |
4.031226 |
rr_injrti_male |
risk ratio of RTI when male compared to females |
Real |
2.7 |
rr_injrti_excessalcohol |
risk ratio of RTI in those that consume excess alcohol compared to those who do not |
Real |
6.53 |
imm_death_proportion_rti |
Proportion of those involved in an RTI that die at site of accident or die before seeking medical intervention |
Real |
0.007 |
prob_bleeding_leads_to_shock |
The proportion of those with heavily bleeding injuries who go into shock |
Real |
0.042222 |
prob_death_iss_less_than_9 |
Proportion of people who pass away in the following month after medical treatment for injuries with an ISSscore less than or equal to 9 |
Real |
0.00733191462346883 |
prob_death_iss_10_15 |
Proportion of people who pass away in the following month after medical treatment for injuries with an ISSscore from 10 to 15 |
Real |
0.0111021545889758 |
prob_death_iss_16_24 |
Proportion of people who pass away in the following month after medical treatment for injuries with an ISSscore from 16 to 24 |
Real |
0.0313608577284893 |
prob_death_iss_25_35 |
Proportion of people who pass away in the following month after medical treatment for injuries with an ISSscore from 25 to 34 |
Real |
0.133987145668097 |
prob_death_iss_35_plus |
Proportion of people who pass away in the following month after medical treatment for injuries with an ISSscore 35 and above |
Real |
0.22782740761579 |
prob_perm_disability_with_treatment_severe_TBI |
probability that someone with a treated severe TBI is permanently disabled |
Real |
0.199 |
prob_death_TBI_SCI_no_treatment |
probability that someone with a spinal cord injury will die without treatment |
Real |
0.9 |
prop_death_burns_no_treatment |
probability that someone with a burn injury will die without treatment |
Real |
0.6 |
prob_death_fractures_no_treatment |
probability that someone with a fracture injury will die without treatment |
Real |
0.1 |
prob_TBI_require_craniotomy |
probability that someone with a traumatic brain injury will require a craniotomy surgery |
Real |
0.124 |
prob_exploratory_laparotomy |
probability that someone with an internal organ injury will require a exploratory_laparotomy |
Real |
0.319 |
prob_depressed_skull_fracture |
Probability that a skull fracture will be depressed and therefore require surgery |
Real |
0.14 |
prob_mild_burns |
Probability that a burn within a region will result in < 10% total body surface area |
Real |
0.56 |
prob_dislocation_requires_surgery |
Probability that a dislocation will require surgery to relocate the joint. |
Real |
0.01 |
number_of_injured_body_regions_distribution |
The distribution of number of injured AIS body regions, used to decide how many injuries a person has |
List |
[[1, 2, 3, 4, 5, 6, 7, 8], [0.7362050184224718, 0.19421990546958515, 0.051237591074077896, 0.013517104401461814, 0.0035659777825202245, 0.0009407486372638106, 0.0002481810186400668, 6.547319397917849e-05]] |
injury_location_distribution |
The distribution of where injuries are located in the body, based on the AIS body region definition |
List |
[[1, 2, 3, 4, 5, 6, 7, 8], [0.1438, 0.1325, 0.021, 0.0945, 0.0612, 0.0155, 0.1685, 0.363]] |
mean_los_ISS_less_than_4 |
Mean length of stay for someone with an ISS score < 4 |
Real |
4.97 |
sd_los_ISS_less_than_4 |
Standard deviation in length of stay for someone with an ISS score < 4 |
Real |
4.86 |
mean_los_ISS_4_to_8 |
Mean length of stay for someone with an ISS score between 4 and 8 |
Real |
8.91 |
sd_los_ISS_4_to_8 |
Standard deviation in length of stay for someone with an ISS score between 4 and 8 |
Real |
5.93 |
mean_los_ISS_9_to_15 |
Mean length of stay for someone with an ISS score between 9 and 15 |
Real |
15.46 |
sd_los_ISS_9_to_15 |
Standard deviation in length of stay for someone with an ISS score between 9 and 15 |
Real |
11.16 |
mean_los_ISS_16_to_24 |
Mean length of stay for someone with an ISS score between 16 and 24 |
Real |
24.73 |
sd_los_ISS_16_to_24 |
Standard deviation in length of stay for someone with an ISS score between 16 and 24 |
Real |
17.03 |
mean_los_ISS_more_than_25 |
Mean length of stay for someone with an ISS score between 16 and 24 |
Real |
30.86 |
sd_los_ISS_more_that_25 |
Standard deviation in length of stay for someone with an ISS score between 16 and 24 |
Real |
34.03 |
daly_wt_unspecified_skull_fracture |
daly_wt_unspecified_skull_fracture - code 1674 |
Real |
0.195 |
daly_wt_basilar_skull_fracture |
daly_wt_basilar_skull_fracture - code 1675 |
Real |
0.149 |
daly_wt_epidural_hematoma |
daly_wt_epidural_hematoma - code 1676 |
Real |
0.185 |
daly_wt_subdural_hematoma |
daly_wt_subdural_hematoma - code 1677 |
Real |
0.21 |
daly_wt_subarachnoid_hematoma |
daly_wt_subarachnoid_hematoma - code 1678 |
Real |
0.214 |
daly_wt_brain_contusion |
daly_wt_brain_contusion - code 1679 |
Real |
0.174 |
daly_wt_intraventricular_haemorrhage |
daly_wt_intraventricular_haemorrhage - code 1680 |
Real |
0.174 |
daly_wt_diffuse_axonal_injury |
daly_wt_diffuse_axonal_injury - code 1681 |
Real |
0.239 |
daly_wt_subgaleal_hematoma |
daly_wt_subgaleal_hematoma - code 1682 |
Real |
0.174 |
daly_wt_midline_shift |
daly_wt_midline_shift - code 1683 |
Real |
0.239 |
daly_wt_facial_fracture |
daly_wt_facial_fracture - code 1684 |
Real |
0.067 |
daly_wt_facial_soft_tissue_injury |
daly_wt_facial_soft_tissue_injury - code 1685 |
Real |
0.008 |
daly_wt_eye_injury |
daly_wt_eye_injury - code 1686 |
Real |
0.054 |
daly_wt_neck_soft_tissue_injury |
daly_wt_neck_soft_tissue_injury - code 1687 |
Real |
0.1 |
daly_wt_neck_internal_bleeding |
daly_wt_neck_internal_bleeding - code 1688 |
Real |
0.1 |
daly_wt_neck_dislocation |
daly_wt_neck_dislocation - code 1689 |
Real |
0.187 |
daly_wt_chest_wall_bruises_hematoma |
daly_wt_chest_wall_bruises_hematoma - code 1690 |
Real |
0.143 |
daly_wt_hemothorax |
daly_wt_hemothorax - code 1691 |
Real |
0.143 |
daly_wt_lung_contusion |
daly_wt_lung_contusion - code 1692 |
Real |
0.205 |
daly_wt_diaphragm_rupture |
daly_wt_diaphragm_rupture - code 1693 |
Real |
0.205 |
daly_wt_rib_fracture |
daly_wt_rib_fracture - code 1694 |
Real |
0.187 |
daly_wt_flail_chest |
daly_wt_flail_chest - code 1695 |
Real |
0.211 |
daly_wt_chest_wall_laceration |
daly_wt_chest_wall_laceration - code 1696 |
Real |
0.143 |
daly_wt_closed_pneumothorax |
daly_wt_closed_pneumothorax - code 1697 |
Real |
0.164 |
daly_wt_open_pneumothorax |
daly_wt_open_pneumothorax - code 1698 |
Real |
0.164 |
daly_wt_surgical_emphysema |
daly_wt_surgical_emphysema aka subcuteal emphysema - code 1699 |
Real |
0.164 |
daly_wt_abd_internal_organ_injury |
daly_wt_abd_internal_organ_injury - code 1700 |
Real |
0.182 |
daly_wt_spinal_cord_lesion_neck_with_treatment |
daly_wt_spinal_cord_lesion_neck_with_treatment - code 1701 |
Real |
0.589 |
daly_wt_spinal_cord_lesion_neck_without_treatment |
daly_wt_spinal_cord_lesion_neck_without_treatment - code 1702 |
Real |
0.732 |
daly_wt_spinal_cord_lesion_below_neck_with_treatment |
daly_wt_spinal_cord_lesion_below_neck_with_treatment - code 1703 |
Real |
0.296 |
daly_wt_spinal_cord_lesion_below_neck_without_treatment |
daly_wt_spinal_cord_lesion_below_neck_without_treatment - code 1704 |
Real |
0.623 |
daly_wt_vertebrae_fracture |
daly_wt_vertebrae_fracture - code 1705 |
Real |
0.111 |
daly_wt_clavicle_scapula_humerus_fracture |
daly_wt_clavicle_scapula_humerus_fracture - code 1706 |
Real |
0.035 |
daly_wt_hand_wrist_fracture_with_treatment |
daly_wt_hand_wrist_fracture_with_treatment - code 1707 |
Real |
0.01 |
daly_wt_hand_wrist_fracture_without_treatment |
daly_wt_hand_wrist_fracture_without_treatment - code 1708 |
Real |
0.014 |
daly_wt_radius_ulna_fracture_short_term_with_without_treatment |
daly_wt_radius_ulna_fracture_short_term_with_without_treatment - code 1709 |
Real |
0.028 |
daly_wt_radius_ulna_fracture_long_term_without_treatment |
daly_wt_radius_ulna_fracture_long_term_without_treatment - code 1710 |
Real |
0.043 |
daly_wt_dislocated_shoulder |
daly_wt_dislocated_shoulder - code 1711 |
Real |
0.062 |
daly_wt_amputated_finger |
daly_wt_amputated_finger - code 1712 |
Real |
0.005 |
daly_wt_amputated_thumb |
daly_wt_amputated_thumb - code 1713 |
Real |
0.011 |
daly_wt_unilateral_arm_amputation_with_treatment |
daly_wt_unilateral_arm_amputation_with_treatment - code 1714 |
Real |
0.039 |
daly_wt_unilateral_arm_amputation_without_treatment |
daly_wt_unilateral_arm_amputation_without_treatment - code 1715 |
Real |
0.118 |
daly_wt_bilateral_arm_amputation_with_treatment |
daly_wt_bilateral_arm_amputation_with_treatment - code 1716 |
Real |
0.123 |
daly_wt_bilateral_arm_amputation_without_treatment |
daly_wt_bilateral_arm_amputation_without_treatment - code 1717 |
Real |
0.383 |
daly_wt_foot_fracture_short_term_with_without_treatment |
daly_wt_foot_fracture_short_term_with_without_treatment - code 1718 |
Real |
0.026 |
daly_wt_foot_fracture_long_term_without_treatment |
daly_wt_foot_fracture_long_term_without_treatment - code 1719 |
Real |
0.026 |
daly_wt_patella_tibia_fibula_fracture_with_treatment |
daly_wt_patella_tibia_fibula_fracture_with_treatment - code 1720 |
Real |
0.05 |
daly_wt_patella_tibia_fibula_fracture_without_treatment |
daly_wt_patella_tibia_fibula_fracture_without_treatment - code 1721 |
Real |
0.055 |
daly_wt_hip_fracture_short_term_with_without_treatment |
daly_wt_hip_fracture_short_term_with_without_treatment - code 1722 |
Real |
0.258 |
daly_wt_hip_fracture_long_term_with_treatment |
daly_wt_hip_fracture_long_term_with_treatment - code 1723 |
Real |
0.058 |
daly_wt_hip_fracture_long_term_without_treatment |
daly_wt_hip_fracture_long_term_without_treatment - code 1724 |
Real |
0.402 |
daly_wt_pelvis_fracture_short_term |
daly_wt_pelvis_fracture_short_term - code 1725 |
Real |
0.279 |
daly_wt_pelvis_fracture_long_term |
daly_wt_pelvis_fracture_long_term - code 1726 |
Real |
0.182 |
daly_wt_femur_fracture_short_term |
daly_wt_femur_fracture_short_term - code 1727 |
Real |
0.111 |
daly_wt_femur_fracture_long_term_without_treatment |
daly_wt_femur_fracture_long_term_without_treatment - code 1728 |
Real |
0.042 |
daly_wt_dislocated_hip |
daly_wt_dislocated_hip - code 1729 |
Real |
0.016 |
daly_wt_dislocated_knee |
daly_wt_dislocated_knee - code 1730 |
Real |
0.113 |
daly_wt_amputated_toes |
daly_wt_amputated_toes - code 1731 |
Real |
0.006 |
daly_wt_unilateral_lower_limb_amputation_with_treatment |
daly_wt_unilateral_lower_limb_amputation_with_treatment - code 1732 |
Real |
0.039 |
daly_wt_unilateral_lower_limb_amputation_without_treatment |
daly_wt_unilateral_lower_limb_amputation_without_treatment - code 1733 |
Real |
0.173 |
daly_wt_bilateral_lower_limb_amputation_with_treatment |
daly_wt_bilateral_lower_limb_amputation_with_treatment - code 1734 |
Real |
0.088 |
daly_wt_bilateral_lower_limb_amputation_without_treatment |
daly_wt_bilateral_lower_limb_amputation_without_treatment - code 1735 |
Real |
0.443 |
rt_emergency_care_ISS_score_cut_off |
A parameter to determine which level of injury severity corresponds to the emergency health care seeking symptom and which to the non-emergency generic injury symptom |
Integer |
5 |
prob_death_MAIS3 |
A parameter to determine the probability of death without medical intervention with a military AISscore of 3 |
Real |
0.05 |
prob_death_MAIS4 |
A parameter to determine the probability of death without medical intervention with a military AISscore of 4 |
Real |
0.31 |
prob_death_MAIS5 |
A parameter to determine the probability of death without medical intervention with a military AISscore of 5 |
Real |
0.59 |
prob_death_MAIS6 |
A parameter to determine the probability of death without medical intervention with a military AISscore of 6 |
Real |
0.83 |
femur_fracture_skeletal_traction_mean_los |
The mean length of stay for a person with a femur fracture being treated with skeletal traction |
Integer |
52 |
other_skeletal_traction_los |
The mean length of stay for a person with a non-femur fracture being treated with skeletal traction |
Integer |
42 |
prob_foot_frac_require_cast |
The probability that a person with a foot fracture will be treated with a plaster cast |
Real |
0.613 |
prob_foot_frac_require_maj_surg |
The probability that a person with a foot fracture will be treated with a major surgery |
Real |
0.263 |
prob_foot_frac_require_min_surg |
The probability that a person with a foot fracture will be treated with a major surgery |
Real |
0.038 |
prob_foot_frac_require_amp |
The probability that a person with a foot fracture will be treated with amputation via a major surgery |
Real |
0.086 |
prob_tib_fib_frac_require_cast |
The probability that a person with a tibia/fibula fracture will be treated with a plaster cast |
Real |
0.71 |
prob_tib_fib_frac_require_maj_surg |
The probability that a person with a tibia/fibula fracture will be treated with a major surgery |
Real |
0.066 |
prob_tib_fib_frac_require_min_surg |
The probability that a person with a tibia/fibula fracture will be treated with a minor surgery |
Real |
0.175 |
prob_tib_fib_frac_require_amp |
The probability that a person with a tibia/fibula fracture will be treated with an amputation via major surgery |
Real |
0.024 |
prob_tib_fib_frac_require_traction |
The probability that a person with a tibia/fibula fracture will be treated with skeletal traction |
Real |
0.025 |
prob_femural_fracture_require_major_surgery |
The probability that a person with a femur fracture will be treated with major surgery |
Real |
0.187 |
prob_femural_fracture_require_minor_surgery |
The probability that a person with a femur fracture will be treated with minor surgery |
Real |
0.007 |
prob_femural_fracture_require_cast |
The probability that a person with a femur fracture will be treated with a plaster cast |
Real |
0.024 |
prob_femural_fracture_require_amputation |
The probability that a person with a femur fracture will be treated with amputation via major surgery |
Real |
0.005 |
prob_femural_fracture_require_traction |
The probability that a person with a femur fracture will be treated with skeletal traction |
Real |
0.777 |
prob_pelvis_fracture_traction |
The probability that a person with a pelvis fracture will be treated with skeletal traction |
Real |
0.71 |
prob_pelvis_frac_major_surgery |
The probability that a person with a pelvis fracture will be treated with major surgery |
Real |
0.12 |
prob_pelvis_frac_minor_surgery |
The probability that a person with a pelvis fracture will be treated with minor surgery |
Real |
0.05 |
prob_pelvis_frac_cast |
The probability that a person with a pelvis fracture will be treated with a cast |
Real |
0.12 |
prob_dis_hip_require_maj_surg |
The probability that a person with a dislocated hip will be treated with a major surgery |
Real |
0.167 |
prob_dis_hip_require_cast |
The probability that a person with a dislocated hip will be treated with a plaster cast |
Real |
0.333 |
prob_hip_dis_require_traction |
The probability that a person with a dislocated hip will be treated with skeletal traction |
Real |
0.5 |
hdu_cut_off_iss_score |
The ISS score used as a criteria to admit patients to the HDU/ICU units |
Integer |
29 |
mean_icu_days |
The mean length of stay in the ICUfor those without TBI |
Real |
4.8 |
sd_icu_days |
The standard deviation in length of stay in the ICU for those without TBI |
Real |
6.0 |
mean_tbi_icu_days |
The mean length of stay in the ICU for those with TBI |
Real |
8.4 |
sd_tbi_icu_days |
The standard deviation in length of stay in the ICU for those with TBI |
Real |
6.4 |
prob_open_fracture_contaminated |
The probability that an open fracture will be contaminated |
Real |
0.07 |
allowed_interventions |
List of additional interventions that can be included when performing model analysis |
List |
[] |
head_prob_112 |
The probability that this person’s head injury is a skull fracture |
Real |
0.0455 |
head_prob_113 |
The probability that this person’s head injury is a basilar skull fracture |
Real |
0.0045 |
head_prob_133a |
The probability that this person’s head injury is a Subarachnoid hematoma |
Real |
0.09149906 |
head_prob_133b |
The probability that this person’s head injury is a Brain contusion |
Real |
0.301946898 |
head_prob_133c |
The probability that this person’s head injury is an Intraventricular haemorrhage |
Real |
0.013724859 |
head_prob_133d |
The probability that this person’s head injury is a Subgaleal hematoma |
Real |
0.050324483 |
head_prob_134a |
The probability that this person’s head injury is an Epidural hematoma |
Real |
0.086670324 |
head_prob_134b |
The probability that this person’s head injury is a Subdural hematoma |
Real |
0.080003376 |
head_prob_135 |
The probability that this person’s head injury is a Diffuse axonal injury/midline shift |
Real |
0.061731 |
head_prob_1101 |
The probability that this person’s head injury is a laceration |
Real |
0.253536 |
head_prob_1114 |
The probability that this person’s head injury is a burn |
Real |
0.010564 |
face_prob_211 |
The probability that this person’s face injury is a Facial fracture (nasal/unspecified) |
Real |
0.158585 |
face_prob_212 |
The probability that this person’s face injury is a Facial fracture (mandible/zygomatic) |
Real |
0.294515 |
face_prob_241 |
The probability that this person’s face injury is a soft tissue injury |
Real |
0.339 |
face_prob_2101 |
The probability that this person’s face injury is a laceration |
Real |
0.194845 |
face_prob_2114 |
The probability that this person’s face injury is a burn |
Real |
0.010255 |
face_prob_291 |
The probability that this person’s face injury is an eye injury |
Real |
0.0028 |
neck_prob_3101 |
The probability that this person’s neck injury is a laceration |
Real |
0.06972 |
neck_prob_3113 |
The probability that this person’s neck injury is a burn |
Real |
0.01428 |
neck_prob_342 |
The probability that this person’s neck injury is a Soft tissue injury in neck (vertebral artery laceration) |
Real |
0.004 |
neck_prob_343 |
The probability that this person’s neck injury is a Soft tissue injury in neck (pharynx contusion) |
Real |
0.004 |
neck_prob_361 |
The probability that this person’s neck injury is a Sternomastoid m. hemorrhage/ Hemorrhage, supraclavicular triangle/Hemorrhage, posterior triangle/Anterior vertebral vessel hemorrhage/ Neck muscle hemorrhage |
Real |
0.495 |
neck_prob_363 |
The probability that this person’s neck injury is a Hematoma in carotid sheath/Carotid sheath hemorrhage |
Real |
0.405 |
neck_prob_322 |
The probability that this person’s neck injury is an Atlanto-occipital subluxation |
Real |
0.00264 |
neck_prob_323 |
The probability that this person’s neck injury is an Atlanto-axial subluxation |
Real |
0.00536 |
thorax_prob_4101 |
The probability that this person’s thorax injury is a laceration |
Real |
0.49036 |
thorax_prob_4113 |
The probability that this person’s thorax injury is a burn |
Real |
0.04264 |
thorax_prob_461 |
The probability that this person’s thorax injury is Chest wall bruises/haematoma |
Real |
0.0945 |
thorax_prob_463 |
The probability that this person’s thorax injury is Haemothorax |
Real |
0.0945 |
thorax_prob_453a |
The probability that this person’s thorax injury is a Lung contusion |
Real |
0.0539 |
thorax_prob_453b |
The probability that this person’s thorax injury is a Diaphragm rupture |
Real |
0.0161 |
thorax_prob_412 |
The probability that this person’s thorax injury is a rib fracture |
Real |
0.0392 |
thorax_prob_414 |
The probability that this person’s thorax injury is flail chest |
Real |
0.0098 |
thorax_prob_441 |
The probability that this person’s thorax injury is a Chest wall lacerations/avulsions |
Real |
0.08586 |
thorax_prob_442 |
The probability that this person’s thorax injury is a Surgical emphysema |
Real |
0.01749 |
thorax_prob_443 |
The probability that this person’s thorax injury is a Closed pneumothorax/ open pneumothorax |
Real |
0.05565 |
abdomen_prob_5101 |
The probability that this person’s abdomen injury is a laceration |
Real |
0.11026 |
abdomen_prob_5113 |
The probability that this person’s thorax injury is a burn |
Real |
0.03874 |
abdomen_prob_552 |
The probability that this person’s thorax injury is a skull fracture |
Real |
0.047656 |
abdomen_prob_553 |
The probability that this person’s thorax injury is an Injury to stomach/intestines/colon |
Real |
0.77441 |
abdomen_prob_554 |
The probability that this person’s thorax injury is an Injury to spleen/Urinary bladder/Liver/Urethra/Diaphragm |
Real |
0.028934 |
spine_prob_612 |
The probability that this person’s spine injury is a vertabrae fracture |
Real |
0.364 |
spine_prob_673a |
The probability that this person’s spine injury is a Spinal cord injury at neck level |
Real |
0.015840216 |
spine_prob_673b |
The probability that this person’s spine injury is a Spinal cord injury below neck level |
Real |
0.040731984 |
spine_prob_674a |
The probability that this person’s spine injury is a Spinal cord injury at neck level |
Real |
0.074477731 |
spine_prob_674b |
The probability that this person’s spine injury is a Spinal cord injury below neck level |
Real |
0.116490809 |
spine_prob_675a |
The probability that this person’s spine injury is a Spinal cord injury at neck level |
Real |
0.134791137 |
spine_prob_675b |
The probability that this person’s spine injury is a Spinal cord injury below neck level |
Real |
0.210827163 |
spine_prob_676 |
The probability that this person’s spine injury is a Spinal cord injury at neck level |
Real |
0.04284096 |
upper_ex_prob_7101 |
The probability that this person’s upper extremity injury is a laceration |
Real |
0.43896 |
upper_ex_prob_7113 |
The probability that this person’s upper extremity injury is a burn |
Real |
0.03304 |
upper_ex_prob_712a |
The probability that this person’s upper extremity injury is a Fracture to Clavicle, scapula, humerus |
Real |
0.10802 |
upper_ex_prob_712b |
The probability that this person’s upper extremity injury is a Fracture to Hand/wrist |
Real |
0.28969 |
upper_ex_prob_712c |
The probability that this person’s upper extremity injury is a Fracture to Radius/ulna |
Real |
0.09329 |
upper_ex_prob_722 |
The probability that this person’s upper extremity injury is a dislocated shoulder |
Real |
0.025 |
upper_ex_prob_782a |
The probability that this person’s upper extremity injury is an Amputated finger |
Real |
0.00750024 |
upper_ex_prob_782b |
The probability that this person’s upper extremity injury is a Unilateral arm amputation |
Real |
0.00102276 |
upper_ex_prob_782c |
The probability that this person’s upper extremity injury is a Thumb amputation |
Real |
0.002841 |
upper_ex_prob_783 |
The probability that this person’s upper extremity injury is a bilateral arm amputation |
Real |
0.000636 |
lower_ex_prob_8101 |
The probability that this person’s lower extremity injury is a laceration |
Real |
0.186094109 |
lower_ex_prob_8113 |
The probability that this person’s lower extremity injury is a burn |
Real |
0.014007083 |
lower_ex_prob_811 |
The probability that this person’s lower extremity injury is a foot fracture |
Real |
0.023610948 |
lower_ex_prob_813do |
The probability that this person’s lower extremity injury is an open foot fracture |
Real |
0.013281158 |
lower_ex_prob_812 |
The probability that this person’s lower extremity injury is a Fracture to patella, tibia, fibula, ankle |
Real |
0.354164215 |
lower_ex_prob_813eo |
The probability that this person’s lower extremity injury is an open Fracture to patella, tibia, fibula, ankle |
Real |
0.199217371 |
lower_ex_prob_813a |
The probability that this person’s lower extremity injury is a Hip fracture |
Real |
0.029513685 |
lower_ex_prob_813b |
The probability that this person’s lower extremity injury is a Pelvis fracture |
Real |
0.023610948 |
lower_ex_prob_813bo |
The probability that this person’s lower extremity injury is an open Pelvis fracture |
Real |
0.005902737 |
lower_ex_prob_813c |
The probability that this person’s lower extremity injury is a Femur fracture |
Real |
0.076765094 |
lower_ex_prob_813co |
The probability that this person’s lower extremity injury is an open Femur fracture |
Real |
0.01177596 |
lower_ex_prob_822a |
The probability that this person’s lower extremity injury is a Dislocated hip |
Real |
0.037338982 |
lower_ex_prob_822b |
The probability that this person’s lower extremity injury is a Dislocated knee |
Real |
0.002383339 |
lower_ex_prob_882 |
The probability that this person’s lower extremity injury is an Amputation of toes |
Real |
0.00731139 |
lower_ex_prob_883 |
The probability that this person’s lower extremity injury is a Unilateral leg amputation |
Real |
0.007511491 |
lower_ex_prob_884 |
The probability that this person’s lower extremity injury is a Bilateral leg amputation |
Real |
0.007511491 |
blocked_interventions |
A list of interventions that are blocked in a simulation |
List |
[] |
unavailable_treatment_mortality_mais_cutoff |
A cut-off score above which an injury will result in additional mortality if the person has sought healthcare and not received it. |
Integer |
5 |
consider_death_no_treatment_ISS_cut_off |
A cut-off score above which an injuries will be considered severe enough to cause mortality in those whohave not sought care. |
Integer |
15 |
maximum_number_of_times_HSI_events_should_run |
limit on the number of times an HSI event can run |
Integer |
5 |
Schisto
Name |
Description |
Type |
Value |
---|---|---|---|
prob_sent_to_lab_test_children |
Probability that infected child gets sent to lab test |
Real |
0.9 |
prob_sent_to_lab_test_adults |
Probability that an infected adults gets sent to lab test |
Real |
0.6 |
delay_till_hsi_a_repeated |
Time till seeking healthcare again after not being sent to schisto test: start |
Real |
5.0 |
delay_till_hsi_b_repeated |
Time till seeking healthcare again after not being sent to schisto test: end |
Real |
20.0 |
PZQ_efficacy |
The efficacy of Praziquantel in clearing burden of any Schistosomiasis worm species |
Real |
1.0 |
MDA_coverage_historical |
Probability of getting PZQ in the MDA for PSAC, SAC and Adults in historic rounds |
Dataframe |
|
MDA_coverage_prognosed |
Probability of getting PZQ in the MDA for PSAC, SAC and Adults in future rounds, with the frequency given in months |
Dataframe |
|
sm_beta_PSAC |
Contact/exposure rate of PSAC |
Real |
0.3 |
sm_beta_SAC |
Contact/exposure rate of SAC |
Real |
1.0 |
sm_beta_Adults |
Contact/exposure rate of Adults |
Real |
0.05 |
sm_worms_fecundity |
Fecundity parameter, driving density-dependent reproduction |
Real |
0.0006 |
sm_worm_lifespan |
Lifespan of the worm in human host given in years |
Real |
4.0 |
sm_high_intensity_threshold |
Threshold of worm burden indicating high intensity infection |
Real |
46.0 |
sm_low_intensity_threshold |
Threshold of worm burden indicating low intensity infection |
Real |
2.0 |
sm_high_intensity_threshold_PSAC |
Worm burden threshold for high intensity infection in PSAC |
Real |
20.0 |
sm_reservoir_2010 |
Initial reservoir of infectious material per district in 2010 |
Series |
|
sm_gamma_alpha |
Parameter alpha for Gamma distribution for harbouring rates |
Series |
|
sm_R0 |
Effective reproduction number, for the FOI |
Series |
|
sh_beta_PSAC |
Contact/exposure rate of PSAC |
Real |
0.3 |
sh_beta_SAC |
Contact/exposure rate of SAC |
Real |
1.0 |
sh_beta_Adults |
Contact/exposure rate of Adults |
Real |
0.05 |
sh_worms_fecundity |
Fecundity parameter, driving density-dependent reproduction |
Real |
0.005 |
sh_worm_lifespan |
Lifespan of the worm in human host given in years |
Real |
6.0 |
sh_high_intensity_threshold |
Threshold of worm burden indicating high intensity infection |
Real |
20.0 |
sh_low_intensity_threshold |
Threshold of worm burden indicating low intensity infection |
Real |
2.0 |
sh_high_intensity_threshold_PSAC |
Worm burden threshold for high intensity infection in PSAC |
Real |
5.0 |
sh_reservoir_2010 |
Initial reservoir of infectious material per district in 2010 |
Series |
|
sh_gamma_alpha |
Parameter alpha for Gamma distribution for harbouring rates |
Series |
|
sh_R0 |
Effective reproduction number, for the FOI |
Series |
MDA_coverage_historical
PSAC |
SAC |
Adults |
---|---|---|
0 |
0.85 |
0.44 |
0 |
0.92 |
0.88 |
0 |
0.87 |
0.88 |
0 |
0.73 |
0.02 |
0 |
0.8 |
0.155 |
0 |
0.87 |
0.29 |
0 |
0.87 |
0.9 |
0 |
0.48 |
0.96 |
0 |
0.605 |
0.96 |
Only first 10 rows of 128 are shown.
MDA_coverage_prognosed
PSAC |
SAC |
Adults |
---|---|---|
0.5 |
0.8 |
0.5 |
0.5 |
0.8 |
0.5 |
0.5 |
0.8 |
0.5 |
0.5 |
0.8 |
0.5 |
0.5 |
0.8 |
0.5 |
0 |
0.8 |
0.5 |
0 |
0.8 |
0.5 |
0 |
0.8 |
0.5 |
0 |
0.8 |
0.5 |
Only first 10 rows of 32 are shown.
sm_reservoir_2010
Reservoir |
---|
0.0796066 |
0.0796066 |
0.0243277 |
0.158777 |
0 |
0 |
0 |
0.0891927 |
0 |
Only first 10 rows of 32 are shown.
sm_gamma_alpha
alpha_value |
---|
0.0652093 |
0.0652093 |
0.056 |
0.07445 |
0.05 |
0.05 |
0.05 |
0.0665 |
0.05 |
Only first 10 rows of 32 are shown.
sm_R0
R0_value |
---|
1.46175 |
1.46175 |
2.18968 |
1.26817 |
0 |
0 |
0 |
1.42196 |
0 |
Only first 10 rows of 32 are shown.
sh_reservoir_2010
Reservoir |
---|
1.87216 |
0 |
0 |
2.81222 |
0 |
0 |
0 |
0 |
0 |
Only first 10 rows of 32 are shown.
sh_gamma_alpha
alpha_value |
---|
0.107616 |
0.04664 |
0.0805 |
0.1377 |
0.08905 |
0.0698 |
0 |
0.0643 |
0.0793714 |
Only first 10 rows of 32 are shown.
sh_R0
R0_value |
---|
1.12956 |
1.1253 |
1.1248 |
1.14141 |
1.12577 |
1.12423 |
0 |
1.12421 |
1.12471 |
Only first 10 rows of 32 are shown.
Stunting
Name |
Description |
Type |
Value |
---|---|---|---|
prev_HAZ_distribution_age_0_5mo |
Distribution of HAZ among less than 6 months of age in 2015 (mean, standard deviation) |
List |
[-0.8482365, 1.416337] |
prev_HAZ_distribution_age_6_11mo |
Distribution of HAZ among 6 months and 1 year of age in 2015 (mean, standard deviation) |
List |
[-0.9940219, 1.504431] |
prev_HAZ_distribution_age_12_23mo |
Distribution of HAZ among 1 year olds in 2015 (mean, standard deviation) |
List |
[-1.522101, 1.431207] |
prev_HAZ_distribution_age_24_35mo |
Distribution of HAZ among 2 year olds in 2015 (mean, standard deviation) |
List |
[-1.669291, 1.343577] |
prev_HAZ_distribution_age_36_47mo |
Distribution of HAZ among 3 year olds in 2015 (mean, standard deviation) |
List |
[-1.797365, 1.212469] |
prev_HAZ_distribution_age_48_59mo |
Distribution of HAZ among 4 year olds in 2015 (mean, standard deviation) |
List |
[-1.620094, 1.11541] |
or_stunting_male |
Odds ratio of stunting if male gender |
Real |
1.38 |
or_stunting_preterm_and_AGA |
Odds ratio of stunting if born preterm and adequate for gestational age |
Real |
2.13 |
or_stunting_SGA_and_term |
Odds ratio of stunting if born term and small for geatational age |
Real |
2.36 |
or_stunting_SGA_and_preterm |
Odds ratio of stunting if born preterm and small for gestational age |
Real |
5.95 |
or_stunting_hhwealth_Q5 |
Odds ratio of stunting if household wealth is poorest Q5, ref group Q1 |
Real |
1.69 |
or_stunting_hhwealth_Q4 |
Odds ratio of stunting if household wealth is poorer Q4, ref group Q1 |
Real |
1.48 |
or_stunting_hhwealth_Q3 |
Odds ratio of stunting if household wealth is middle Q3, ref group Q1 |
Real |
1.4 |
or_stunting_hhwealth_Q2 |
Odds ratio of stunting if household wealth is richer Q2, ref group Q1 |
Real |
1.29 |
base_inc_rate_stunting_by_agegp |
Baseline incidence rate per year of stunting by age group (1-5, 6-11, 12-23, 24-35, 36-47, 48-59mo |
List |
[0.8, 0.8, 0.8, 0.8, 0.8, 0.8] |
rr_stunting_preterm_and_AGA |
Relative risk of stunting if born preterm and adequate for gestational age |
Real |
1.62 |
rr_stunting_SGA_and_term |
Relative risk of stunting if born term and small for gestational age |
Real |
1.65 |
rr_stunting_SGA_and_preterm |
Relative risk of stunting if born preterm and small for gestational age |
Real |
2.98 |
rr_stunting_prior_wasting |
Relative risk of stunting if prior wasting in the last 3 months |
Real |
1.93 |
rr_stunting_untreated_HIV |
Relative risk of stunting for untreated HIV+ |
Real |
1.5 |
rr_stunting_wealth_level |
Relative risk of stunting if wealth-level is greater than 1 compared 1 |
Real |
0.2 |
rr_stunting_no_exclusive_breastfeeding |
Relative risk of stunting for not exclusively breastfed babies < 6 months |
Real |
1.4 |
rr_stunting_no_continued_breastfeeding |
Relative risk of stunting for not continued breastfed infants 6-24 months |
Real |
1.3 |
rr_stunting_per_diarrhoeal_episode |
Relative risk of stunting for recent diarrhoea episode |
Real |
1.04 |
r_progression_severe_stunting_by_agegp |
Rates per year of progression to severe stunting by age group (1-5, 6-11, 12-23, 24-35, 36-47, 48-59mo |
List |
[0.8, 0.8, 0.8, 0.8, 0.8, 0.8] |
rr_progress_severe_stunting_if_prior_wasting |
Relative risk of severe stunting if previously wasted |
Real |
1.93 |
rr_progress_severe_stunting_untreated_HIV |
Relative risk of severe stunting for untreated HIV+ |
Real |
1.3 |
mean_years_to_1stdev_natural_improvement_in_stunting |
Mean time (in years) to a one standard deviation improvement in stunting without any treatment. |
Real |
1.840675229013975 |
effectiveness_of_complementary_feeding_education_in_stunting_reduction |
Probability of stunting being reduced by one standard deviation (category) by education about supplementary feeding (but not supplying supplementary feeding consmables). |
Real |
0.25 |
effectiveness_of_food_supplementation_in_stunting_reduction |
Probability of stunting being reduced by one standard deviation (category) by supplementary feeding. |
Real |
0.41 |
prob_stunting_diagnosed_at_generic_appt |
Probability of a stunted or severely stunted person being checked and correctly diagnosed |
Real |
0.01 |
SymptomManager
Name |
Description |
Type |
Value |
---|---|---|---|
generic_symptoms_spurious_occurrence |
probability and duration of spurious occureneces of generic symptoms |
Dataframe |
|
spurious_symptoms |
whether or not there will be the spontaneous occurrence of generic symptoms. NB. This is over-ridden if a module key-word argument is provided. |
Boolean |
True |
generic_symptoms_spurious_occurrence
name |
odds_ratio_health_seeking_in_children |
odds_ratio_health_seeking_in_adults |
prob_spurious_occurrence_in_children_per_day |
prob_spurious_occurrence_in_adults_per_day |
duration_in_days_of_spurious_occurrence_in_children |
duration_in_days_of_spurious_occurrence_in_adults |
prob_seeks_emergency_appt_in_adults |
prob_seeks_emergency_appt_in_children |
---|---|---|---|---|---|---|---|---|
vomiting |
1.31 |
0.48 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
stomachache |
0.7 |
0.48 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
sore_throat |
1.07 |
0.58 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
respiratory_symptoms |
0.55 |
0.48 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
headache |
0.39 |
0.28 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
skin_complaint |
2.82 |
0.76 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
dental_complaint |
0.39 |
0.92 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
backache |
1 |
0.56 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
injury |
0.55 |
0.68 |
0.001 |
0.001 |
7 |
4 |
0 |
0 |
Only first 10 rows of 13 are shown.
Tb
Name |
Description |
Type |
Value |
---|---|---|---|
prop_mdr2010 |
Proportion of active tb cases with multidrug resistance in 2010 |
Real |
0.0186 |
followup_times |
times(weeks) tb treatment monitoring required after tx start |
Dataframe |
|
tb_high_risk_distr |
list of ten high-risk districts |
Dataframe |
|
ipt_coverage |
national estimates of coverage of IPT in PLHIV and paediatric contacts |
Dataframe |
|
rr_tb_child |
relative risk of tb infection if under 16 years of age |
Real |
0.1 |
monthly_prob_relapse_tx_complete |
monthly probability of relapse once treatment complete |
Real |
0.0027 |
monthly_prob_relapse_tx_incomplete |
monthly probability of relapse if treatment incomplete |
Real |
0.0116 |
monthly_prob_relapse_2yrs |
monthly probability of relapse 2 years after treatment complete |
Real |
0.0001 |
rr_relapse_hiv |
relative risk of relapse for HIV-positive people |
Real |
4.7 |
rr_relapse_diabetes |
relative risk of relapse for people with diabetes (treated/untreated) |
Real |
1.86 |
scaling_factor_WHO |
scaling factor applied to WHO estimates to account for the impact of interventions in place |
Real |
1.60303 |
duration_active_disease_years |
duration of active disease from onset to cure or death |
Real |
3.0 |
prop_smear_positive |
proportion of new active cases that will be smear-positive |
Real |
0.62 |
prop_smear_positive_hiv |
proportion of hiv+ active tb cases that will be smear-positive |
Real |
0.35 |
death_rate_smear_pos_untreated |
probability of death in smear-positive tb cases with untreated tb |
Real |
0.7 |
death_rate_smear_neg_untreated |
probability of death in smear-negative tb cases with untreated tb |
Real |
0.2 |
death_rate_child0_4_treated |
probability of death in child aged 0-4 years with treated tb |
Real |
0.05 |
death_rate_child5_14_treated |
probability of death in child aged 5-14 years with treated tb |
Real |
0.06 |
death_rate_adult_treated |
probability of death in adult aged >=15 years with treated tb |
Real |
0.107 |
rr_death_diabetes |
additional risk of death if person has diabetes (treated/untreated) |
Real |
1.51 |
rr_tb_bcg |
relative risk of progression to active disease for children with BCG vaccine |
Real |
0.42 |
rr_tb_hiv |
relative risk of progression to active disease for PLHIV |
Real |
5.0 |
rr_tb_aids |
relative risk of progression to active disease for PLHIV with AIDS |
Real |
26.0 |
rr_tb_art_adult |
relative risk of progression to active disease for adults with HIV on ART |
Real |
0.35 |
rr_tb_art_child |
relative risk of progression to active disease for adults with HIV on ART |
Real |
0.3 |
rr_tb_obese |
relative risk of progression to active disease if obese |
Real |
0.4 |
rr_tb_diabetes |
relative risk of progression to active disease with any type diabetes |
Real |
3.0 |
rr_tb_alcohol |
relative risk of progression to active disease with heavy alcohol use |
Real |
2.9 |
rr_tb_smoking |
relative risk of progression to active disease with smoking |
Real |
1.3 |
rr_ipt_adult |
relative risk of active TB with IPT in adults |
Real |
0.4 |
rr_ipt_child |
relative risk of active TB with IPT in children |
Real |
0.55 |
rr_ipt_adult_hiv |
relative risk of active TB with IPT in adults with hiv |
Real |
0.68 |
rr_ipt_child_hiv |
relative risk of active TB with IPT in children with hiv |
Real |
0.31 |
rr_ipt_art_adult |
relative risk of active TB with IPT and ART in adults |
Real |
0.63 |
rr_ipt_art_child |
relative risk of active TB with IPT and ART in children |
Real |
0.76 |
sens_xpert_smear_negative |
sensitivity of Xpert test in smear negative TB cases |
Real |
0.68 |
sens_xpert_smear_positive |
sensitivity of Xpert test in smear positive TB cases |
Real |
0.98 |
spec_xpert_smear_negative |
specificity of Xpert test in smear negative TB cases |
Real |
0.99 |
spec_xpert_smear_positive |
specificity of Xpert test in smear positive TB cases |
Real |
0.99 |
sens_sputum_smear_positive |
sensitivity of sputum smear microscopy in sputum positive cases |
Real |
1.0 |
spec_sputum_smear_positive |
specificity of sputum smear microscopy in sputum positive cases |
Real |
1.0 |
sens_clinical |
sensitivity of clinical diagnosis in detecting active TB |
Real |
0.209 |
spec_clinical |
specificity of clinical diagnosis in detecting TB |
Real |
0.953 |
sens_xray_smear_negative |
sensitivity of x-ray diagnosis in smear negative TB cases |
Real |
0.8 |
sens_xray_smear_positive |
sensitivity of x-ray diagnosis in smear positive TB cases |
Real |
0.91 |
spec_xray_smear_negative |
specificity of x-ray diagnosis in smear negative TB cases |
Real |
0.67 |
spec_xray_smear_positive |
specificity of x-ray diagnosis in smear positive TB cases |
Real |
0.67 |
prob_tx_success_ds |
Probability of treatment success for new and relapse TB cases |
Real |
0.837 |
prob_tx_success_mdr |
Probability of treatment success for MDR-TB cases |
Real |
0.597 |
prob_tx_success_0_4 |
Probability of treatment success for children aged 0-4 years |
Real |
0.94 |
prob_tx_success_5_14 |
Probability of treatment success for children aged 5-14 years |
Real |
0.92 |
rate_testing_general_pop |
rate of screening / testing per month in general population |
Real |
0.025 |
rate_testing_active_tb |
rate of screening / testing per month in population with active tb |
Dataframe |
|
ds_treatment_length |
length of treatment for drug-susceptible tb (first case) in months |
Real |
6.0 |
ds_retreatment_length |
length of treatment for drug-susceptible tb (secondary case) in months |
Real |
8.0 |
mdr_treatment_length |
length of treatment for mdr-tb in months |
Real |
24.0 |
prob_retained_ipt_6_months |
probability of being retained on IPT every 6 months if still eligible |
Real |
0.9 |
age_eligibility_for_ipt |
eligibility criteria (years of age) for IPT given to contacts of TB cases |
Real |
5.0 |
ipt_start_date |
year from which IPT is available for paediatric contacts of diagnosed active TB cases |
Integer |
2014 |
first_line_test |
name of first test to be used for TB diagnosis |
String |
sputum |
second_line_test |
name of second test to be used for TB diagnosis |
String |
xpert |
tb_healthseekingbehaviour_cap |
number of repeat visits assumed for healthcare services |
Integer |
5 |
data_end |
last year for which data are available |
Integer |
2022 |
length_of_inpatient_stay_if_terminal |
length of inpatient stay for end-of-life TB patients |
List |
[5, 10] |
type_of_scaleup |
argument to determine type scale-up of program which will be implemented, can be ‘none’, ‘target’ or ‘max’ |
String |
none |
scaleup_start_year |
the year when the scale-up starts (it will occur on 1st January of that year) |
Integer |
2025 |
scaleup_parameters |
the parameters and values changed in scenario analysis |
Dataframe |
followup_times
ds_sputum |
ds_clinical_monitor |
ds_retreatment_sputum |
ds_retreatment_clinical |
mdr_sputum |
mdr_clinical_monitor |
shine_sputum |
shine_clinical_monitor |
---|---|---|---|---|---|---|---|
5 |
2 |
5 |
2 |
5 |
2 |
4 |
2 |
6 |
3 |
8 |
3 |
6 |
3 |
nan |
3 |
nan |
4 |
nan |
4 |
8 |
4 |
nan |
4 |
nan |
5 |
nan |
5 |
10 |
5 |
nan |
nan |
nan |
6 |
nan |
6 |
12 |
6 |
nan |
nan |
nan |
nan |
nan |
7 |
14 |
7 |
nan |
nan |
nan |
nan |
nan |
8 |
16 |
8 |
nan |
nan |
nan |
nan |
nan |
nan |
18 |
9 |
nan |
nan |
nan |
nan |
nan |
nan |
20 |
10 |
nan |
nan |
Only first 10 rows of 24 are shown.
tb_high_risk_distr
district_name |
---|
Blantyre |
Blantyre City |
Chikwawa |
Chiradzulu |
Chitipa |
Dedza |
Dowa |
Karonga |
Kasungu |
Only first 10 rows of 32 are shown.
ipt_coverage
year |
coverage_plhiv |
source |
coverage_paediatric |
source2 |
---|---|---|---|---|
2011 |
0 |
not_implemented |
0 |
nan |
2012 |
0 |
not_implemented |
0 |
nan |
2013 |
0 |
not_implemented |
0 |
nan |
2014 |
0 |
not_implemented |
35 |
NTP2019 |
2015 |
0 |
not_implemented |
42 |
NTP2019 |
2016 |
0 |
not_implemented |
51 |
NTP2019 |
2017 |
0 |
not_implemented |
61 |
NTP2019 |
2018 |
0.31 |
MoH_quart_repQ1 |
57 |
NTP2019 |
2019 |
0.3 |
MoH_quart_repQ2 |
57 |
NTP2020 |
Only first 10 rows of 41 are shown.
rate_testing_active_tb
year |
case_notification_rate_per_100k |
treatment_coverage |
treatment_success_rates |
death_rate |
percent_hiv_positive |
number_notified_mdr_cases |
percent_mdr_treatment_success |
percent_death_mdr_cases |
coverage_ipt_paediatric_contacts |
---|---|---|---|---|---|---|---|---|---|
2011 |
nan |
46 |
82.7 |
10.7 |
nan |
nan |
nan |
nan |
nan |
2012 |
138 |
51 |
81.8 |
10.7 |
nan |
27 |
63.2 |
31.6 |
nan |
2013 |
126 |
48 |
83.3 |
9.8 |
nan |
91 |
52.6 |
36.8 |
nan |
2014 |
112 |
46 |
85 |
8.9 |
nan |
106 |
58.6 |
34 |
35 |
2015 |
105 |
46 |
81.6 |
10.6 |
42.6 |
107 |
60.9 |
32.8 |
42 |
2016 |
101 |
47 |
82.1 |
10.3 |
38.8 |
66 |
58.6 |
29.3 |
51 |
2017 |
95 |
50 |
86 |
9.7 |
39.1 |
85 |
55 |
35 |
61 |
2018 |
88 |
48 |
87.2 |
8.6 |
38.5 |
126 |
68.8 |
17 |
57 |
2019 |
92 |
51 |
87.6 |
8.2 |
35.5 |
104 |
73 |
16 |
57 |
Only first 10 rows of 12 are shown.
scaleup_parameters
parameter |
target_value |
min_value |
max_value |
---|---|---|---|
tb_treatment_coverage |
90 |
0 |
100 |
tb_prob_tx_success_ds |
0.9 |
0 |
1 |
tb_prob_tx_success_mdr |
0.9 |
0 |
1 |
tb_prob_tx_success_0_4 |
0.9 |
0 |
1 |
tb_prob_tx_success_5_14 |
0.9 |
0 |
1 |
first_line_test |
xpert |
sputum |
xpert |
second_line_test |
sputum |
sputum |
xpert |
ipt_coverage_plhiv |
0.9 |
0 |
1 |
ipt_coverage_paediatric |
90 |
0 |
100 |